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Abstract 
Background 
With the increase in human immunodeficiency virus (HIV) and non-communicable diseases 
in low to middle-income countries, the rise in HIV-related stroke incidences is becoming a 
concern. The sub-Saharan region is where the majority of the global HIV population reside. 
This places an even greater burden on an already strained healthcare system and economy, 
as HIV-infected people may have an increased chance of stroke and tend to be significantly 
younger than the conventional stroke population. With the physical and cognitive deficits 
that may occur due to HIV infection, along with the neurological deficits caused by stroke, 
this young population now becomes more dependent, increasing the number of 
unproductive members of society. Hence, it is important to know whether the combination 
of stroke and HIV further impairs the function of these individuals. Previous studies 
assessing the function of HIV-infected patients post stroke focused on mortality rather than 
the morbidity of HIV+ stroke patients. Furthermore, the outcomes measures used to assess 
their function were global and not specific enough to describe function adequately. 
Aim 
The primary aim of this thesis is to describe the functional outcomes of HIV positive, HIV 
negative and HIV undiagnosed patients post stroke following inpatient rehabilitation using 
various outcome measures. Secondary aims include describing demographics, risk factors, 
length of stay and patient perception. 
Setting 
The Western Cape Rehabilitation Centre (WCRC), situated in Cape Town, South Africa.  
Study design 
A prospective descriptive cohort study. 
Methods 
Approval for conducting the study was obtained from the Committee of Human Research 
(HREC) at Stellenbosch University (S15/10/232). From July to December 2016, patients 
who were admitted to the WCRC post stroke were recruited for the study. Written informed 
consent was obtained from all eligible participants. Data were collected on admission and 
just prior to discharge, using the Modified Rankin Scale for stroke severity; the Barthel Index 
and use of assistive devices to assess function in activities of daily living, level of 
independence and mobility; the Berg Balance Scale and MatScan (pressure mapping) to 
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assess balance. Data on HIV and immune status, demographics, risk factors and length of 
stay were also collected. The EQ5D was used to assess participant’s perception of health 
related quality of life. All data were entered into an Excel spreadsheet, coded and analysed. 
Continuous data including mRS, BI, BBS and pressure mapping were summarised using 
median and range. Categorical data were represented as proportions and graphically 
displayed using a histogram. Statistical analysis was performed using STATA version 14.2 
(Statacorp, 2015).  Association between categorical variables was assessed using the chi-
squared or Fisher’s exact test. Differences in distribution of continuous variables over 
different levels of a categorical variable were evaluated using the Kruskal-Wallis test, and 
where differences were detected, the Dunn’s test was used for pairwise comparisons. 
Relationships between patient characteristics and pain and anxiety were evaluated using 
ordinal logistic regression. The Kaplan-Meier curve was used to describe the length of stay. 
Statistical significance was assessed at 5%. 
Results 
Out of 54 potential participants, 49 met the inclusion criteria and were recruited; 9 HIV 
positive (+), 17 HIV negative (-) and 23 HIV undiagnosed participants. The study sample 
had 51.02% (n = 25) females and 48.98% (n = 24) males. The majority of the sample were 
mixed race (53.06%, n = 34), 34.69% (n = 17) were of black ethnicity, 10.20% (n = 5) were 
white and 2.04% (n = 1) were Indian. A significant difference was found with regard to age. 
The median age for the HIV+ groups was 30 years, and 50 and 51 years for the other groups, 
respectively (p = 0.0046). The more common risk factors for the HIV- and undiagnosed 
groups were hypertension and diabetes (p = 0.001 and p = 0.042) respectively. Substance 
abuse (p = 0.038) and opportunistic infections (p = 0.005) were more prevalent in the HIV+ 
group. The median CD4 count was 130 (54-883).  
All groups showed significant improvements in all functional outcome assessments. The 
HIV+ group had a higher percentage of participants who scored in the higher percentiles for 
each functional outcome, but no significant results were seen among groups with regard to 
change in score in stroke severity (mRS p = 0.748), ADLs, independence and mobility (BI p 
= 0.886; use of assistive devices p = 0. 722) balance and risk of falling (BBS p = 0.4170 and 
MatScan results). The HIV+ group scored themselves lower than the other groups on the 
EQ5D VAS scale. This may have been attributed to their age as they were younger and 
possibly more functionally abled than their older counterparts, but no significant differences 
were seen among groups (EQ5D p = 0.805). The HIV+ group had a median length of stay 
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of 45 days, while the HIV- and undiagnosed groups stayed for 55 and 53 days respectively. 
This difference was not statistically significant (p = 0.0671). 
Conclusion 
Even though the HIV+ group was significantly younger and had fewer risk factors, no 
statistical significant differences were seen with regard to functional outcome. Functional 
outcome could be affected by a number of variables. In this sample, HIV status did not seem 
to affect functional outcome negatively. Larger cohorts are required for more generalisable 
results, to give a better understanding of the functional outcomes of HIV+ stroke patients. 
 
Key words 
Stroke, HIV, functional outcome. 
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Opsomming 
 
Agtergrond 
Met die toename in menslike immuniteitsgebreks virus (MIV) en nie-oordraagbare siektes in 
lae tot middelinkomste lande, word die styging in MIV-verwante beroertes kommerwekkend. 
Die Sub-Sahara-streek is waar die meerderheid van die wêreldwye MIV-bevolking woon. Dit 
plaas 'n groter las op 'n reeds belaste gesondheidsorgstelsel en ekonomie aangesien MIV-
geïnfekteerde mense 'n groter kans op beroerte kan hê en geneig is om aansienlik jonger 
te wees as die konvensionele beroerte populasie. Met die fisiese en kognitiewe probleme 
wat mag voorkom as gevolg van MIV-infeksie, saam met die neurologiese disfunksie wat 
veroorsaak word deur beroerte, word hierdie jong bevolking nou meer afhanklike en 
onproduktiewe lede van die samelewing. Daarom is dit belangrik om te weet of die 
kombinasie van beroerte en MIV verder die funksie van hierdie individue benadeel. Vorige 
studies wat die funksie van MIV-geïnfekteerde pasiënte na beroerte beskryf, fokus op 
mortaliteit eerder as die morbiditeit van MIV-positiewe  beroerte pasiënte. Meer so, die meet 
instrumente wat gebruik word om funksie te assesseer was globaal en nie spesifiek genoeg 
om die funksionele probleme in detail te beskryf nie.  
Doel 
Om die funksionele uitkomste van MIV-positiewe, MIV-negatiewe en MIV-ondiagnoseerde 
pasiënte, post beroerte, na binne-pasiënt rehabilitasie met behulp van verskeie meet 
instrumente te beskryf. Sekondêre doelwitte sluit in die beskrywing van demografie, 
risikofaktore, lengte van verblyf en pasiënt persepsie. 
Omgewing 
Wes-Kaapse Rehabilitasiesentrum (WKRS), geleë in Kaapstad, Suid-Afrika. 
Studieontwerp 
'n Voornemende beskrywende kohortstudie. 
Metodes 
Goedkeuring vir die uitvoering van die studie is verkry by die Komitee vir Menslike Navorsing 
van Stellenbosch Universiteit (S15/10/232). Van Julie tot Desember 2016 is pasiënte, post 
beroerte, wat tot WKRS toegelaat is, gewerf vir die studie. Skriftelike ingeligte toestemming 
is verkry van alle kwalifiserende deelnemers. Data is ingesamel by toelating en net voor 
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ontslag, met behulp van die Modified Rankin Scale om die erns van beroerte te bepaal; die 
Barthel-indeks en die gebruik van hulpmiddels om funksies in die daaglikse lewe, vlak van 
onafhanklikheid en mobiliteit te assesseer; die Berg Balance Scale en MatScan (druk 
metings) om balans te evalueer. MIV en immuunstatus, demografie, risikofaktore en lengte 
van verblyf is ook ingesamel. Die EQ5D is gebruik om pasiënt persepsie van hoe hulle 
gesondheid hulle kwaliteit van hulle lewe beïnvloed te beskryf. Alle data is in 'n Excel-sigblad 
ingevoer, gekodeer en ontleed. Opeenvolgende data, insluitend mRS, BI, BBS en MatScan 
(druk metings), is opgesom met behulp van mediane en omvang. Kategoriese data is as 
proporsies voorgestel en grafies vertoon met behulp van histogramme. Statistiese analise 
is uitgevoer met behulp van STATA weergawe 14.2 (Statacorp, 2015). Die assosiasie 
tussen kategoriese veranderlikes is geassesseer met behulp van die chi-kwadraat toets of 
Fisher’s exact test. Verspreiding van deurlopende veranderlikes oor verskillende vlakke van 
kategoriese veranderlikes is geëvalueer met behulp van die Kruskal-Wallis toets, en waar 
die verskille opgespoor is, is die Dunn toets vir tweerigtingvergelykings gebruik. 
Verhoudings tussen die volgende pasiënt eienskappe naamlik pyn en angs is geëvalueer 
met behulp van ordinale logistieke regressie. Die Kaplan-Meier-kurwe is gebruik om die 
lengte van die verblyf te beskryf. Statistiese betekenisvolheid is geassesseer teen 5%. 
Resultate 
Uit 54 potensiële deelnemers het 49 aan die insluitingskriteria voldoen en is gewerf, naamlik 
9 MIV-positiewe (+), 17 MIV-negatiewe (-) en 23 MIV-ondiagnoseerde deelnemers. Die 
studie het 51,2% (n = 25) vroue en 48,98% (n = 24) mans ingesluit. Meerderheid van die 
deelnemers was van gemengde ras (53.06%, n = 34), 34.69% (n = 17) was swart, 10.20% 
(n = 5) was wit en 2,04% (n = 1) was Indiër. 'n Beduidende verskil is gevind met betrekking 
tot ouderdom. Die mediane ouderdom vir die MIV + groepe was 30 jaar en 50 en 51 jaar vir 
die ander groepe onderskeidelik (p = 0.0046). Die algemene risikofaktore vir die MIV- en 
ondiagnoseerde groepe was onderskeidelik hipertensie en diabetes (p = 0.001 en p = 
0.042). Middelmisbruik (p = 0.038) en opportunistiese infeksies (p = 0.005) was meer 
algemeen in die MIV +. Die mediaan CD4 telling was 130 (54-883). 
Alle groepe het beduidende verbeterings in alle funksionele uitkomsmetings getoon. Die 
MIV+ groep het 'n hoër persentasie deelnemers gehad wat vir elke funksionele uitkoms in 
die hoër persentiele behaal het, maar daar was geen beduidende resultate tussen groepe 
met betrekking tot verandering in telling in erns van beroerte nie (mRS p = 0.748), ADL's, 
onafhanklikheid en mobiliteit (BI: p = 0.886; gebruik van hulpmiddels: p = 0.722) balans en 
risiko van val (BBS p = 0.4170 en MatScan resultate). Die MIV + groep het hulself laer ge-
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evalueer as die ander groepe op die EQ5D VAS-skaal. Dit kan toegeskryf word aan hul 
ouderdom aangesien hulle jonger was en moontlik meer funksioneel as hul ouer eweknieë, 
maar geen beduidende verskille is tussen groepe (EQ5D p = 0,805) gevind nie. Die MIV + 
groep het 'n mediane hospitalisasie van 45 dae gehad, terwyl die MIV- en ondiagnoseerde 
groepe onderskeidelik 55 en 53 dae gehospitaliseer was. Hierdie verskil was nie statisties 
betekenisvol nie (p = 0.0671). 
Samevatting 
Alhoewel die MIV + groep aansienlik jonger was en minder risikofaktore gehad het, is daar 
geen statisties beduidende verskille met betrekking tot funksionele uitkomste gesien nie. 
Funksionele uitkomste kan beïnvloed word deur 'n aantal veranderlikes. In hierdie 
steekproef het MIV-status nie die funksionele uitkomste negatief beïnvloed nie. Groter 
kohorte word benodig vir meer veralgemeende resultate om 'n beter begrip van die 
funksionele uitkomste van MIV+ beroerte pasiënte te gee. 
 
Sleutelwoorde 
Beroerte, MIV, funksionele uitkoms. 
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Chapter 1:  Background and Rationale 
 
Human immunodeficiency virus (HIV) related stroke has become an increasingly concerning 
issue as incidence of stroke is higher in regions with a high HIV prevalence (Zimba, Ntanda, 
Lakhi & Atadzhanov, 2017; Benjamin, Bryer, Emstey, Khoo, Solomin, & Conner, 2012). 
Internationally, the incidence of stroke and HIV infection have risen, particularly in low to 
middle-income countries (UNAID, 2016; Feigin, Forouzanter, Krishnamurthi… & Murray, 
2014). With approximately 52% of the global population residing in sub-Saharan Africa, 
there is a disproportionately high HIV-infected population (UNAIDS, 2016).  
HIV infection and HIV treatment can result in vascular damage adding to the already high 
rates of conventional vascular risk factors (i.e. aging, hypertension, diabetes, hyper-
cholesterolaemia and smoking) which increase the incidence of stroke (Benjamin et al., 
2012). Other than vascular changes, HIV positive (+) individuals may suffer from a range of 
neurological disorders. HIV infects, destroys and impairs cells of the immune system (i.e. 
macrophages and CD4 cells), making the infected person more susceptible to further 
infections (WHO, 2015). Macrophages and CD4 cells which play an important part in the 
central nervous system (CNS) are infected through the bloodstream (Ellis, Calero & Stockin, 
2009). Patients often discover they are HIV+ once a stroke has occured and this arises due 
to CNS infections that occur in 10% to 20% of HIV+ patients (Ellis et al, 2009; Mochan, Modi 
& Modi, 2003). 
The rise in HIV-related stroke, particularly in low to middle-income countries, is of great 
concern as it intensifies the burden of disease on an already strained healthcare system and 
economy (Zimba et al., 2017; Mochan et al., 2003). Furthermore, it is concerning that those 
suffering from HIV-related strokes are significantly younger than the conventional stroke 
population (Heikinheimo, Chimbayo, Kumwenda, Kampodeni & Allain, 2012; Mlay & Bakari, 
2010; Tipping, de Villiers, Wainwright, Candy & Bryer, 2007). This may be a greater burden 
in sub-Saharan Africa as 34% of patients are aged between 15 and 24 years, whereas 
globally 22% of the HIV+ population are aged between 15 and 24 (UNAIDS, 2016). Studies 
show that 40% to 66% of stroke survivors still require assistance with activities of daily living 
(ADL) and mobility (Verma, Arya, Sharma & Garg, 2012; Connor, Thorogoog, Casserly, 
Dobson & Warlow, 2004). The inability to perform ADL impairs workability and the ability to 
be a functional member of society, putting further strain on the sub-Saharan economy 
(Mochan et al., 2003). 
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HIV in itself can negatively affect an infected person’s physical and cognitive well-being 
(Moore, Letendre, Morris… & Grant, 2011; Woods, Moore, Weber & Grant, 2009; Dudgeon, 
Phillips, Carson, Sarson, Brewer, Durbstein & Hand, 2006). The added neurological 
impairments caused by conditions such as stroke may lead to these patients being more 
dependent and unable to be productive members of society (Mochan et al., 2003). More 
importantly, the quality of life of these individuals decreases drastically with these 
compounding conditions (Rouillard, de Weerdt, De Wit & Jelsma, 2012; Hughes, Jelsma, 
Maclean, Darder & Tinise, 2004).  
Rehabilitation post stroke is aimed at improving quality of life by enhancing physical and 
cognitive well-being (Kitzman, Hudson, Sylvia, Feltner & Lovins, 2017; Langhorne, 
Bernhardt & Kwakkel, 2011). It is aimed at attaining the highest level of functional 
independence so that the patients may be reintegrated into their communities (Kitzman et 
al., 2017; Langhorne et al., 2011). Functional outcomes may differ between conventional 
and HIV+stroke patients due to demographic differences between groups as well as risk 
factors and disease manifestations (Heikinheimo et al., 2012; Tipping et al., 2007; 
Kumwenda, Mateyu, Kampondeni, van Dam, van Lieshout & Zijlstra, 2005). It is postulated 
therefore that the management of these groups would also differ.  
Little is known about the functional outcomes of HIV+ stroke individuals living in sub-
Saharan Africa. Hence, the current study is aimed at describing the differences in functional 
outcomes of stroke patients in terms of their HIV status. To understand this better, Chapter 
two, the literature review and scoping review, discusses the findings and limitations of 
current literature as they pertain to functional outcomes of stroke patients in sub-Saharan 
Africa according to their HIV status. Chapter three elaborates on the aims and objectives 
and the methods used to implement and conduct the study based on the limitations found 
in current literature. Chapter four describes the results obtained from the current study and 
Chapter five further discusses the findings and their relation to literature. Chapter six 
concludes the findings of the current study, identifies its limitations and presents 
recommendations for future research. 
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Chapter 2:  Literature Review 
 
2.1 Introduction 
Stroke as an HIV-related manifestation is an increasingly recognised and evolving issue, 
but it is poorly characterised due to the fact that most HIV/AIDS patients presenting with 
a stroke are likely to have underlying central nervous system infection or tumours that are 
responsible for their symptoms (Modi, Modi & Mochan, 2008). Given that these patients 
are considerably younger than stroke patients who are HIV negative (HIV-), the aetiology 
or cause of stroke may be different and the diagnosis of stroke initially may be seen as 
unlikely (Modi et al., 2008). This literature review focuses on the relationship between HIV 
and stroke as well as the functional outcomes of the HIV+ group. 
The aim of this literature review is to understand the relationship between stroke and HIV 
and to review the current literature on the functional outcome of HIV+ patients who have 
suffered a stroke.  
This review describes HIV and stroke as separate entities, particularly their effects on 
patient function in terms of morbidity and mortality. A scoping review was also conducted 
to describe the causal relationship between HIV and stroke, showing the demographics 
and risk factors of these patients in Southern Africa, and reviewing the current literature 
describing the functional outcomes of HIV+ stroke patients. 
 
2.2 A General Overview of HIV, Stroke and HIV Positive Stroke Patients 
HIV is a group of retroviruses in which clinical symptoms take years to develop and 
patients are diagnosed only in the late stages of HIV or advanced AIDS (Senocak, Oguz, 
Ozgen, Ozgen, Kurne, Ozkaya, Unal & Cilia, 2010). The virus infiltrates the blood stream 
by infecting the CD4+ cells that are immune cells (Ellis et al., 2009). The virus reproduces 
quickly and infects the macrophages that also assist with the body’s immunity. 
Macrophages play a vital part in the central nervous system (Ellis et al., 2009). They play 
an imperative part in the innate and adaptive immune response as they phagocytose 
pathogens and cellular debris. Macrophages also act as antigen presenting cells, 
triggering antibody responses when pathogen derived peptides are detected through the 
MHC-11 pathway to CD4 T cells and activating CD8 cytotoxic T cells by cross-
presentation of HIV-1 antigens (Murray & Wynn, 2011; Ackerman & Cresswell, 2004). 
The CNS infections or abnormalities appear in 10% to 20% of HIV-infected patients (Ellis 
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et al., 2009; Mochan et al., 2003). Until these neurological manifestations, including 
stroke, arise many patients are not aware that they are HIV-infected. 
The African continent is said to have a disproportionately high HIV-infected population. 
The global estimate of people living with HIV was 36.7 million for the year 2015, 19 million 
(approximately 52%) of whom reside in Eastern and Southern Africa (UNAIDS, 2016). 
Approximately seven million cases of HIV in South Africa were reported in 2015 (UNAIDS, 
2016). The global mortality rate of AIDS related deaths in 2015 was 1.1 million; 470,000 
of reported cases were from Eastern and Southern Africa (UNAIDS, 2016).  
The HIV infected population is prone to chronic diarrhoea and weakness as well as a high 
prevalence of gastrointestinal disorders, leading to one of the most distinctive signs of 
HIV infection, known as the wasting syndrome (Dudgeon et al., 2006). This syndrome is 
defined as an involuntary weight loss of more than 10% of the baseline body weight 
(Dudgeon et al., 2006). This results in impaired functional ability and severe fatigue 
(Dudgeon et al., 2006). Robinson-Papp, Byrd, Mindt, Oden, Simpson & Morgello (2008) 
report that there is a high prevalence of cognitive, behavioural and motor impairments in 
HIV-infected people. These impairments include loss of concentration, distractibility, 
unsteady gait, balance disturbances, dementia and sensory neuropathies (Moore et al., 
2011; Woods et al., 2009). Physical deficits, with the added effect of neurological 
impairments, put a great strain on the ability of an HIV-infected individual to perform 
activities of daily living (ADL). Being dependent on basic ADLs impacts their ability to 
work and be functioning members of society. This puts a major burden on the sub-
Saharan economy (Mochan et al., 2003). 
The World Health Organization (WHO) describes stroke as a “rapidly developing clinical 
sign of focal, or at times/global disturbance of cerebral function, lasting more than 24 
hours or leading to death with no apparent cause other than vascular origin” (WHO, 
2002:108).  
Cardiovascular diseases including stroke are predicted to exceed infectious diseases in 
their cause of morbidity and mortality in sub-Saharan Africa by the year 2020 (Yusuf, 
Hawken, Oupuu, Dans… & Linsheng, 2004). Due to the high mortality rates and health 
systems being under-resourced, stroke and non-communicable diseases are some of the 
main priorities in public healthcare in Africa (Chin, 2012). Globally, cardiovascular disease 
kills more people than tuberculosis, HIV and malaria combined. In South Africa during 
2001, stroke was the fourth leading natural cause of mortality (Modi, Modi, Mochan, 
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2006). In the 2014 annual report by the Heart and Stroke Foundation South Africa, 
cardiovascular diseases, including stroke, are second only to HIV/AIDS in mortality rate. 
This report also stated that per day +240 people suffer a stroke and 60 of those strokes 
will be fatal.     
The burden of stroke is on the rise in many low and middle-income countries (LMIC), 
particularly sub-Saharan Africa (Feigin et al., 2014). This has been attributed to the 
increase in cardiovascular disease modifiable risk factors namely, hypertension, 
diabetes, obesity, and high levels of cholesterol (Heart and Stroke Foundation South 
Africa, 2015; Hoshino, Mizuno, Shimizu & Uchiyama, 2013). According to the 2014 annual 
report by The Heart and Stroke Foundation South Africa, one in three adults over the age 
of 15 years has hypertension and 49% of women and 74% of men are unaware that they 
are hypertensive. This report also states that there is a 10% prevalence of diabetes in the 
entire population and nearly one in four people have increased levels of cholesterol. 
Additionally, obesity is prevalent in two in three women, one in three men and a quarter 
of all children in South Africa. HIV itself is considered a risk factor for stroke due to the 
neurological and vascular manifestations infected patients are prone to (this will further 
be elaborated on in the scoping review). Ellis et al (2009) reports that up to 20% of HIV 
infected patients suffer various neurological conditions including stroke. 
People who suffer a stroke may suffer variable degrees of severity and symptoms of 
stroke depending on the area of the brain affected. Some of the common symptoms are: 
hemiparesis; hemisensory loss; hemineglect; dysphasia; dysarthria; ataxia; visual 
impairments; hearing impairments and vertigo (Markus, 2012). These impairments affect 
patient function and ultimately their ADL and quality of life. These impairments may be so 
severe that patients are no longer able to continue work or may need full-time care. Stroke 
with the added effects and impairment of HIV is thus of great concern for quality of life 
and is a heavy burden on the economy (Mochan et al., 2003). 
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2.3 Scoping Review on the Functional Outcomes of HIV PositiveStroke 
Patients 
 
2.3.1 Searching 
A search was conducted for relevant articles related to the functional outcomes of HIV+ 
stroke patients in sub-Saharan Africa during April 2015 by one researcher using the 
Stellenbosch University library website. The following databases were searched namely: 
Pubmed; Ebscohost; Scopus; Cochrane and PEDro.  
The search strings used are listed below. 
 HIV AND cerebrovascular infarction. 
 HIV AND cerebrovascular accident. 
 HIV AND cerebrovascular event. 
 HIV AND ischemic cerebrovascular events. 
 HIV AND intracerebral hemorrhage. 
 HIV AND hemorrhagic stroke. 
 Stroke AND HIV. 
 Stroke AND HIV AND outcomes. 
 Stroke AND HIV AND functional outcomes. 
 Stroke AND HIV AND prognosis. 
 Stroke AND HIV AND ICF. 
 
2.3.2 Study eligibility 
Inclusion criteria  
 Published between January 1995 and March 2015. 
 Conducted in sub-Saharan Africa.  
 Written in English. 
 HIV positive patients’ with first ever stroke.  
 Studies that looked at the association of HIV and stroke.  
 Studies reported on patients’ functional ability post stroke.  
Exclusion criteria  
Studies were excluded if they were not looking at adults and/or if they were 
pharmacological studies. 
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2.3.3 Study selection and data extraction 
One reviewer independently screened and evaluated the titles, abstracts and then full 
texts of all publications supplied by the search strategy for potentially relevant 
publications. Full texts were retrieved by accessing electronic journals, manually 
searching journals or by contacting the authors via e-mail. Any uncertainty regarding 
paper selection and data extraction was resolved by consensus and discussion with 
supervisors if needed. The same reviewer independently extracted all relevant data items 
from the included papers, using an electronic data extraction form. The data form was 
compiled by the researcher in consultation with supervisors to optimise data synthesis. 
2.3.4 Methods of analysis and synthesis 
Included papers were assessed for homogenous data, such as comparable patient 
populations and outcome measures. Due to the heterogeneity of the data, statistical 
pooling was not appropriate and the results were summarised in a narrative form. 
 
2.4 Results of the Scoping Review 
 
2.4.1 Publications 
The searches initially yielded 2,996 articles. Thereafter 1,772 duplicates were removed. 
Of the remaining articles, eleven were selected; seven South African studies (Modi et al., 
2008; Modi, Hari, Modi & Mochan, 2007; Tipping et al., 2007; Modi et al., 2006; Patel, 
Sacoor, Francis, Bill, Bhigjee & Connolly, 2005; Mochan et al.,2003; Hoffman, Berger, 
Nath & Rayens, 2000), two Malawian studies (Heikinheimo et al., 2012; Kumwenda et al., 
2005), one Tanzanian (Mlay & Bakari, 2010) and one Kenyan (Jowi, Mativo & Musoke, 
2007) study were included. 
2.4.2 Findings of scoping review 
The scoping review describes the manifestations of HIV+ stroke patients in terms of 
neurological and vascular factors, as well as the effect of antiretroviral treatment and its 
relationship with stroke in HIV+ individuals. Furthermore, the demographics, risk factors 
and functional outcomes of the HIV+ stroke population in sub-Saharan Africa are 
described, and whether or not methods and outcome measures used were appropriate in 
describing their functional outcome. 
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2.4.2.1 Neurological manifestations caused by HIV  
Mlay and Bakari (2010) reported that many studies seem to confirm HIV infection as a 
risk factor for stroke, but the underlying mechanism remains unclear. It has been said that 
the diagnosis of neurological manifestations is often delayed because in most instances 
the clinical presentation goes unnoticed, as they are subtle in the early stages of HIV 
(Jowi et al., 2007). It is thought that the CNS is one of the main sites for HIV infection 
(Peridsky, Stins, Way, Witte, Weinand, Kim, Bock, Gendelman & Fiala, 1997) and CNS 
infections happen as early as the first week of being infected (Albright, Soldon & 
Gonzalez-Scarano, 2003; Gartner & Liu, 2002). HIV is believed to enter the CNS via 
infected immune cells (CD4+ lymphocytes) or as a free virus, crossing one of the physical 
barriers that protect the CNS, namely the brain blood barrier and/or the cerebrospinal 
fluid (Albright et al., 2003). HIV being neurotropic, enters the glial cells via the surface 
and co-receptors (Albright et al., 2003; Gartner & Liu, 2002). The primary receptor is the 
CD4+ molecule and the co-receptors are CCR5 and CX CR4 (Jowi et al., 2007; Albright 
et al., 2003; Gartner & Liu, 2002). The primary receptors, along with other factors, 
increase the incidence of HIV/AIDS opportunistic infections (Li, Galey, Mattson & Nath, 
2005). These factors may also include CD4 count depletion, immune dysfunction, chronic 
hyper immune activation and neuronal damage (Li et al., 2005).  
There are two basic categories of HIV/AIDS neurological manifestations. The first 
category is primary HIV infection such as aseptic meningitis, HIV associated dementia, 
minor cognitive motor disorders, myelopathy, myopathy and peripheral neuropathy. The 
second category is opportunistic infections such as cryptococcal meningitis, encephalitis, 
tuberculosis (TB), CNS lymphoma, amongst others (Brew, Pemberton, Cunningham & 
Law, 1997). Another group of manifestations is the vasculitis phenomenon that is related 
to anti-thrombin and protein deficiency. These include ischemic stroke, intracranial 
hemorrhage, subdural haematoma, deep vein thrombosis and cerebral venous sinus 
thrombosis (Jowi & Musoke, 2004). 
2.4.2.2 Vascular manifestations caused by HIV  
Various HIV/AIDS neurological consequences have been shown to manifest according to 
CD4 count levels (Bartlett, 2002). The majority of severe complications, such as TB 
meningitis and HIV associated dementia complex, occur when CD4 cell count is below 
200 (Jowi et al., 2010). In a severe immune compromised state where the CD4 count is 
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below 100, complications such as cerebral toxoplasmosis and cryptococcal meningitis 
occur (Jowi et al., 2007; Bartlett, 2002). 
Patients with low CD4 counts usually have an increased risk of coronary event through 
atherosclerosis (Mlay & Bakari, 2010). Other studies suggest that HIV patients have 
increased systemic inflammation, making them susceptible to atherosclerosis 
(Stollberger & Finsterer, 2002). It is presumed that vascular damage induced HIV can 
result in coagulopathy by induced autoantibodies and protein deficiency (Mochan, Modi 
& Modi, 2005).  
These vascular manifestations often result in stroke (Mochan et al., 2005). MRI and CT 
scans are critical in not only diagnosing but also distinguishing any differences between 
the HIV+ strokes and HIV- strokes. The main clinical subtypes were cerebral infarctions 
and intracerebral hemorrhage, as seen in all eleven studies included in the scoping 
review. In most studies cerebral infarcts constituted the majority of strokes ranging from 
58% to 96% in the HIV+ population (Heinkinheimo et al., 2012; Tipping et al., 2007; Patel 
et al., 2005; Kumwenda et al., 2005; Modi et al., 2003). In these studies, no significant 
differences were reported between the HIV+ and HIV- groups with regard to the cerebral 
infarction. However, the majority of hemorrhagic strokes occurred in the HIV- group, 
possibly due to hypertension (Heinkinheimo et al., 2012; Tipping et al., 2007; Patel et al., 
2005). There was, however, a statistical significance between HIV+ and HIV- groups with 
regard to large vessel occlusion and other vasculopathic findings, with the HIV+ group 
having a significantly higher large vessel occlusion, as reported by two studies (Modi et 
al., 2008; Hoffmann et al., 2000). Thus, considering the degree to which HIV+ individuals 
are affected neurologically, it is clear that the severity of stroke and extent of damage 
impact greatly on patient prognosis and outcome. 
2.4.2.3 Antiretroviral (ARV) drugs 
The standard adult antiretroviral therapy (ART) consists of a combination of at least three 
ARV drugs. They are used to maximally suppress the HIV and stop the progression of 
the disease with suppressive ART regimes. There are also non-suppressive ART regimes 
to reduce mother to child transmission or for healthcare workers following a low risk 
occupational exposure which normally consist of prophylaxis (Meintjies, Black, 
Conradie… & Wilson., 2014).   
The main aims of ART are “to improve quality of life; reduce HIV-related morbidity and 
mortality, provide maximal and durable suppression of viral load (VL); restore and/or 
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preserve immune function.” (Meintjies et al., 2014:121, 1). These aims are attained by 
suppressing viral replication entirely for as long as possible, using well-tolerated and 
maintainable treatment taken with good adherence. With lengthy viral suppression, the 
CD4+ lymphocyte count generally increases, which is accompanied by a renewal of 
pathogen-specific immune function. For most patients this results in a significant 
decrease in the risk of HIV-associated morbidity and mortality. It is still uncertain whether 
immune function ever returns to complete normality. Long-term cohorts show that patients 
who adhere well to ART (refer to Table 2.1) have a near-normal life expectancy (Johnson, 
Mossong, Dorrington… & Boulle, 2013). 
 
Table 2.1:  Classes of ARV Agents 
Class  Abbreviation  Mechanism of action  Specific action  
Nucleoside and 
nucleotide reverse 
transcriptase 
inhibitors  
NRTIs and 
NtRTIs  
Reverse transcriptase 
inhibition  
Nucleic acid analogues mimic 
the normal building blocks of 
DNA, preventing transcription 
of viral RNA to DNA  
 
Non-nucleoside 
reverse 
transcriptase 
inhibitors  
NNRTIs  Reverse transcriptase 
inhibition  
Alter the conformation of the 
catalytic site of reverse 
transcriptase and directly 
inhibit its action  
 
Protease inhibitors  PIs  Protease inhibition  Inhibit the final maturation 
stages of HIV replication, 
resulting in the formation of 
non-infective viral particles  
 
Integrase inhibitors  
(also termed 
integrase strand 
transfer inhibitors) 
  
InSTIs  Inhibition of viral 
integration  
Prevent the transfer of 
proviral DNA strands into the 
host chromosomal DNA  
 
Entry inhibitors  -  Entry inhibition  Bind to viral gp41 or gp120 or 
host cell CD4+ or chemokine 
(CCR5) receptors  
 
ARV = antiretroviral; CCR5 = C-C chemokine receptor type 5. 
(Meintjies, Black, Conradie et al., 2014) 
 
The use of ARV therapy has been suggested to have an associated risk for 
cerebrovascular events including stroke via several metabolic complications that include 
hyperlipidemia, which is an established risk for cerebrovascular events (Brown, Cole, Li, 
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Kingsley, Palella, Riddler, Visscher, Margolick & Dobs, 2005). A review done by Modi et 
al. (2008) shows that evidence with respect to protease inhibitor ARVs can cause 
accelerated atherosclerosis with an increased risk of myocardial infarction. The 
observation of pathological and clinical studies is that stroke occurs in the advanced HIV 
infection but the role ARVs have in the causation of stroke remains controversial (Modi et 
al., 2008). The review by Modi et al. (2008) states that more case-control studies are 
needed to identify the atherogenicity in HIV patients on ARVs, as well as ARV naïve 
patients both with and without stroke. 
Most studies have focused on the association and mechanism which include ARVs that 
cause stroke in the HIV positive population with the majority of these patients being ARV 
naïve (Mlay & Bakari, 2010; Modi et al. 2008; Jowi et al., 2007; Kumwenda et al., 2005; 
Mochan et al., 2005). Therefore, a clear conclusion on whether or not ARVs result in 
stroke cannot be confirmed. 
2.4.2.4 Demographics of HIV+ stroke population in sub-Saharan Africa  
In order to get a better sense of the HIV status of populations in sub-Saharan Africa, it is 
necessary to review the demographics of these countries. Most studies included in this 
scoping review showed that the majority of people with HIV were female, although the 
male to female ratio was not statistically significant (Heikinheimo, 2012; Mlay & Bakari, 
2010; Tipping et al., 2007; Modi et al., 2007; Kumwenda et al., 2005; Patel et al., 2005; 
Mochan et al., 2003). 
Although stroke is more common in the elderly, 25% of strokes occur in young adults who 
are HIV+, thus it is considered a risk factor for stroke in the younger population (Hoffmann, 
2000). A common thread throughout was that HIV+ individuals with stroke were 
significantly younger than those without HIV (Heikinkeimo et al., 2012; Tipping et al., 
2007; Kumwenda et al., 2005; Hoffmann et al., 2000). Nine of the eleven included studies 
reported this difference (Heikinkeimo et al., 2012; Tipping et al., 2007; Kumwenda et al., 
2005; Hoffmann et al., 2000). 
The mean age of the HIV+ stroke patients was also similar throughout the eleven included 
studies. In a study conducted by Tipping et al. (2007) in Johannesburg, South Africa, 
6.16% of their stroke population was HIV+. Of the 6.16%, 91% were below 45 years of 
age and their mean age was 33.4 years, whereas the control group’s mean age was 64 
years. In a study conducted in Malawi (Kumwenda et al., 2005) where 48% of the sample 
population were HIV+, HIV+ patients had a mean age of 37.5 years, whereas HIV- 
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patients had a mean age of 58.6 years. This Malawian study also reported a bimodal 
pattern distribution with peaks at 21 to 30 years (with 74% of HIV patients) and more than 
60 years (with 8% of the HIV population) indicating that the majority of the HIV+ patients 
were younger (Kumwenda et al., 2005). In another Malawian study (Heikinheimo et al., 
2012), a similar difference was noted in the mean age of HIV+ participants being younger 
with a statistical significance of p<0.0001. A study conducted in Johannesburg, South 
Africa (Modi et al., 2006), discovered that 92% of HIV+ participants who had neurological 
manifestations were aged between 21 and 50 years; with a mean age of 37 years.  
Markus (2012) conducted a study looking at causes and clinical features of stroke in the 
HIV- population. He reported that there was a higher percentage of stroke patients who 
were of black ethnicity compared to those who were white in the United Kingdom and 
America. Both hemorrhagic and ischemic stroke were increased in the black population, 
which he related to an increase in hypertension. A study conducted in KwaZulu Natal, 
South Africa by Hoffmann et al. (2000) showed significant differences between races. 
This study compared not only HIV+ and HIV- participants, but white and black ethnicities 
as well. Their control groups consisted of white and black HIV- participants. A significant 
difference was noted, since the mean age for the total population of white patients was 
61 years, and the black population 41.5 years. Of a total of 1,298 stroke patients, 2.02% 
were HIV+, 96% of whom were black, the other percentage was Asian. The mean age for 
the black HIV+ group was 29.1 years while the control group of black HIV- patients was 
31 years. There was no significant difference between these two groups. With none of 
the white population being HIV+, the comparison between the race groups could not be 
made with regard to the effect of HIV and stroke and its relation to their age. However, 
this study reiterates what previous studies have reported i.e. that HIV+ patients have a 
significantly younger mean age, showing that HIV may be a risk factor for stroke 
(Hoffmann et al., 2000).  
It is important to note that these findings cannot be applied to the general population as 
none of these studies were epidemiological studies. Eight studies were hospital based, 
limited to one location (Heikinheimo et al., 2012; Mlay & Bakari, 2010; Jowi et al., 2007; 
Modi et al., 2007; Tipping et al., 2007; Patel et al., 2005; Kumwenda et al., 2005; Mochan 
et al., 2003); two of the studies excluded patients over 50 years of age (Tipping et al., 
2007; Patel et al., 2005). These led to selection biases or samples of convenience that 
were not representative of the entire population. The exclusion of people of a certain age 
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was also not reflective of the entire population, hence, a conclusion could not be drawn 
nor could study results be applied to their specific country or the sub-Saharan population. 
Epidemiological studies as well as large cohorts are needed to gather data that are more 
appropriate on the demographics of the HIV+ stroke population in sub-Saharan Africa. 
2.4.2.5. Risk factors for HIV associated stroke 
As pointed out before, HIV in itself may be a risk factor for stroke. Hoffmann et al. (2000) 
and Tipping et al. (2007) stated that the presentation of first stroke often coincided with 
the diagnosis of HIV in individuals who were unaware of their status. These authors 
suspected that these patients, being significantly younger, did not have the usual risk 
factors for stroke. Another study resulted in similar findings with young stroke patients 
being more likely to have HIV than the common risk factors such as hypertension, 
diabetes, excessive smoking and drinking (Heikinheimo et al., 2012). Seven of the eleven 
studies yielded similar results with thrombosis and opportunistic infections being the main 
causes of stroke in the HIV+ population (Jowi et al., 2007; Modi et al., 2007; Tipping et 
al., 2007; Kumwenda et al., 2005; Patel et al., 2005; Modi et al., 2003; Hoffmann, 2000). 
All included studies evaluated participants for associated risk factors; past medical history 
was taken into account, and laboratory investigations were undertaken. Blood analysis 
was conducted. The most frequently used blood analysis test in indicating HIV severity, 
was checking the CD4 count levels. Five studies had similar findings and showed that a 
CD4 count of less than 200 cells/mm³ was seen in most HIV+ stroke patients 
(Heikinheimo et al., 2012; Jowi et al., 2007; Modi et al., 2007; Tipping et al., 2007; Mlay 
& Bakari, 2010). This seems to support the assumption that suggests that stroke in HIV-
infected patients occurs in the late stages of HIV or in extremely immune-compromised 
patients (Mlay & Bakari, 2010; Modi et al., 2008; Modi et al., 2006). Mlay and Bakari 
(2010) stated that early detection of HIV is imperative as stroke may be a late 
manifestation of HIV infection. 
Another common investigation was cerebrospinal fluid via lumbar puncture (Kumwenda 
et al., 2005). In a study conducted by Mochan et al. (2003) 86.84% of HIV+ patients had 
lumbar punctures, 55% of which had abnormalities. Of these, 27.27% had meningitis, 
9.09% had isolated lymphocytes and 18.18% had isolated raised protein levels. In 
another study it was found that of 150 HIV+ patients, 59 underwent a lumbar puncture. 
Of these patients 67.8% had 0 to 5 white cells/mm³ and 45.76% of them presented with 
a stroke; 10.17% had infection and 11.86% had other diagnoses. Of the patients who had 
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6 to 100 white cells/mm³, 18.64% had a stroke, 1.7% had infection and 5.08% had other 
diagnoses, 6.78% of the patients had white cells more than 100 cells/mm³. Of those, 
5.08% had TB meningitis and 1.7% had cerebral toxoplasmosis (Kumwenda et al., 2005). 
Five studies had similar findings and suggested that stroke in HIV patients may have a 
strong correlation with opportunistic infections (Tipping et al., 2007; Kumwenda et al., 
2005; Patel et al., 2005; Mochan et al., 2003; Hoffmann et al., 2000). The risk factors of 
opportunistic infections in these studies were more prevalent than the conventional risk 
factors of hypertension, diabetes and long-term substance abuse (Modi et al., 2007; Jowi 
et al., 2007; Kumwenda et al., 2005). 
Cardiac evaluations are important, as cardiovascular disease is a known risk factor for 
stroke (Kumwenda, 2005; Mochan et al., 2003). Four studies reported in their findings on 
cardiac evaluations that no significant results were found with regard to HIV status 
(Kumwenda et al., 2005; Mochan et al., 2005; Patel et al., 2005; Hoffmann et al., 2000) 
but results showed significant correlation with age. Patients over 40 years old in both 
HIV+ and HIV- groups were prone to cardiac conditions (Kumwenda et al., 2005; Mochan 
et al., 2003). 
The usual risk factors for stroke such as diabetes mellitus and hypertension were not 
common features in the HIV+ population as they were significantly younger (Heikinheimo 
et al., 2012; Tipping et al., 2007; Hoffmann, 2000). In a study conducted by Heikinheimo 
et al. (2012), comparing HIV+ and HIV- stroke patients, of 147 first ever stroke patients, 
it was found that hypertension was significantly less of a risk factor with a significant 
difference between HIV+ and HIV- population of p<0.0001. These risk factors were again 
strongly correlated with age (Heikinheimo et al., 2012; Tipping et al., 2007; Hoffmann et 
al., 2000). The more common risk factors in HIV+ patients were vasculitis, coagulopathy 
(specifically protein S deficiency), cardiac embolism and opportunistic infections with the 
odds ratio (OR) of 6.4 (95% CI 3.1 to 13.2) as reported by Tipping et al. (2005). These 
results were also noted in two other studies (Heikinheimo et al., 2012; Mochan et al., 
2003;). Deep vein thrombosis was significantly more common in the HIV+ population as 
seen in Tipping et al. (2007) with a statistical significance of p = 0.02. These risk factors 
also correlate with the significantly common ischemic stroke in HIV+ patients 
(Heikiniheimo et al., 2012; Tipping et al., 2007; Mochan et al., 2003). 
In summary, conclusions could not be drawn from the four studies that compared HIV- 
and HIV+ stroke populations in terms of risk factors and demographics (Heikinheimo et 
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al., 2012; Mlay & Bakari, 2010; Patel et al., 2005; Kumwenda et al., 2005). Further 
research is needed with HIV+ and HIV- stroke groups who are age matched and have 
similar risk factors. 
2.4.2.6. Outcome measures used to assess function in scoping review 
To describe functional outcome adequately, relevant outcome measures should be used 
which appropriately describe function according to the International Classification of 
Functioning, Disability and Health (ICF). The ICF is a “multipurpose classification system 
designed to serve various disciplines and sectors” (WHO 2001:5). The ICF describes 
functioning as an “umbrella term for body function, body structures, activities and 
participation. It denotes the positive or neutral aspects of the interaction between a 
person’s health condition(s) and that individual’s contextual factors (environment and 
personal factors)” (WHO 2001:8,10). It also describes disability as “an umbrella term for 
impairments, activity limitations and participation restrictions. It denotes the negative 
aspects of the interaction between a person’s health condition(s) and that individual’s 
contextual factors (environmental and personal factors)” (WHO 2001:8,10). It is 
imperative that outcome measures encompass all the factors that make up function.  
Functional outcome measures are focused mainly on assessing a person’s ability to 
perform ADL that are related to activities and participation components of the ICF 
(Scheepers, Ketelaar, van de Port, Visser-Meily, de Groot, Twisk & Lindeman, 2007). 
Functional outcome measures and the ICF are applied simultaneously to stroke 
rehabilitation, so understanding their relationship and which outcome measures are most 
appropriate is imperative (Stucki, Ewert & Cieza, 2003). 
 
A total of four outcome measures were identified in the scoping review namely the 
Modified Rankin Scale, Canadian Neurological Scale, National Institute of Health and 
Stroke Scale and the Barthel Index. Each outcome measure and its psychometric 
properties will be discussed in this section.  
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i) Modified Rankin Scale (mRS) 
The mRankin Scale is a commonly used scale to measure the degree of disability or 
dependence in activities of daily living (Bonita & Beaglehole, 1988; Rankin, 1957). 
Patients are given a score, ranging from one to six, which rates their degree of disability. 
Higher scores indicate more severe disability. A score of one indicates that patients have 
no significant disability and are able to carry out their usual daily activities. A score of two 
indicates slight disability where patients are unable to carry out all previous activities but 
are able to look after their own affairs without assistance. Three shows moderate disability 
where patients need help but are able to walk without assistance. Four indicates 
moderately severe disability where patients require assistance with all daily activities. A 
score of five shows severe disability where patients are bedridden, incontinent and 
require nursing care. A score of six indicates death. 
A study conducted by Kasner (2006) who looked at the clinical interpretation of several 
stroke scales showed that the mRankin Scale lacks in inter-rater reliability. Due to the 
scale being so global and lacking more specific questions the authors suggested a 
structured interview. The scale has moderate concurrent validity with respect to infarct 
volumes that are similar to the Barthel Index, which is seen as the gold standard stroke 
scale. The mRankin Scale’s construct validity has been shown to have excellent 
agreement with other rating scales such as the Glasgow Outcome Scale (Kasner, 2006). 
This scale is more suitable for (bio)medical investigations for infarct volumes and risk of 
mortality (Kasner, 2006). 
ii) Canadian Neurological Scale (CN scale) 
The CN scale is a tool used to monitor and evaluate the neurological symptoms of stroke 
patients in the acute phase (Cote, Battista, Wolfson et al., 1989; Bushnell, Johnston & 
Goldstein, 2001). The scale is divided into three subsections namely, mentation which 
assesses level of consciousness, orientation and speech. It also assesses the non-
comprehensive deficit and comprehensive deficits (symmetry and weakness) of the face, 
upper and lower limbs (Cote, Battista, Wolfson, Boucher, Adam & Hachinski, 1989; 
Bushnell, Johnston & Goldstein, 2001). Each domain is assigned a score, and a total 
score from 1.5 to 11.5 is calculated (Cote et al., 1989). Muscle power is scored according 
to no weakness, mild weakness or severe weakness. No weakness scores 1.5; mild 
scores 1.0; severe weakness scores 0.5; and no movement scores 0.0. Each domain is 
scored similarly (Cote et al., 1989). 
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In a study conducted by Stavem, Lossius & Ronning (2003) a retrospective algorithm was 
used to evaluate the CN scale. A high inter-rater reliability was found as well as a high 
predictive validity. This was also a global scale more suitable for (bio)medical purposes 
to predict mortality and disability. Functional limitations were not assessed adequately 
using this scale. 
iii) National Institute of Health and Stroke Scale (NIHSS) 
The NIHSS is another assessment tool often used in the acute phase and follow-up 
evaluation (Meyer & Lyden, 2009). The assessment can be applied at baseline, two hours 
post stroke, 24 hours post stroke, seven to ten days post stroke, three months post stroke 
and where relevant. It assesses 11 categories. The first construct assessed is level of 
consciousness; second is best gaze (eye movement), third is vision or checking visual 
fields, fourth is facial palsy, fifth is motor function of the arms, sixth is motor function of 
the legs, seventh is the assessment of ataxia in the limbs, eighth is testing the sensation 
of touch, ninth is the assessment of best language, tenth assesses dysarthria and the 
eleventh category assesses the extinction and inattention or, in other words, neglect of 
the affected side (Meyer & Lyden, 2009). 
Its reliability and validity have been established for prospective clinical research and its 
predictive validity for long-term stroke outcome (Kasner, 2006). Its intra-rater reliability is 
high but this has been established only with studies where raters were trained in using 
the NIHSS. It also has good concurrent validity in detecting infarct volumes (Kasner, 
2006). The NIHSS is a global scale used mainly by doctors and paramedics to predict 
mortality and stroke severity (Kasner, 2006). 
iv) Gold standard - Barthel Index 
The Barthel Index (BI) is a commonly used outcome measure of functional disability. This 
index measures the degree to which somebody can function independently and has 
mobility in their ADLs, i.e. feeding, bathing, grooming, dressing, bowel control, bladder 
control, toileting, chair transfer, ambulation and stair climbing. These ten items are each 
scored from zero to five or zero to ten. The index indicates the need for assistance with 
these particular ADLs (Loewen & Anderson, 1990). 
In terms of its psychometric properties, the BI has been shown to have good reliability 
and validity. In a study conducted by Hsueh, Lin, Jeng, Hsieh (2002) the BI was shown 
to have high concurrent validity and had a high responsiveness to detecting changes in 
ADLs. In another study by van der Putten, Hobart, Freeman & Thompson (1999) the BI 
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was compared to the functional independence measurement (FIM) scale, which is a 
widely used scale for stroke patients. Even though the FIM scale had more items, it was 
shown to have no advantage over the BI and was simpler and quicker to use. The 
reliability of the BI was shown to be excellent as reported by Collin et al. (1988); the BI 
had excellent test-retest reliability (k = 0.93) for both trained and untrained raters and this 
was echoed by Wolfe, Taub, Woodrow & Burney (1991) (k = 0.98). The BI also had 
excellent inter-rater reliability (k = 0.94) as seen in a study conducted by Hsueh, Lee & 
Hseih (2001). 
Choosing an outcome measure for research or clinical purposes requires information on 
the specific content at item level. Unfortunately, the selection procedure is determined 
mainly by measures that are readily at hand (Finch, Brook, Stratford & Mayo, 2002) or is 
directed only by the psychometric properties. Scheepers et al. (2007) suggested that 
more emphasis should be placed on the question of whether an outcome measure is 
appropriate (Wade, 1992), i.e. which specific items should be measured and which 
outcome measures match these items. The ICF provides a framework to evaluate the 
content of a measure in a systematic way. Scheepers et al. (2007) used an ICF tool to 
evaluate outcome measures and found the mRankin Scale to be general and viewed it 
as a global health index (de Haan, Limburg, Bossuyt, van der Meulen & Aaronson, 1995). 
However, used in conjuction with the BI, as is common in stroke literature, the mRS could 
be a useful tool to gauge stroke severity (Cioncoloni, Tassi, Acampa, Guideri, Bielli, 
Martini & Mazzocchio, 2012; Huybrechts & Caro, 2007; Sulter, Steen & De Keyser, 1999). 
 
 
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
 19 
 
   
2.4.3 Results of scoping review 
Scoping review primary study articles are summarized in Table 2.2  
 
Name Year Study design Country Setting Sample Age Gender HIV status
Primary and secondary 
outcomes
Functional 
assessed
Outcome 
measures
Findings
Heikinheimo et al 2012
Prospective 
cohort
Malawi- Queen 
Elizabeth Central 
Hospital
Hospital 
based
n= 147
18 years or older,   mean: 
54.2 years.    HIV+ mean: 
39.8 yrs  HIV- mean: 61.9 
yrs
Both male 
and female
Both HIV+ 
and HIV-
To determine the functional 
outcome of first ever stroke at one 
year follow up in a population 
with a high prevalence of 
HIV.Secondary aim was to 
determine effect of baseline 
demographics, including presence 
of HIV infection
No specific 
function
mRankin 
Scale, NIHSS
No significant results 
found for outcome 
measures
Mlay &Bakari 2010 Cross-sectional
Tanzanian- 
Muhimbil 
National Hospital 
Dar es Salaam
Hospital
n= 215        
20.9% HIV+)
Mean age of HIV+: 47.2 yrs                                       
HIV-: 56.1 yrs                  
(p<0.001)
Both male 
and female
Both HIV+ 
and HIV-
To determine the prevalence of 
HIV and assess its impact on the 
clinical presentation and outcome 
of patients admitted with stroke
Commented 
on outcome
No outcome 
measure used
No significant results  
for outcome
Modi et al 2007
Prospective 
cohort
South Africa- 
Helen Joseph 
Hospital
Hospital n= 506 Mean age 37 yrs
Both male 
and female
HIV only
To determine the frequency and 
spectrum of neurological illnesses 
in black South African hospital 
based HIV infected pts
Commented 
on outcome
No Outcome 
measure used
No comment on 
functional outcome but 
stated that the 
neurological profile in 
HIV patients are related 
to their environment 
and CD4 count
Tipping et al 2007
Prospective 
cohort
South Africa- 
Groote Schuur 
Hospital
UCT- stroke 
register
n= 1089
<46 yrs of age included 
only.                                  
Mean age 33.4 yrs
Both male 
and female
HIV only
To report the nature of stroke in 
pts infected with HIV in a region 
with high HIV prevalence and to 
describe HIV associated 
vasculopathy
No specific 
function
mRankin scale
No significant results for 
outcome
Table 2.2: Primary Study Article Summaries                                       Page 1 of 2
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Name Year Study design Country Setting Sample Age Gender HIV status
Primary and secondary 
outcomes
Functional 
assessed
Outcome 
measures
Findings
Jowi et al 2007
Retrospective 
cohort
Kenya- Mairobi 
Hospital
Hospital 
based
n= 708 HIV+ 
pts, 150 neuro 
manifestations 
12.7% stroke
Mean age 38.84 yrs
Both male 
and female
HIV only
To determine the profile of 
clinical and laboratory 
characteristics of hospitalized HIV 
positive pts with neurological 
complications
Commented 
on physical 
outcome
No measure
Mention that all 
patients were 
discharged home with 
50% having motor 
deficits, 12.7% of these 
being stroke patients
Patel et al 2005 Cross-sectional
South Africa- 
Durban-Ihkosi 
Albat Luthuli 
Hospital
Hospital 
based
n= 594 n= 293 aged 15-44
Both male 
and female
Both HIV+ 
and HIV-
To determine whether HIV 
seropositivity confers a 
predisposition to stroke by 
comparing age-matched HIV+ and 
HIV- black African patients with 
cerebrovascular disease
No mention 
of outcome
No outcome 
measures
HIV+ and HIV- groups 
did not differ in cardiac 
nor serologic tests. An 
HIV+ test does not 
provide causal 
information or diagnosis
Kumwenda et al 2005
Prospective 
cohort
Malawi- Queen 
Elizabeth Central 
Hospital
Hospital 
based
n= 98                      
HIV+ = 47              
HIV- = 51
Mean age- 37.5 yrs
Both male 
and female
Both HIV+ 
and HIV -
To study causes of stroke in areas 
with high HIV prevalence
Commented 
on initial 
physical 
findings
No outcome 
measures
On discharge-                
HIV+ : 7 of 47 patients 
were alive and not 
disabled; 33 of 47 alive 
and disabled; 6 of 47 
died; 1 absconded              
HIV-: 8 of 51 alive and 
not disabled; 36 of 51 
alive and disabled; 7 
died
Mochan et al 2003
Prospective 
cohort
South Africa- 
Chris Hani 
Baragwanith 
Hospital
Hospital 
Based
n= 35 Mean age 32.1 yrs
Both male 
and female
HIV only
To analyze the association of 
stroke in HIV+ black population
Commented 
on initial 
clinical 
findings
No outcome 
measures
Clinical presentation: 
28% Hemiparesis; 11% 
Hemiparesis and 
hemisensory loss; 20% 
hemiparesis, 
hemisensory loss and 
hemianopia; 17% 
hemiparesis, 
hemisensory loss and 
hemianopia  aphasia; 
6% ataxia
Hoffmann 2000
Retrospective 
case control
South Africa-
Durban
Durban 
stroke data 
bank
n= 1298        
(16% HIV+)
15-49 yrsMean age of 
white pts- 61 yrs, black 
(HIV+ pts) 31 yrs
Both male 
and female
HIV + only
To elucidate the mechanism of an 
ischemic stroke in HIV infected 
population
No specific 
function
mRankin 
scale, 
Canadian 
neurological 
scale
No significant results
Table 2.2: Primary Study Article Summaries                                        Page 2 of 2
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2.4.3.1. The functional outcomes of HIV Positive Stroke Patients 
Eight studies commented on the clinical presentation and functional outcome of patients 
(Heikiheimo et al., 2012; Mlay & Bakari, 2010; Jowi et al., 2007; Modi et al., 2007; Tipping 
et al., 2007; Kumwenda et al., 2005; Mochan et al., 2003; Hoffmann et al., 2000), but only 
three used functional outcome measures (Heikinheimo et al., 2012; Tipping et al., 2007; 
Hoffmann et al., 2000). These studies briefly described clinical presentation in terms of 
patients being aphasic or having hemiplegia. Later their outcome was discussed 
comparing only the HIV+ and HIV- stroke patients and it was reported that no statistical 
difference was seen in their functional outcome.  
Mlay and Bakari (2010), Kumwenda et al. (2005) and Mochan et al. (2003) found no 
significant difference between HIV+ and HIV- patients in terms of baseline physical 
findings such as facial asymmetry and hemiplegia. In terms of cognitive impairment 
Hoffmann et al. (2000) found that HIV+ patients had more cognitive impairments, but no 
statistically significant differences were found. 
Hoffmann et al. (2000) measured the neurological deficit with the CN scale (Bushnell et 
al., 2001; Cote et al., 1989) as well as the mRankin Scale (Bonita & Beaglehole, 1988; 
Rankin, 1957) to assess the degree of disability. Neither neurological deficit nor degree 
of disability was statistically significantly different between HIV+ and HIV- patients. 
Hoffman et al. (2000) did not adequately report on what was found using the outcome 
measures, hence it was not possible to compare their results with other studies. The 
mRankin Scale was also used by Tipping et al. (2007); the mean score for HIV- patients 
was 4.2 and the mean score for the HIV+ group was 4 and no statistical differences were 
found. This study failed to describe findings or compare results to other similar studies. 
Heikinheimo et al. (2012) did a one-year follow up assessing patients’ functional levels 
on admission, using the mRankin Scale and the NIHSS. The NIHSS was conducted only 
on admission. On admission, six to eight weeks, six months, and one-year follow-up only 
the mRankin Scale was used. A total of 19.7% of 147 patients were transferred to 
residential rehabilitation units; 6.1% received outpatient therapy. No significant results 
were obtained on admission (p = 0.46). A significant difference (p = 0.0920) was found 
for the NIHSS in favour of the HIV+ group on admission. The significance for the NIHSS 
was p = 0.092. The scores for the mRankin Scale at six to eight weeks showed a 
significance of p = 0.015 in favour of the HIV+ group, with no significant difference at six 
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months (p = 0.58) and at one year (p = 0.29). At one year 46.6% of the sample population 
scored 0 to 3 (good outcome); 53.4% scored 4 to 6 (poor outcome) and 22.4% had died. 
No significance in relation to HIV status was noted. Severity of stroke was seen to be 
related to older age and female gender (Heikinheimo et al., 2012). This study also had an 
average post stroke length of stay of 15.7 days with no significant differences between 
HIV- and HIV+ patients. This differed from Mlay and Bakari (2010) where the length of 
stay for HIV- patients was 7.3 days and HIV+ with 10.3 days which demonstrated a 
significant difference (p = 0.001). Thirteen patients had had another non-fatal stroke at 
the one-year follow-up (Mlay & Bakari, 2010). Mlay and Bakari (2010) did not comment 
on treatment received or if patients had ongoing therapy for the entire year. No 
information was given on patient prognosis, if they would be able to function 
independently in the community or if they would need ongoing care and assistance. No 
information was given on patients who were previously working and if they would be able 
to return to their previous function. 
The outcome measures used in the studies of this scoping review were too global and of 
little use in conveying patient functional outcomes according to the ICF as reported by 
Scheepers et al. (2007), and as seen with the mRankin Scale which was often used but 
from which limited information could be gathered. The outcome measures used by the 
studies in this scoping review gave very little information or detail about patient function 
in terms of ADLs or participation restriction and whether or not HIV+ patients would need 
full time care post stroke. 
2.4.3.2. Limitations of the Scoping Review 
The limitations were that the seven studies were either hospital based or patients were 
selected from a database. These results therefore could not be applied to the population 
of South Africa or of other sub-Saharan countries. Three South African studies were 
hospital based (Modi et al., 2007; Patel et al., 2005; Mochan et al., 2003) and two studies 
(Tipping et al., 2007; Hoffman et al., 2000) recruited their patients from a database, but 
these databases had patients from a specific region or hospital.  All four other sub-
Saharan studies were hospital based (Heikinheimo et al., 2012; Mlay & Bakari, 2010; 
Jowi et al., 2007; Kumwenda et al., 2005). There were significant differences with regard 
to demographics and risk factors between HIV+ and HIV- groups in four studies that 
compared these groups (Heikinheimo et al., 2012; Mlay & Bakari, 2010; Kumwenda et 
al., 2005; Patel et al., 2005). These differences make it difficult to draw a conclusion on 
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whether or not there were significant differences between HIV+ and HIV- stroke patients. 
Due to the fact that nine of the studies included being observational cohorts (Heikinheimo 
et al., 2012; Mlay & Bakari, 2010; Modi et al., 2007; Jowi et al., 2007; Tipping et al., 2007; 
Kumwenda et al., 2005; Patel et al., 2005; Mochan et al., 2003; Hoffmann, 2000), the 
researchers had no control over the sample size in each group, and hence the HIV+ 
groups were always significantly smaller, which also influenced interpretation and 
generalisation. No sample size was calculated and therefore one cannot generalise these 
results.  
Ten of the studies were based on the black ethnic population (Heikinheimo et al., 2012; 
Mlay & Bakari, 2010; Modi et al., 2008; Jowi et al., 2007; Modi et al., 2007; Tipping et al., 
2007; Modi et al., 2006; Kumwenda et al., 2005; Patel et al., 2005; Mochan et al., 2003).  
The eleventh study, which compared the black and white populations, still had 96% of its 
HIV+ participants being black (Hoffmann, 2000). This makes it hard to apply the findings 
to the general population. Standardised outcome measures were used in only three 
studies and their findings, except for one study that was not detailed or well documented 
(Heikinheimo et al., 2012; Tipping et al., 2007; Hoffmann, 2000). Studies that reported on 
functional outcomes gave minimal information on the outcome measures used or how 
reliable or valid these measures were in determining the functional outcomes of patients. 
No therapeutic protocol for rehabilitation interventions used was described. None of the 
included studies described the patients’ previous functions and whether or not they were 
able to return to these functions, whether activities of daily living or even work.  
The four studies that compared HIV+ and HIV- people concluded that there was no 
statistical significance between the HIV+ and HIV- stroke patients in terms of functional 
outcome (Heikinheimo et al., 2012; Mlay & Bakari, 2010; Kumwenda et al., 2005; Patel 
et al., 2005). However, these groups were not matched in terms of demographics such 
as age nor risk factors such as hypertension or opportunistic infections, hence a 
conclusion could not be drawn. Age may have a role in functional recovery. Spengos and 
Vemmas (2010) conducted a study of young adults with stroke in Athens. Their findings 
were compared to other studies and the general consensus was that young stroke 
patients tend to have a good functional outcome. However, in a study conducted in South 
Korea by Lee, Sung, Jung & Dae-ll. (2011), it was found that only a minority of young 
Korean stroke patients returned to work post-stroke. The five studies that looked only at 
the HIV+ stroke population were biased by small sample sizes and being hospital based, 
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therefore their findings could not be generalised to the general population (Jowi et al., 
2007; Modi et al., 2007; Tipping et al., 2007; Mochan et al., 2003; Hoffmann, 2000).  
 
2.5 Conclusion 
Thus far, a conclusion could not be drawn on whether or not HIV+ and HIV- stroke 
populations differ in functional outcomes. First, the comparison between the two groups 
could not be made due to the significant difference in demographics and risk factors. The 
sample sizes of the five studies that included HIV+ groups were small and the participants 
in the studies were not representative of the entire population. The studies included in 
this review used global outcome measures that were not specific enough to adequately 
describe function as in the ICF. Only three studies used functional outcomes and gave 
only brief descriptions of their findings. The outcome measures used were global scales 
used to determine mortality and severity of stroke, but they were not specific enough in 
determining functional outcomes in terms of returning to previous ADL, work, and whether 
or not these patients, being as young as they are, will live productive lives, or if they will 
be an economic burden on society. Even though Spengos and Vemmas (2010) found the 
functional outcomes of young stroke patients who were HIV- to be better than their older 
counterparts, this was not the case for the patients seen in this review, as they showed 
no significant difference from the older stroke patients who tended to have a poorer 
outcome. However, this cannot be confirmed with the current literature, as their results 
do not reflect the sub-Saharan population, and the outcome measures used in studies 
within the scoping review were not detailed enough to describe patient outcomes. 
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Chapter 3:  Methodology 
 
This chapter presents the research question, study objectives, study structure, study 
population, sampling and instrumentation. The procedure, data analysis and ethical 
considerations are also described. 
 
3.1 Research Question 
The research question posed is “What are the functional outcomes of post stroke patients 
following inpatient rehabilitation who are HIV positive, -negative and -undiagnosed?” 
 
3.2 Study Objectives 
To describe the functional outcomes of stroke patients in terms of activity or activity 
limitations on admission versus discharge from inpatient rehabilitation focusing on the 
following specific outcomes: 
1) HIV status (HIV+, HIV- and undiagnosed) and immune status (CD4 count if 
relevant); 
2) Severity of stroke using the Modified Rankin Scale; 
3) Function in activities of daily living using the Barthel Index; 
4) Level of independence using the Barthel Index; 
5) Wheelchair or other assistive devices issued on discharge;  
6) Balance, safety and risk of falling using the Berg Balance Scale (BBS) and 
pressure mapping. 
 
Secondary objectives  
To describe: 
7) Demographics of participants admitted for inpatient rehabilitation in terms of age, 
gender and race; 
8) Documented risk factors of stroke, i.e. hypertension, diabetes, opportunistic 
infections, etc.; 
9) Length of stay at rehabilitation facility (from date of admission to date of 
discharge, including suspension or days at home); 
10) Patient perception of quality of life and function on discharge from inpatient 
rehabilitation (EQ5D). 
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3.3 Study Design 
A descriptive study design was chosen. This study design is used to estimate prevalence 
and describe associations as was intended in the current project to highlight the 
prevalence and association with regard to HIV+ stroke patients (Kelly, Clark, Brown & 
Sitzia, 2003). It allows for the use of quantitative (observational data) and qualitative 
(interviews) data making the study more feasible and countenancing for patient 
perception (Hulley, Cummings, Browner, Grady & Newman, 2013). The disadvantage is 
that interpretation is often muddied due to confounding variables (Kelley et al., 2003). 
However, when reporting on findings is done in a transparent manner, the researcher can 
overcome these disadvantages (von Elm, Altman, Egger, Pocock, Gotzche & 
Vandenbroucke, 2008). 
 
3.4 Study Setting 
This study was based at the Western Cape Rehabilitation Center (WCRC) located in Cape 
Town. The WCRC has a catchment area that encompasses the entire Western Cape 
province as well as the surrounding provinces with some admissions from the Northern 
and Eastern Cape provinces. Some patients are also referred from neighbouring 
countries such as Lesotho, Zimbabwe and Namibia.  The conditions seen at the WCRC 
range from spinal cord to traumatic brain injuries, stroke and amputations (WCRC, 2015). 
The WCRC is a specialised rehabilitation centre for people with physical disabilities which 
accepts appropriate referrals from all levels of healthcare (WCRC, 2015). Clients are also 
able to refer themselves to the outpatient department for assessment and management 
purposes (WCRC, 2015).  
The WCRC has a total of 156 available beds for comprehensive inpatient rehabilitation. 
Patients are treated until they are able to return home safely, back either to their previous 
ADL or into the care of relatives. Most patients are referred to their nearest community 
health centre or day hospital for follow up management (Hartley, 2015). 
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3.5 Study Population 
The study population consisted of all patients over the age of 18 years who had their first 
ever stroke and were admitted for inpatient rehabilitation at the WCRC between 1 July 
and 15 November 2016. 
 
3.6 Study Sample 
All patients at the WCRC fitting the inclusion criteria, who were admitted from 1 July to 15 
November 2016 and consented to participate in the study, were recruited.  
 
3.7 Inclusion Criteria 
Patients over 18 years of age admitted to the WCRC with first ever stroke, that were able 
to respond to simple verbal cues or commands were eligible for inclusion in this study. 
Participants needed to understand basic English and/or Afrikaans and/or isiXhosa. 
 
3.8 Exclusion Criteria 
Patients with stroke who presented with documented cardiac problems i.e. recent 
myocardial infarction, severe angina, left ventricular failure, congestive heart failure; renal 
insufficiency; liver insufficiency or failure; systemic infection; severe psychiatric disorder 
and pre-existing disability were excluded from this study (Duncan, Jorgensen & Wade, 
2000). Individuals who were unable to understand basic English, Afrikaans or isiXhosa 
were also excluded. 
 
3.9 Instrumentation 
A number of outcome measures were used in this study, which focused on severity of 
stroke, function, balance and health-related quality of life. More information on these 
specific measures is provided below. 
Functional outcome measures that have been closely linked to the ICF were used to 
assess stroke patients in this study (Stucki et al., 2003). The functional outcome measures 
used were focused mainly on assessing a person’s ability to perform activities of daily 
living which are related to activities and participation components of the ICF (Scheepers 
et al., 2007). Along with a socio-demographic data sheet and medical history (Appendix 
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D), the following functional outcome measures (OM) were used: Modified Rankin Scale 
(mRS), Barthel Index (BI), the Berg Balance Scale (BBS) (Appendices E through G). 
Pressure mapping was utilised along with the BBS as an objective measure for patients’ 
static standing balance. For gathering the patients’ perception of their health-related 
quality of life, the European Quality of Life Five Domain Three Language Health 
Questionnaire (EQ5D) (Appendices H through J) was used.  
The justification for selection and psychometric properties of the selected functional 
outcome measures are discussed below. 
3.9.1 Modified Rankin Scale (mRS) 
The mRS is a frequently used scale to assess stroke severity and dependence. Patients 
are given a score of 1 to 6, 1 being little to no dependence and 6 being death (Bonita & 
Beaglehole, 1988; Rankin, 1957). (Refer to 2.4.2.6.). 
3.9.2 Barthel Index (BI) 
The BI is the most widely used outcome measure of functional disability in the stroke 
population and is often the gold standard criterion to assess the validity of other measures 
(Salter, Jutai, Teasell, Foley, Bitensky & Bayley, 2005). It is also one of the simplest 
outcome measures to assess ADL. The BI requires no training and has been developed 
in many forms (Salter, Campbell, Richardson… & Teasell, 2013). This study utilised the 
10-item index BI as a self-reported measure. Each item is scored between 0 to 10. (Refer 
to 2.4.2.6). 
The index indicates the need for assistance with each item. It yields a total score of 100 
with a higher score indicating an increased level in functional independence. A score of 
less than 60 is seen as unfavourable, indicating maximal assistance required with ADLs, 
a score of more than 60 is seen as a pivotal point in which patients are transitioning from 
dependency to assisted dependence and a score of 90 to 100 indicates slight dependence 
to complete indepedence (Sulter et al, 1999).  
3.9.3 Berg Balance Scale (BBS) 
The BBS provides a quantitative assessment of balance in older adults as well as 
determining risk of falls (Berg, Wood-Dauphinee, Williams & Maki, 1989). The scale 
consists of 14 items used in everyday life. The assessment requires easily accessible 
objects namely: a ruler, stopwatch, chair and a wide room in which to do a 360° turn (Berg, 
Wood-Dauphine & Williams, 1995). Patients are required to complete movements of 
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varying difficulty and maintain various positions independently. The items receive a score 
of 0 to 4 where a score of 0 indicates inability to do an activity and 4 means ability to 
complete the activity. The maximum score is 56 and a score of 45 or less indicates 
balance impairment (Berg, Wood-Dauphinee, Williams & Maki, 1992). A score of 41 to 56 
indicates a low risk of falling whereas a score of 21 to 40 indicates a medium risk of falling 
and a score of 0 to 20 indicates a high risk of falling (Berg et al., 1992). On average it 
takes 10 to 15 minutes to complete the BBS (Berg et al., 1995). 
The BBS has good validity as an outcome measure for balance with excellent concurrent 
validity in relation to the balance subscale of the Fugl-Meyer test (r = 0.90-0.92), the 
Postural Assessment Scale for Stroke Patients (0.92-0.95) as well as a high correlation 
with the Timed Up and Go test (r = -0.76) (Mao, Hsueh, Tang, Sheu & Hsieh, 2002; Berg 
et al., 1992). Its predictive validity was high to moderate with a moderate prediction of 
length of stay (Juneja, Czyrny & Linn, 1998). The BBS has excellent validity and is a 
feasible tool as it requires no special training and relatively little space and equipment 
(Salter et al., 2013). 
Berg et al. (1995) showed excellent internal consistency as well as excellent intra-rater 
and inter-rater reliability (k = 0.97, k = 0.98 and k = 0.92 respectively) when assessing 
stroke patients. Flansbjer, Blom & Brogardh (2012) also found the BBS test-retest 
reliability to be excellent (k = 0.88). Overall the BBS shows excellent reliability when 
assessing the stroke population (Salter et al., 2013). 
In summary, it has been reported that both of these functional outcome measures, i.e. the 
BI and BBS, have excellent validity and reliability in stroke patients. Responsiveness of 
measures is also an important factor in the assessment of stroke patients and this was 
also well established for the BI as well as the BBS. These two outcome measures have 
been well researched and reported on and are effective in assessing mobility, balance 
and risk of falling, as well as the ADL of stroke patients in our study. 
3.9.4 Pressure mapping (Matscan pressure measurement platform) 
The pressure measurement platform is a validated pressure mapping system. Combined 
with Tekscan software, the mats are usable in various applications including evaluating 
balance. The device allows the practitioner to capture data in seconds knowing that the 
data captured are objective and quantifiable. The mat itself is easy to use and portable 
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(www.tekscan.com/medical). This measure was utilised along with the BBS as a more 
objective measure for static standing balance. 
A common consequence of stroke is weight-bearing asymmetry (WBA) (Kamphuis, de 
Kam, Geurts & Weerdesteyn, 2013). During static standing a significant amount of WBA 
in favour of the non-hemiplegic leg is commonly observed (Aruin, Hanke, Chaudhuri, 
Harvey & Rao, 2000; Sackley, 1991; Mizrahi, Solzi, Ring & Nisell, 1989). On average 10% 
more weight is borne on the non-hemiplegic leg (Mansfield, Danells, Inness, Machizuki & 
Mcllroy, 2011; Barra, Oujamaa, Chauvineau, Rougier & Perennou, 2009; de Haart, 
Geurts, Huidekoper, Fasotti & van Limbeek, 2004). 
During static standing, the central nervous system aims to keep the center of gravity within 
the base of support (Shumway-Cook & Woollacott, 2007). Therefore, the amount of 
movement of the center of gravity (postural sway) is considered an indicator of the 
integrity of the balance control system (Fearing, 1924). Pressure mapping can be used to 
offer reasonable approximations of postural sway through integration of shear forces 
recorded during static standing (Zatsiorsky & King, 1997). Furthermore, pressure 
mapping can directly measure the position of the centre of pressure (COP) underneath 
the feet; it is by changing the position of the COP that individuals control the position of 
the center of gravity in static standing (Winter, 1995). 
WBA is the mean vertical force recorded by the pressure map under both limbs, 
expressed as a percentage of total body weight on either side or how evenly weight is 
distributed on each foot (Eng & Chu, 2002). Test–retest reliability using the pressure 
mapping system is high for weight-bearing asymmetry during static standing (ICC = 0.95 
for the mean of two 30-second trials) and maximal loading (ICCs = 0.93–0.99 for the mean 
of five six-second trials) among individuals with chronic stroke (Eng & Chu, 2002). 
Other variables include the anteroposterior (AP) and mediolateral (ML) COP 
displacement. Root mean square (RMS) of net AP and ML COP are measures of the 
variability of the COP displacement under both limbs combined; RMS of COP is calculated 
separately for the AP and ML directions (Kapteyn, Bles, Njiokiktjien, Kodde, Massen & 
Mol, 1983). The RMS of COP is a recommended measure of stability within clinical 
posturography (Kapteyn et al., 1983). As the position of the COP and centre of gravity are 
correlated, high RMS of COP suggests high postural sway (de Haart et al., 2004). 
Therefore, high RMS of COP can generally be interpreted as poor overall balance control. 
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There is some evidence that increased RMS of ML COP is related to increased risk of 
falling (Mansfield, Wong, Mcllroy, Biasin Bruton, Bayley & Inness, 2015). 
3.9.5 European Quality of Life Five Domain Three Language Health 
Questionnaire (EQ5D-3L) 
Most post stroke assessments focus on the functional status of the patient which is done 
objectively, but many forget that patient perception of function and/or quality of life is vital, 
hence self-reported measures are considered essential in assessing physical and mental 
well-being (Hunger, Sabariego, Stollenwerk, Cieza, Leidl, 2012).  
The EQ5D is a generic self-reported measurement tool used in various conditions 
including HIV/AIDS and stroke. It has been translated adhering strictly to the European 
Quality of Life Group’s (Euroqol) protocol for translation and tested in the Afrikaans and 
isiXhosa speaking populations in South Africa and found to be a valid and reliable tool in 
these populations (Hunger et al., 2012). The only other measure that was found to have 
good validity and reliability in the South African population was the Short Form Health 
Survey-36 (SF36) (Hunger et al., 2012). However, the SF-36 is long and results are 
somewhat difficult to analyse without a weighting algorithm (Hunger et al., 2012). The 
EuroQol Group developed the EQ5D, a health related quality of life (HRQoL) 
questionnaire, which describes health state in terms of five domains namely mobility, self-
care, usual activities, anxiety/depression and pain/discomfort (Hunger et al., 2012). In 
scoring, patients are asked to tick off the statement that best describes their current health 
status in each domain. Patients are also asked to score their health status using a Visual 
Analog Scale (VAS) rating 0 to 100; the score of 0 being worst imaginable health state 
and the score of 100 being best imaginable health state. This instrument has been 
validated in a wide range of settings, including Zimbabwe (Hunger et al., 2012). It has 
also been used specifically to examine HRQoL in subjects with HIV/AIDS in South Africa 
(Hunger et al., 2012). 
When correlating the EQ5D with the Stroke Impact Scale (SIS), a quality of life scale using 
the Spearman Rank correlation coefficient, the criterion validity in each domain namely 
mobility (r = 0.74), self-care (r = 0.65), usual activities (r = 0.61), pain/discomfort and 
anxiety/depression (r= 0.39), the EQ5D showed a strong correlation with the SIS in all 
domains except for the pain and anxiety domain (Hunger et al., 2012). In terms of test-
retest reliability the EQ5D was shown to have adequate test-retest reliability scores in all 
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domains (k = 0.62-0.7). Overall the EQ5D was shown to have reasonable validity and 
reliability in the stroke population (Hunger et al., 2012).  
Although the EQ5D is seemingly a valid and reliable tool, it is also worth noting that one 
cannot measure the reliability and validity of the EQ5D appropriately as a self-reported 
quality of life (QoL) measurement tool because there is no gold standard. Permission was 
granted by the EuroQoL group to use the EQ5D for this study. 
3.9.6 Self-developed data capture form for socio-demographic information and 
medical history 
To obtain documented medical history for each patient included in this study, their medical 
records at the WCRC were reviewed. A self-developed checklist/data capture form was 
developed to facilitate the extraction of the following information from all participants’ 
medical folders: 
 Age; 
 Dates of incident (of stroke), admission and discharge; 
 Language (English, isiXhosa or Afrikaans); 
 Gender; 
 Race (black, mixed race, white, Indian and other); 
 Type of stroke (hemorrhage or infarction); 
 Area affected (right cerebrovascular accident, left cerebrovascular accident, 
cerebellar or brainstem); 
 Special investigations (CT brain scan, MRI or other); 
 Risk factors (hypertension, diabetes, cholesterol, smoker, obesity, substance 
abuse, atherosclerosis, opportunistic, not known and other); 
 HIV-status (HIV positive, negative, undiagnosed); 
 Assistive device received on admission and discharge. 
 
3.10 Procedures for the Pretest and Main Study 
 
3.10.1 Pretest 
The pretest was conducted at the WCRC. Two patients were recruited based on inclusion 
criteria. The principal investigator (PI) obtained their written consent to participate in the 
pretest. The pretest assisted the PI by becoming familiar with the objective measures, 
alerting the PI to any adjustments of the procedures for logistical and practical time 
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management. At the facility, the following items were required to conduct the pretest: a 
3X4m room, a height adjustable Bobath plinth, a step, two chairs with backrests (one with 
and one without arm support), a small table and an outlet for a laptop. 
The pretest was conducted with two participants who met the inclusion criteria. The PI 
conducted all assessments, procedures and logistical issues were amended. 
- Venues with sufficient space and equipment were booked. 
- A patient booking system was established where clinicians identified potential 
participants who met the inclusion criteria and informed the therapy clerks who 
made the bookings. 
- A second person was employed for testing to ensure the safety of patients during 
the assessments. 
- A translator was employed for isiXhosa speaking patients. 
- Datasheets were amended. 
- A sequence for outcome measures of the assessments and documentation was 
established.   
 
3.10.2 Main study 
 1) Recruitment of subjects 
The WCRC healthcare practitioners and ward admission clerks were informed of the aim, 
objectives and inclusion criteria of the envisaged study. The clerks notified the PI of any 
new stroke patient admissions between June and November 2016. The PI screened the 
patients to see if they fitted the inclusion criteria, and gained their written consent to 
participate in the study.  
 2) Data collection for the main study 
The PI explained the aims and study procedure to all participants once informed consent 
was obtained. All consent forms were available in English, Afrikaans and isiXhosa. For 
isiXhosa speaking participants who did not understand English or Afrikaans, an isiXhosa 
translator was employed. On admission the PI reviewed the medical records of eligible 
and recruited participants to capture their socio-demographic data and relevant medical 
history. The PI, having had experience using the outcome measures, then conducted the 
pretest in four stages. The first stage was the interview using the EQ5D and BI. The EQ5D 
was separated into three sections namely, prior to stroke (premorbid function), on 
admission (present function) and on discharge. Participants were asked the same six 
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questions (refer to Appendix F) regarding their function prior to stroke and on admission. 
The BI, also a self-reported measure, was reported on admission only. The second stage 
was the pressure mapping system. This was conducted on participants who were able to 
stand independently. The third stage was just the BBS. The MatScan (pressure mapping), 
which is also a balance assessment tool was done prior to this. During the second and 
third stage, the second person employed assisted with patient safety during the physical 
assessment, ensuring that the PI could appropriately observe each activity. Thereafter, in 
the final stage, the PI used the mRS to rate participant stroke severity. The PI conducted 
all assessments and was not blinded to participant HIV-status. All scores were 
documented and entered into an Excel spreadsheet. Once participants completed their 
rehabilitation (treated by the therapists at the WCRC) and were in their final week prior to 
discharge, the PI reassessed these same participants using the EQ5D, BI, pressure 
mapping and BBS as well as the mRS for participant discharge results. The specific 
procedures used during the data collection of the main study are described in Appendix I. 
 3) Data management 
All the patients’ relevant data, i.e. demographic information, medical history and outcome 
measure results were collected in the assessment form (see Appendices A and B). All the 
data findings were entered into an Excel spreadsheet, coded and the results were 
interpreted with the programme STATA. The patients’ confidentiality was kept by a coding 
process whereby the patients’ names on the assessment forms were substituted by a 
code. All raw data and data collection forms were locked in a secure cupboard housed in 
the Physiotherapy Division, Stellenbosch University. The records of the patients’ names 
and corresponding codes were known to the PI and supervisors only.  
 4) Statistical analysis 
All the data from the socio-demographic data sheet and outcome measures were entered 
into an Excel spreadsheet, coded and analysed. Continuous data including mRS, BI, BBS 
and pressure mapping were summarised using median and range. The EQ5D, which is 
the patients’ perception of function, was categorical data so it had different analysis. 
Categorical data were represented as proportions and graphically displayed using a 
histogram. Statistical analysis was performed using STATA version 14.2 (Statacorp, 
2015). Association between categorical variables was assessed using the chi-squared or 
Fisher’s exact test. Differences distribution of continuous variables over different levels of 
a categorical variable were evaluated using the Kruskal-Wallis test, and where differences 
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were detected, the Dunn’s test was used for pairwise comparisons. Relationships 
between patient characteristics and pain and anxiety were evaluated using ordinal logistic 
regression. The Kaplan-Meier curve was used to describe the length of stay. Statistical 
significance was assessed at five percent. 
 5) Ethical considerations 
Approval for conducting the study was obtained from the Committee of Human Research 
(HREC) at Stellenbosch University. The study was conducted according to the 
internationally accepted ethical standards and guidelines as stipulated in the Declaration 
of Helsinki (2013) and the South African Guideline for Good Clinical Practice. Permission 
was also sought from the Western Cape Department of Health and management of the 
WCRC. All the procedures were explained to each participant and their written informed 
consent was obtained before proceeding with data collection. Once feedback was 
received from the Ethics Committee (HREC), the consent form was translated into 
Afrikaans and isiXhosa.  
Participants were informed that they could withdraw from the study at any point without 
any repercussions. A code/number was allocated to each participant once the raw data 
were captured electronically and analysed to ensure their anonymity. All results were 
described at group level and no individual data were made known to parties other than 
the PI and supervisors. The results were shared with the participants and top 
management at the WCRC only.  
There were minimal foreseeable risks involved in this study; they included a risk of falling 
and possible fatigue post assessment. Snacks and regular breaks were given during data 
collection to combat fatigue. Participants did not receive any remuneration for 
participating in the study. It is hoped that the information gained in this study will provide 
a better understanding of the functional outcomes of HIV+ stroke patients, which may lead 
to better future management strategies. This study will act as a springboard for much 
needed epidemiological and large cohort studies.  
The results of the study will be disseminated via scientific publications and conference 
presentations. A bound copy and electronic version will be given to the WCRC Library 
and a presentation will be given to WCRC staff.  
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Chapter 4:  Results 
 
The results chapter describes the demographic information of participants and their 
functional outcome on admission and discharge. The differences between the HIV+, HIV- 
and HIV undiagnosed participant groups with regard to demographic data, baseline 
characteristics and the findings of outcome measurements are highlighted. 
 
4.1 Participation Allocation and HIV-status Grouping 
The recruitment of participants for this study, together with the number of participants in 
each group, are detailed in Figure 4.1. Of the initial 54 patients screened at the WCRC 
between June 2016 and November 2016, 49 met the inclusion criteria, provided informed 
consent and were subsequently recruited into the study. There were nine participants 
with a confirmed HIV+ diagnosis, 17 who were negative and 23 individuals who were 
undiagnosed. Overall, eight participants dropped out; reasons are provided in the 
following figure (see figure 4.1).  
Stellenbosch University  https://scholar.sun.ac.za
 37 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1:  Study flow diagram detailing participant allocation 
4.2 Demographic Characteristics of the Study Sample 
The study sample’s demographic characteristics were tabulated (Table 4.1) to illustrate 
the differences between the HIV+, HIV- and HIV undiagnosed participant groups.  
Table 4.1:  Demographic characteristics of each group and the combined study    
sample 
Demographic Characteristics HIV+ HIV- HIV undiagnosed Total 
 n=9 (18.36%) n=17 (34.69%) n=23 (46.94%) n=49 (100%) 
Gender n (%) 
Female 6 (66.67)  8 (47.06) 11 (47.83) 25 (51.02) 
Male 3 (33.33)  9 (52.94) 12 (52.17) 24 (48.98) 
Race n (%) 
Black 6 (66.67) 4 (23.53) 7 (30.43) 17 (34.69) 
Mixed Race 3 (33.33) 9 (52.94) 14 (60.87) 26 (53.06) 
White 0 (0.00) 3 (17.65) 2 (8.7) 5 (10.20) 
Indian 0 (0.00) 1 (5.88) 0 (0.00) 1 (2.04) 
Other 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00) 
Age median (min-max) 
 30 (22-62) 50 (26-75) 51 (24-77) 48 (22-77) 
Mdn- median; Min- minimum; Max- maximum 
Included 
n = 49 
HIV+ = 9 
HIV- = 17 
HIV Undiagnosed = 23 
Participants screened 
n = 54 
Excluded 
n = 5  
Unable to 
communicate = 3 
Previous strokes = 2 
Participants who completed initial and 
reassessments 
n = 41 
HIV+ = 7 
HIV- = 13 
HIV Undiagnosed = 21 
 
Discharged early (before 
final assessment)  
n = 6 
HIV+ = 1 
HIV-= 4 
HIV Undiagnosed= 1 
Deceased  
n = 2 
HIV+= 1 
HIV Undiagnosed= 1 
 
Drop Out 
n = 8 
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4.2.1 Gender 
The male to female ratio for the entire study sample was closely matched, having one 
more female than males. Even though the HIV+ group was the only subgroup with more 
females than males, there was no statistical significance between male or female 
participants in either group or in the sample size as a whole (p = 0.607).  
4.2.2 Race 
More than half of the study sample was mixed race with 34.69% from the black racial 
category. The HIV+ participants had a majority of black participants (66.67%) with 
33.33% mixed race; while the HIV- and undiagnosed groups had a majority of mixed race 
participants (52.94% and 60.87% respectively). Even though differences were shown in 
race distribution, there was no statistical significance between groups (p = 0.254) with 
regard to race.  
4.2.3 Age 
The age range of the study sample was similar to the HIV- and undiagnosed groups. 
There was, however, a difference between ages when comparing HIV status. There was 
no statistical significant difference between ages in the HIV- and undiagnosed groups (p 
= 0.3045) but the HIV+ group was significantly younger compared to the HIV- and 
undiagnosed groups (p = 0.0046). 
 
4.3 Stroke Related Information 
Stroke characteristics are presented in Table 4.2.  
4.3.1 Type of stroke 
The majority of the study sample (89.80%) suffered a cerebral infarct as cause of stroke. 
All HIV+ participants sustained cerebral infarcts; likewise, the majority of the HIV- and 
undiagnosed groups were also diagnosed as such (82.35% and 91.30% respectively). 
Haemorrhagic strokes occurred in the HIV- and undiagnosed groups. No statistical 
significance between groups was found (p = 0.569) in terms of stroke type. 
4.3.2 Area affected by stroke 
The area affected did not differ significantly in the sample. The same was seen for all 
groups having an almost equal ratio of left and right sided strokes with one participant in 
the HIV undiagnosed group suffering a cerebellar stroke. No statistical significance 
between groups was found (p = 0.967). 
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4.3.3 Special investigations following stroke 
The majority of participants (87.71%) received computed tomographic scans of the brain 
(CTB), while others received Carotid Doppler Ultrasound imaging and unspecified 
diagnostic investigations (14.29%).  
Table 4.2:  Stroke characteristics of the study sample 
Stroke Characteristics HIV+ HIV- HIV undiagnosed Total 
 n= 9 
(18.36%) 
n= 17 
(34.69%) 
n= 23 
(46.94%) 
n= 49 
(100%) 
Type of stroke n (%) 
Haemorrhagic 0 (0.00) 3 (17.65) 2 (8.70) 5 (10.20) 
Infarction 9 (100) 14 (82.35) 21 (91.30) 44 (89.80) 
Affected area n (%) 
Right CVA (Left hemiplegia) 5 (55.56) 8 (47.06) 12 (52.17) 25 (51.02) 
Left CVA (Right hemiplegia) 4 (44.44) 9 (52.94) 10 (43.48) 23 (46.94) 
Cerebellar CVA (balance disorder) 0 (0.00) 0 (0.00) 1 (4.35) 1 (2.04) 
Special investigations n (%) 
CT brain 9 (100) 15 (88.24) 18 (78.26) 42 (85.71) 
MRI/ other 0 (0.00) 2 (11.76) 5 (21.74) 7 (14.29) 
Mdn- median; Min- minimum; Max- maximum 
4.4 Risk Factors Associated with Stroke 
Stroke risk factors are presented in Tables 4.3 and 4.4. 
Some of the typical risk factors for stroke were reported in our study (see Table 4.3). A 
few of these risk factors appeared more amongst the HIV+ group, for example, 
hypertension and diabetes along with substance abuse and opportunistic infections. 
There was no statistical significant difference between the HIV- and undiagnosed groups 
with regard to hypertension and diabetes. Compared to the HIV+ group, however, the 
HIV- and HIV undiagnosed groups showed greater statistical significant difference for 
hypertension and diabetes (p = 0.001 and p = 0.042 respectively). Cholesterol and 
smoking had no statistical significance between any of the groups (p =1.00 and p = 0.671 
respectively). Documented substance abuse in the HIV+ group was 22.22%, compared 
to 5.8% in the HIV- and 0% for the HIV undiagnosed groups. This difference was found 
to be significant (p = 0.038). There was no documented occurrence of atherosclerosis in 
this sample. In the HIV+ group there was 22.22% with no known risk factors. None of the 
HIV- or undiagnosed groups showed any documented risk of opportunistic infections 
while the HIV+ group had 33.33% of participants suffering from infections ranging from 
cryptococcol meningitis to cystic brain lesions (p = 0.005). The CD4 count of the HIV+ 
group ranged from 54 to 883 with the median of 130. 
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Table 4.3:  Risk factors for/of each group and the combined study sample 
Risk factors n (%) HIV+ HIV- HIV undiagnosed Total 
 n= 9 (18.36%) n= 17 (34.69%) n= 23 (46.94%) n= 49 (100%) 
None 2 (22.22) 0 (0.00) 0 (0.00) 0 (0.00) 
Hypertension 1 (11.11) 15 (88.24) 20 (86.96) 36 (73.47) 
Diabetes 0 (0.00) 4 (23.53) 10 (43.48) 14 (28.57) 
Cholesterol 1 (11.11) 2 (11.76) 3 (13.04) 6 (12.24) 
Smoking 2 (22.22) 7 (41.18) 7 (30.43) 16 (32.65) 
Substance abuse 2 (22.22) 1 (5.88) 0 (0.00) 3 (6.12) 
Artherosclerosis 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00) 
Opportunistic infection 3 (33.33) 0 (0.00) 0 (0.00) 3 (6.12) 
Mdn- median; Min- minimum; Max- maximum 
The most common combination of risk factors seen in the sample were hypertension and 
smoking as well as hypertension and diabetes (n = 14; 28.57% and n =13; 26.3% 
respectively) (see Table 4.4). With regard to a combination of risk factors in each group 
the following was noted: the combination of risk factors in the HIV+ group (excluding HIV) 
was substance abuse and smoking, found in two (22.22%) participants one of whom also 
had high cholesterol. When including HIV as a risk factor 66.67% (n = 6) of the HIV+ 
group had a combination of risk factors, the majority being HIV and opportunistic 
infections. None of the other groups had opportunistic infections. Hypertension and 
cholesterol occurred only once in the HIV+ group unlike the HIV- and undiagnosed groups 
where these risk factors were most common.  
Hypertension (n = 15; 88.24%) was the leading risk factor in the HIV- group, often 
combined with smoking (n = 7; 41.18%), diabetes (n = 4; 23.53%) and cholesterol  
(n = 2; 11.76%). The HIV undiagnosed group yielded similar results to the HIV- group 
with 86.96% (n = 20) of participants having hypertension often combined with diabetes 
(n = 9; 39.13%) followed by smoking (n = 7; 30.44%) (See Table 4.4). These are the more 
common lifestyle related non-communicable diseases placing individuals at risk for 
stroke. 
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Table 4.4:  Distribution of multiple risk factors for each group and study sample 
Risk factors n (%) HIV+  HIV- HIV undiagnosed  Total 
 n= 9 (18.36%) n= 17 (34.69%) n= 23 (46.94%) n= 49 (100%) 
Multiple risk factors 
excluding HIV 
2 (22.22) 
 
11 (64.7) 
 
14 (56.2) 
 
27 (55.1) 
 
 
Two risk factors: 
- Hypertension and 
diabetes 
- Hypertension and 
smoking 
- Hypertension and 
cholesterol 
- Substance abuse 
and smoking 
Three risk factors: 
- Hypertension, 
diabetes and 
smoking 
- Hypertension, 
diabetes and 
cholesterol 
- Hypertension, 
smoking and high 
cholesterol 
- Hypertension, 
smoking and 
substance abuse 
- Smoking, high 
cholesterol and 
substance abuse 
 
 
0 (0.00) 
 
0 (0.00) 
 
0 (0.00) 
 
2 (22.22) 
 
 
0 (0.00) 
 
 
0 (0.00) 
 
 
0 (0.00) 
 
 
0 (0.00) 
 
 
1 (11.11) 
 
 
 
4 (23.53) 
 
7 (41.18) 
 
2 (11.77) 
 
1 (5.88) 
 
 
1 (5.88) 
 
 
0 (0.00) 
 
 
1 (5.88) 
 
 
1 (5.88) 
 
 
0 (0.00) 
 
 
 
 
9 (39.13) 
 
7 (30.44) 
 
2 (8.70) 
 
0 (0.00) 
 
 
3 (13.04) 
 
 
2 (8.70) 
 
 
0 (0.00) 
 
 
0 (0.00) 
 
 
0 (0.00) 
 
 
13 (26.53) 
 
14 (28.57) 
 
4 (8.16) 
 
3 (6.13) 
 
 
4 (8.16) 
 
 
2 (4.08) 
 
 
1 (2.04) 
 
 
1 (2.04) 
 
 
1 (2.04) 
Multiple risk factors 
including HIV 
6 (66.67) 
 
  6 (12.25) 
 
Two risk factors (HIV 
and):  
- Opportunistic 
infection 
- Hypertension 
Three/ more risk factors 
(HIV and): 
- Smoking and 
substance abuse 
- High cholesterol, 
smoking and 
substance abuse 
 
 
3 (33.33) 
 
1 (11.11) 
 
 
2 (22.22) 
 
1 (11.11) 
 
 
   
 
3 (6.13) 
 
1 (2.04) 
 
 
2 (4.08) 
 
1 (2.04) 
 
Mdn- median; Min- minimum; Max- maximum 
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4.5 Duration of Stroke until Admission and Length of Stay 
The HIV+ group had the shortest time from stroke incident until admission to rehabilitation 
(two weeks). There was one patient in the HIV- group, however, who had an extended 
period before admission to rehabilitation (218 days). This particular patient in the HIV- 
group had medical complications unrelated to the stroke, hence the delay to 
rehabilitation. These outlying data may have skewed the HIV- group’s data with regard 
to median and range. Therefore, if the outlying data were removed, the HIV+ and HIV- 
groups may have been more similar in this regard. The HIV undiagnosed group had the 
longest period before admission (almost a month), even longer than the overall sample. 
Nonetheless, no statistical significance was found between groups with regard to time of 
stroke to admission (p = 0.5293).  
The median time from stroke incident until admission for the entire sample was 53 days, 
ranging from one month to almost three months. The overall length of stay was similar 
between the HIV- and HIV undiagnosed groups who were admitted over a week later 
than the HIV+ group (Table 4.4). However, no statistical significance was seen between 
groups (p = 0.0671).  
Table 4.5:  Median time between stroke incident and admission (to rehabilitation) 
and length of stay during inpatient rehabilitation  
Time period (Days) HIV+ HIV- HIV undiagnosed Total 
 n= 9 (18.36%) n= 17 (34.69%) n= 23 (46.94%) n= 49 (100%) 
Median time between stroke 
incident and admission  
mdn (min-max) 
14 (6 - 45) 18 (6 - 218) 23 (6 - 42) 21 (6 - 218) 
Length of stay   
mdn (min-max) 
45 (31- 64) 55 (42- 79) 53 (39- 74) 53 (31- 79) 
Mdn- median; Min- minimum; Max- maximum 
 
4.6 Level of Function 
The following section focuses on the outcome measures used to describe patient function 
on initial assessment and discharge. The following function related outcome measures 
were used: Modified Rankin Scale, Barthel Index and the Berg Balance Scale (BSS). 
Pressure mapping was utilised along with the BBS as an objective measure for static 
standing balance. The assistive devices issued on the initial assessment and discharge 
are also described to give a better understanding of participants’ function. The EQ5D was 
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used to describe patient perception of function, prior to stroke, on admission and 
discharge. 
4.6.1 Describing the severity of stroke using the Modified Rankin Scale 
As previously mentioned, the mRS measures the degree of disability or dependence in 
ADL (Bonita & Beaglehole, 1988; Rankin, 1957).  A higher score is more indicative of 
disability.  
The mRS has no established minimally clinically important difference (MCID) nor minimal 
detectable change (MDC) (de Haan et al., 1995). Overall, the majority of participants 
(63.27%, n = 31) were admitted with moderately severe disability. This was found to be 
similar for all groups with the HIV+ group having 66.67% (n = 6) of participants with 
moderately severe disability, the same was seen in 64.71% (n = 11) of the HIV- group 
and 60.87% (n = 14) of the HIV undiagnosed group. On discharge, 31.71% of the total 
group had no significant disability despite symptoms, and were able to carry out all usual 
duties and activities. In the HIV+ group two thirds (57.14, n = 4) had no significant 
disability, whereas a third of the HIV- group (30.77%, n= 4) and HIV undiagnosed groups 
(28.57%, n = 6) had no significant disability. Even though having a smaller sample size, 
the HIV+ group had a better mRS score on discharge than the other groups; however, 
no statistical significant difference was found (p = 0.748) among groups with the change 
in scores from admission to discharge. (Figures 4.2 and 4.3 display and compare the 
severity of stroke among the three groups (HIV+, HIV- and HIV undiagnosed) on 
admission and discharge.) 
                        
Figure 4.2:  Modified Rankin Scale on admission 
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Figure 4.3:  Modified Rankin Scale on discharge 
 
4.6.2 Function and level of independence in activities of daily living using the 
Barthel Index 
The Barthel Index BI is a 10-item index that measures the degree to which somebody 
can function independently in their ADL. A score of 0 indicates complete dependence in 
performing a task and therefore a higher score is indicative of more independence. The 
highest total score is 100. Table 4.6 describes the median and range of scores each 
group received on admission and discharge. It also shows the median difference between 
admission and discharge scores. Overall, the median BI score for admission was 55 
(Table 4.6), indicating assistance required with ADLs. 
The median admission and discharge scores were similar for all groups (Table 4.6). The 
MDC for the BI is an increase or decrease of 4.02 points (Hsieh, Wang, Wu, Chen, Shen 
& Hsieh, 2007). The median MDC for the HIV+ group was 10, HIV- was 25 and the 
undiagnosed group 35. Even though the difference between admission and discharge 
scores was smaller for the HIV+ group, no statistical significant difference was found 
among groups (0.886). 
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Table 4.6: Barthel Index scores for the groups displaying median and range 
scores  
Barthel Index 
(Total scores) 
HIV+  
mdn (min-max) 
HIV-  
mdn (min-max) 
HIV undiagnosed 
mdn (min-max) 
Total  
mdn (min-max) 
 n= 9 (18.36%) n= 17 (34.69%) n= 23 (46.94%) n= 49 (100%) 
Admission  50 (30-95) 55 (15-100) 55 (25-95) 55 (15-100) 
 n= 7 (17.07%) n= 13 (31.71%) n= 21 (51.2%)  n= 41 (100%) 
Discharge 95 (50-100) 95 (50-100) 90 (45-100) 90 (45-100) 
Difference 
(between 
admission and 
discharge scores) 
10 (5-65) 25 (-10-50) 35 (0-60) 35 (-10-65) 
Mdn- median; Min- minimum; Max- maximum 
 
Table 4.7 displays frequency and percentage for individual items on the Barthel Index. 
A total of 20.41% (n = 10) of the study sample were independent in feeding, 32.65% (n = 
16) independent in bathing, 26.53% (n = 13) in dressing and only 12.25% (n = 6) 
independent in mobility (Table 4.7). The rest required assistance or were dependent in 
the above-mentioned ADLs. Upon discharge, 80.49% (n = 33) of the participants who 
participated in the assessment prior to discharge were independent in feeding, 85.36% 
(n = 35) independent in bathing, 73.17% (n = 30) in dressing and 43.9% (n = 18) in 
mobility. One participant, however, displayed deterioration on reassessment prior to 
discharge and this is reflected in the negative score in the range within the HIV- group 
(Table 4.7).  
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Table 4.7:  Barthel Index scores displaying frequency and percentage for individual 
teams 
 
Item Score Admission Discharge Admision Discharge Admission Discharge Admission Discharge
n= 9 
(18.37%)
n= 7 
(17.07%)
n= 17 
(34.69%)
n= 13 
(31.71%)
n= 23 
(46.94%)
n= 21 
(51.21%)
n= 49 
(100%)
n= 41 
(100%)
Feeding 0 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00)
5 7 (77.78) 1 (14.29) 14 (82.35) 2 (15.38) 18 (78.26) 5 (23.81) 39 (79.59) 8 (16.33)
10 2  (22.22) 6 (85.71) 3 (17.65) 11 (84.62) 5 (21.74) 16 (76.19) 10 (20.41) 33 (67.35)
Bathing 0 4 (44.44) 1 (14.29) 12 (70.59) 3 (23.08) 17 (73.91) 2 (9.52) 33(67.35) 6 (12.24)
5 5 (55.56) 6 (85.71) 5 (29.41) 10 (76.92) 6 (26.09) 19 (90.48) 16 (32.65) 35 (71.43)
Grooming 0 5 (55.56) 3 (42.86) 7 (41.18) 3 (23.08) 11 (47.83) 1 (4.76) 23 (46.94) 7 (14.29)
5 4 (44.44) 4 (57.14) 10 (58.82) 10 (76.92) 12 (52.17) 20 (95.24) 26 (53.06) 34 (69.39)
Dressing 0 2 (22.22) 0 (0.00) 2 (11.76) 0 (0.00) 4 (17.39) 0 (0.00) 8 (16.33) 0 (0.00)
5 6 (66.67) 1 (14.29) 8 (47.06) 5 (38.46) 14 (60.87) 5 (23.81) 28 (57.14) 11 (22.45)
10 1 (11.11) 6 (85.71) 7 (41.18) 8 (61.54) 5 (21.74) 16 (76.19) 13 (26.53) 30 (61.22)
Bowels 0 2 (22.22) 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00) 2 (4.08) 0 (0.00)
5 0 (0.00) 0 (0.00) 3 (17.65) 0 (0.00) 2 (8.70) 1 (4.76) 5 (10.20) 1 (2.04)
10 7 (77.78) 7 (100,00) 14 (82.35) 13 (100.00) 21 (91.30) 20 (95.24) 42 (85.71) 40 (81.63)
Bladder 0 2 (22.22) 0 (0.00) 1 (5.88) 1 (7.69) 0 (0.00) 0 (0.00) 3 (6.12) 1 (2.04)
5 0 (0.00) 0 (0.00) 4 (23.53) 2 (15.38) 2 (8.70) 1 (4.76) 6 (12.24) 3 (6.12)
10 7 (77.78) 7 (100.00) 12 (70.59) 10 (76.92) 21 (91.30) 20 (95.24) 40 (81.63) 37 (75.51)
Toilet use 0 0 (0.00) 0 (0.00) 2 (11.76) 0 (0.00) 1 (4.35) 0 (0.00) 3 (6.12) 0 (0.00)
5 5 (55.56) 1 (14.29) 6 (35.29) 3 (23.08) 11 (47.83) 2 (9.52) 22 (44.90) 6 (12.24)
10 4 (44.44) 6 (85.71) 9 (52.94) 10 (76.92) 11 (47.83) 19 (90.48) 24 (48.98) 35 (71.43)
Transfers 0 0 (0.00) 0 (0.00) 1 (5.88) 0 (0.00) 1 (4.35) 0 (0.00) 2 (4.08) 0 (0.00)
5 1 (11.11) 0 (0.00) 0 (0.00) 0 (0.00) 8 (34.78) 2 (9.52) 9 (18.37) 2 (4.08)
10 5 (55.56) 1 (14.29) 9 (52.94) 3 (23.03) 7 (30.43) 2 (9.52) 21 (42.86) 6 (12.24)
15 3 (33.33) 6 (85.71) 7 (41.18) 10 (76.92) 7 (30.43) 17 (80.95) 17 (34.69) 33 (67.35)
Mobility 0 4 (44.44) 1 (14.29) 8 (47.06) 2 (15.38) 11 (47.83) 1 (4.76) 23 (46.94) 4 (8.16)
5 2 (22.22) 0 (0.00) 4 (23.53) 3 (23.08) 7 (30.43) 8 (38.10) 13 (26.53) 11 (22.45)
10 0 (0.00) 1 (14.29) 2 (11.76) 2 (15.38) 5 (21.74) 5 (23.81) 7 (14.29) 8 (16.33)
15 3 (33.33) 5 (71.43) 3 (17.65) 6 (46.15) 0 (0,00) 7 (33.33) 6 (12.24) 18 (36.73)
Stairs 0 6 (66.67) 2 (28.57) 12 (70.59) 4 (30.77) 18 (78.26) 8 (38.10) 36 (73.47) 14 (24.57)
5 1 (11.11) 0 (0.00) 1 (5.88) 3 (23.08) 3 (13.04) 4 (19.05) 5 (10.20) 7 (14.29)
10 2 (22.22) 5 (71.43) 4 (23.53) 6 (46.15) 2 (8.70) 9 (42.86) 8 (16.33) 20 (40.82)
Barthel Index HIV+ HIV- HIV undiagnosed Total
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4.6.3 Assistive devices issued on discharge 
The assistive device issued on discharge is a good indicator of function as it relays how 
dependent participants are in terms of mobility. Table 4.8 below describes how many 
participants in each group required assistive devices on admission and discharge. 
On admission the majority of the study sample required wheelchairs as they were not 
safe to mobilise independently; this was seen for the individual groups, with a larger 
majority occurring in the HIV undiagnosed group. No statistical significance was found 
among groups (p = 0.102.). 
Overall equal numbers of patients required wheelchairs and were independent in 
mobilising on discharge. Looking at the individual groups, more than half of the HIV+ 
group did not require assistive devices and were able to mobilise unaided, whereas in 
the HIV- group, 41.67% (n = 5) required a walking stick and 33.33% (n = 4) required a 
wheelchair. In the HIV undiagnosed group, 40% (n = 8) required a wheelchair, while 30% 
(n = 6) were able to mobilise unaided. Even though the HIV+ group had a larger majority 
of participants mobilising unaided, no statistical significance was found among groups  
(p = 0.722). 
Table 4.8:  Assistive devices issued on admission and discharge  
Assistive Devices HIV+ 
 
HIV- 
 
HIV 
undiagnosed 
Total 
 
Assistive device on admission  
n (%) 
n= 9 (18.36%) n= 17 (34.69%) n= 23 (46.94%) n= 49 (100%) 
1- no aid required 3 (33.33) 5 (29.41) 1 (4.35) 9 (18.37) 
2- walking stick 0 (0.00) 0 (0.00) 1 (4.35) 1 (2.04) 
3- crutches 0 (0.00) 0 (0.00) 1 (4.35) 1 (2.04) 
4- walking frame 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00) 
5- wheelchair 6 (66.67) 12 (70.59) 20 (86.96) 38 (77.55) 
Assistive device on discharge  
n (%) 
n= 7 (17.07%) n= 13 (31.71%) n= 21 (46.94%) n= 41 (100%) 
1- no aid required 4 (57.14) 3 (25.00) 6 (30.00) 13 (33.33) 
2- walking stick 2 (28.57) 5 (41.67) 5 (25.00) 12 (30.77) 
3- crutches 0 (0.00) 0 (0.00) 1 (5.00) 1 (2.56) 
4- walking frame 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00) 
5- wheelchair 1 (14.29) 4 (33.33) 8 (40.00) 13 (33.33) 
Mdn- median; Min- minimum; Max- maximum 
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4.6.4 Balance, safety and risk of falling described using the Berg Balance Scale 
(BBS) and pressure mapping 
4.6.4.1  Berg Balance Scale (BBS) 
The BBS provides a quantitative assessment of balance in older adults as well as 
determining risk of falls. The scale consists of 14 items performed in everyday life. (See 
Tables 4.9 and 4.10 displaying frequency and percentage scores for individual items on 
the BBS for items 1 to 7 and 8 to 14 respectively). The items receive a score of 0 to 4 
where a score of 0 indicates inability to do an activity and 4 means ability to complete the 
activity. The maximum score is 56 (Berg et al., 1992).  
Overall, the median result for the admission scores for the study sample indicated a 
medium risk of falling (Table 4.11). On discharge the median score indicated a low risk 
of falling for the entire sample. Looking at the individual items on the BBS, specifically the 
independent standing balance which required participants to stand unaided for two 
minutes, only 36.73% (n = 18) were able to stand independently. This improved to 
61.22% (n = 30) of the sample who participated in the re-assessment prior to discharge 
(Table 4.9). The MDC is 6.9 points and no MCID has been established for the BBS 
(Hiengkaew, Jitaree & Chaiyawat, 2012). Even though the median MDC score for the 
HIV- and undiagnosed groups were double the HIV+ MCD score (Table 4.11), no 
statistical significance was found among groups (p = 0.4170). 
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Table 4.9:  Berg Balance Scale displaying frequency and percentage scores for 
individual items 1 to 7  
 
Item Score Admission Discharge Admission Discharge Admission Discharge Admission Discharge
n= 9 
(18.37%)
n= 7 
(17.07%)
n= 17 
(34.69%)
n= 13 
(31.71%)
n= 23 
(46.94%)
n= 21 
(51.21%)
n= 49 
(100%)
n= 41 
(100%)
Sitting to standing 0 0 (0.00) 0 (0.00) 3 (17.65) 1 (7.69) 5 (21.74) 1 (4.76) 8 (16.33) 2 (4.08)
1 2 (22.22) 1 (14.29) 2 (11.76) 0 (0.00) 4 (17.39) 1 (4,67) 8 (16.33) 2 (4.08)
2 0 (0.00) 0 (0.00) 2 (11.76) 0 (0.00) 2 (8.70) 0 (0.00) 4 (8.16) 0 (0.00)
3 3 (33.33) 0 (0.00) 5 (29.41) 5 (38.46) 8 (34.78) 5 (23.81) 16 (32.65) 10 (20.41)
4 4 (44.44) 6 (85.71) 5 (29.41) 7 (53.85) 4 (17.39) 14 (66.67) 13 (26.53) 27 (55.10)
Standing unsupported 0 3 (33.33) 1 (14.29) 4 (23.53) 1 (7.69) 8 (34.78) 2 (9.52) 15 (30.61) 4 (8.16)
1 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00)
2 1 (11.11) 0 (0.00) 1 (5.88) 0 (0.00) 0 (0.00) 1 (4.76) 2 (4.08) 1 (2.04)
3 1 (11.11) 0 (0.00) 5 (29.41) 4 (30.77) 8 (34.78) 2 (9.52) 14 (28.57) 6 (12.24)
4 4 (44.44) 6 (85.71) 7 (41.18) 8 (61.54) 7 (30.43) 16 (76.19) 18 (36.73) 30 (61.22)
Sitting unsupported 0 0 (0.00) 0 (0.00) 1 (5.88) 0 (0.00) 0 (0.00) 0 (0.00) 1 (2.04) 0 (0.00)
1 0 (0.00) 0 (0.00) 1 (5.88) 0 (0.00) 0 (0.00) 0 (0.00) 1 (2.04) 0 (0.00)
2 1 (11.11) 0 (0.00) 0 (0.00) 1 (7.69) 0 (0.00) 0 (0.00) 1 (2.04) 1 (2.04)
3 0 (0.00) 0 (0.00) 1 (5.88) 0 (0.00) 3 (13.04) 0 (0.00) 4 (8.16) 0 (0.00)
4 8 (88.89) 7 (100.00) 14 (82.35) 12 (92.31) 20 (86.96) 21 (100.00) 42 (85.71) 40 (81.63)
Standing to sitting 0 0 (0.00) 0 (0.00) 1 (5.88) 1 (7.69) 3 (13.04) 1 (4.76) 4 (8.16) 2 (4.08)
1 2 (22.22) 1 (14.29) 3 (17.65) 0 (0.00) 3 (13.04) 0 (0.00) 8 (16.33) 1 (2.04)
2 1 (11.11) 0 (0.00) 3 (17.65) 0 (0.00) 4 (17.39) 1 (4.76) 8 (16.33) 1 (2.04)
3 2 (22.22) 0 (0.00) 4 (23.53) 4 (30.77) 9 (39.13) 4 (19.05) 15 (30.61) 8 (16.33)
4 4 (44.44) 6 (85.71) 6 (35.29) 8 (61.54) 4 (17.39) 15 (71.43) 14 (28.57) 29 (59.18)
Transfers 0 0 (0.00) 1 (14.29) 2 (11.76) 0 (0.00) 1 (4.35) 1 (4.76) 3 (6.12) 1 (2.04)
1 3 (33.33) 0 (0.00) 2 (11.76) 1 (7.69) 6 (26.09) 0 (0.00) 11 (22.45) 2 (4.08)
2 1 (11.11) 0 (0.00) 3 (17.65) 1 (7.69) 6 (26.09) 2 (9.52) 10 (20.41) 3 (6.12)
3 1 (11.11) 0 (0.00) 5 (29.41) 2 (15.38) 4 (17.39) 3 (14.29) 10 (20.41) 5 (10.20)
4 4 (44.44) 6 (85.71) 5 (29.41) 9 (69.23) 6 (26.09) 15 (71.43) 15 (30.61) 30 (61.22)
Standing with eyes closed 0 3 (33.33) 1 (14.29) 5 (29.41) 1 (7.69) 8 (34.78) 2 (9.52) 16 (32.65) 4 (8.16)
1 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00)
2 0 (0.00) 0 (0.00) 0 (0.00) 2 (15.38) 0 (0.00) 0 (0.00) 0 (0.00) 2 (4.08)
3 3 (33.33) 1 (14.29) 8 (47.06) 2 (15.38) 10 (43.48) 6 (28.57) 21 (42.86) 8 (16.33)
4 3 (33.33) 5 (71.43) 4 (23.53) 8 (61.54) 5 (21.74) 13 (61.90) 12 (24.49) 27 (55.10)
Standing with feet together 0 4 (44.44) 1 (14.29) 5 (29.41) 1 (7.69) 9 (39.13) 3 (14.29) 18 (36.73) 5 (10.20)
1 1 (11.11) 0 (0.00) 1 (5.88) 0 (0.00) 1 (4.35) 0 (0.00) 3 (6.12) 0 (0.00)
2 0 (0.00) 0 (0.00) 2 (11.76) 0 (0.00) 1 (4.35) 1 (4.76) 3 (6.12) 1 (2.04)
3 1 (11.11) 1 (14.29) 6 (35.29) 5 (38.46) 6 (26.09) 5 (23.81) 13 (26.53) 11 (22.45)
4 3 (33.33) 5 (71.43) 3 (17.65) 7 (53.85) 6 (26.09) 12 (57.14) 12 (24.49) 24 (48.98)
Berg balance scale HIV+ HIV- HIV undiagnosed Total
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Table 4.10: Berg Balance Scale displaying frequency and percentage scores for 
individual items 8 to 14  
 
  
Item Score Admission Discharge Admission Discharge Admission Discharge Admission Discharge
n= 9 
(18.37%)
n= 7 
(17.07%)
n= 17 
(34.69%)
n= 13 
(31.71%)
n= 23 
(46.94%)
n= 21 
(51.21%)
n= 49 
(100%)
n= 41 
(100%)
Reaching forward 0 3 (33.33) 1 (14.29) 5 (29.41) 1 (7.69) 8 (34.78) 3 (14.29) 16 (32.65) 5 (10.20)
1 1 (11.11) 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00) 1 (2.04) 0 (0.00)
2 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00)
3 0 (0.00) 0 (0.00) 2 (11.76) 1 (7.69) 4 (17.39) 3 (14.29) 6 (12.24) 4 (8.16)
4 5 (55.56) 6 (85.71) 10 (58.82) 11 (84.62) 11 (47.83) 15 (71.43) 26 (53.06) 32 (65.31)
Retrieving object 0 5 (55.56) 1 (14.29) 6 (35.29) 2 (15.38) 11 (47.83) 4 (19.05) 22 (44.90) 6 (12.24)
1 0 (0.00) 0 (0.00) 1 (5.88) 2 (15.38) 0 (0.00) 0 (0.00) 1 (2.04) 2 (4.08)
2 0 (0.00) 0 (0.00) 0 (0.00) 1 (7.69) 0 (0.00) 0 (0.00) 0 (0.00) 1 (2.04)
3 0 (0.00) 1 (14.29) 5 (29.41) 1 (7.69) 9 (39.13) 6 (28.57) 14 (28.57) 9 (18.37)
4 4 (44.44) 5 (71.43) 5 (29.41) 7 (53.85) 3 (13.04) 11 (52.38) 12 (24.49) 23 (46.94)
Turning to look behind 0 3 (33.33) 1 (14.29) 5 (29.41) 1 (7.69) 8 (34.78) 3 (14.29) 16 (32.65) 5 (10.20)
1 1 (11.11) 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00) 1 (2.04) 0 (0.00)
2 0 (0.00) 0 (0.00) 1 (5.88) 0 (0.00) 1 (4.35) 0 (0.00) 2 (4.08) 0 (0.00)
3 1 (11.11) 1 (14.29) 5 (29.41) 5 (38.46) 9 (39.13) 3 (14.29) 15 (30.61) 9 (18.37)
4 4 (44.44) 5 (71.43) 6 (35.29) 7 (53.85) 5 (21.74) 15 (71.43) 15 (30.61) 27 (55.10)
Turning 360 0 5 (55.56) 1 (14.29) 10 (58.82) 4 (30.77) 13 (56.52) 6 (28.57) 28 (57.14) 11 (22.45)
1 0 (0.00) 1 (14.29) 1 (5.88) 1 (7.69) 1 (4.35) 0 (0.00) 2 (4.08) 2 (4.08)
2 1 (11.11) 0 (0.00) 1 (5.88) 1 (7.69) 4 (17.39) 5 (23.81) 6 (12.24) 6 (12.24)
3 1 (11.11) 0 (0.00) 1 (5.88) 2 (15.38) 2 (8.70) 1 (4.76) 4 (8.16) 3 (6.12)
4 2 (22.22) 5 (71.43) 4 (23.53) 5 (38.46) 3 (13.04) 9 (42.86) 9 (18.37) 19 (38.78)
Placing alternate foot 0 5 (55.56) 2 (28.57) 10 (58.82) 4 (30.77) 15 (65.22) 9 (42.86) 30 (61.22) 15 (30.61)
1 0 (0.00) 0 (0.00) 2 (11.76) 1 (7.69) 0 (0.00) 0 (0.00) 2 (4.08) 1 (2.04)
2 0 (0.00) 0 (0.00) 0 (0.00) 2 (15.38) 0 (0.00) 1 (4.76) 0 (0.00) 3 (6.12)
3 2 (22.22) 0 (0.00) 1 (5.88) 0 (0.00) 3 (13.04) 3 (14.29) 6 (12.24) 3 (6.12)
4 2 (22.22) 5 (71.43) 4 (23.53) 6 (46.15) 5 (21.74) 8 (38.10) 11 (22.45) 19 (38.78)
Standing with feet together 0 6 (66.67) 2 (28.57) 8 (47.06) 5 (38.46) 14 (60.87) 10 (47.62) 28 (57.14) 18 (36.73)
1 1 (11.11) 0 (0.00) 4 (23.53) 2 (15.38) 3 (13.04) 1 (4.76) 8 (16.33) 3 (6.12)
2 0 (0.00) 1 (14.29) 1 (5.88) 0 (0.00) 1 (4.35) 1 (4.76) 2 (4.08) 2 (4.08)
3 0 (0.00) 0 (0.00) 3 (17.65) 3 (23.08) 4 (17.39) 3 (14.29) 7 (14.29) 6 (12.14)
4 2 (22.22) 4 (57.14) 1 (5.88) 3 (23.08) 1 (4.35) 5 (23.81) 4 (8.16) 12 (24.49)
Standing on one foot 0 6 (66.67) 2 (28.57) 9 (52.94) 3 (23,08) 13 (56.52) 7 (33.33) 28 (57.14) 12 (24.49)
1 1 (11.11) 1 (14.29) 2 (11.76) 0 (0.00) 2 (8.70) 3 (14.29) 5 (10.20) 4 (8.16)
2 0 (0.00) 0 (0.00) 0 (0.00) 3 (23.08) 1 (4.35) 1 (4.76) 1 (2.04) 4 (8.16)
3 0 (0.00) 1 (14.29) 2 (11.76) 3 (23.08) 4 (17.39) 5 (23.81) 6 (12.24) 9 (18.37)
4 2 (22.22) 3 (42.86) 4 (23.53) 4 (30.77) 3 (13.04) 5 (23.81) 9 (18.37) 12 (24.49)
HIV- HIV undiagnosed TotalHIV+Berg balance scale
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Table 4.11: Berg Balance Scale displaying median and range scores for balance  
Berg Balance Scale HIV+  
mdn (min-max) 
HIV-  
mdn (min-max) 
HIV undiagnosed 
mdn (min-max) 
Total  
mdn (min-max) 
 n= 9 (18.36%) n= 17 (34.69%) n= 23 (46.94%) n= 49 (100%) 
Admission 27 (7-56) 33 (0-56) 28 (7-56) 29 (0-56) 
 n= 7 (17.07%) n= 13 (31.71%) n= 21 (51.21%) n= 41 (100%) 
Discharge 54 (7-56) 54 (3-56) 45 (4-56) 47 (3-56) 
Difference 
(between 
admission and 
discharge scores) 
8 (0-31) 16 (3-27) 15 (0-52) 15 (0-52) 
Mdn- median; Min- minimum; Max- maximum 
 
4.6.4.2 MatScan 
The MatScan is a pressure measurement platform. Combined with Tekscan software, the 
mat is able to record and evaluate balance using different variables and gives the 
assessor an output for each variable in order to ascertain any impairment and describe 
balance more comprehensively (www.tekscan.com/medical). The variables assessed in 
this study were (i) asymmetry in static standing looking at the difference in percentage 
weight bearing between each lower limb, (ii) center of pressure (COP) velocity, and (iii) 
distance COP travelled in anterior-posterior and mediolateral directions denoted as sway 
(Table 4.12). A few participants, however, displayed deterioration on reassessment prior 
to discharge and this is reflected in the negative scores in the range within the median 
difference between admission and discharge scores (Table 4.12). Normal ranges for the 
following variables have not yet been established (Kumar, Omar, Htwe, Joseph, 
Krishnan, Esfehani & Min, 2014). 
(i) Weight bearing asymmetry 
The overall results for the weight bearing difference between affected and less affected 
lower limbs seemed to have regressed when looking at the median as it showed that the 
weight bearing difference had increased by 2% on discharge. However, the range 
(minimum to maximum values) shows a great improvement, with the maximum difference 
in asymmetry decreasing by 44%. The difference between asymmetry in weight bearing 
for the total study sample when comparing admission and discharge results was 2%. The 
HIV+ group was 4% more than other groups but showed no statistical significant 
difference among groups (p = 0.3834).  
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(ii) COP Velocity 
Overall, the study sample improved by 0.01 m/s in static standing velocity, i.e. COP 
moving slower indicative of increased stability. The individual groups displayed similar 
results. There was no statistically significant difference found for admission and discharge 
results for COP velocity (p = 0.6330). 
(iii) Anterior-posterior and mediolateral sway of COP 
Overall, the anterior-posterior sway improved by 0.62cm and the mediolateral sway 
improved by 0.6cm. A decrease in the distance is indicative of increased stability. Looking 
at the difference between admission and discharge scores, the HIV+ group improved 
more than the other groups in the anterior-posterior sway and regressed more in the 
mediolateral sway. However, no statistical significance was found for the difference 
between admission and discharge results for anterior-posterior nor medio-lateral sway (p 
= 0.9045 and p = 0.7931 respectively).  
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Table 4.12: MatScan results for weight bearing symmetry and centre of pressure   
measurements 
WB= Weight bearing; AP= Anterior Posterior; ML= Mediolateral; Mdn- median; Min- minimum; 
Max- maximum 
  
Variables HIV+  
mdn (min-max  ) 
HIV- 
mdn (min-max  ) 
HIV undiagnosed 
mdn (min-max  ) 
Total 
mdn (min-max  ) 
P-value 
Asymmetry (%) 
 n= 9 (18.36%) n= 17 (34.69%) n= 23 (46.94%) n= 49 (100%)  
 Admission 25 (4 - 52) 14 (2 - 68) 14 (0 - 22) 14 (0 - 68)  
 n= 7 (17.07%) n= 13 (31.71%) n= 21 (51.2%) n= 41 (100%)  
 Discharge 9 (4 - 20) 17 (0 - 100) 18 (0 - 28) 16 (0 - 24)  
Median difference 
between 
admission and 
discharge 
6 (-2 - 42) 2 (-8 - 44) 2 (-14 - 20) 2 (-14 -44) 0.3834 
Velocity (m/s) 
 n= 9 (18.36%) n= 17 (34.69%) n= 23 (46.94%) n= 49 (100%)  
 Admission 0.03 (0.02 - 3.23) 0.03 (0.02 - 0.14) 0.02 (0.01 – 0.05) 0.03 (0.01 – 3.23)  
 n= 7 (17.07%) n= 13 (31.71%) n= 21 (51.2%) n= 41 (100%)  
 Discharge 0.02 (0.02 - 0.03) 0.02 (0.02 - 0.04) 0.02 (0.01 – 1.00) 0.02 (0.01 – 1.00)  
Median difference 
between 
admission and 
discharge 
0.001(-0.001 - 3.21) 0.01 (-0.01 - 0.13) 0.001 (-0.11 – 0.02) 0.01 (-0.11 – 3.21) 0.6330 
AP sway (cm) 
 n= 9 (18.36%) n= 17 (34.69%) n= 23 (46.94%) n= 49 (100%)  
 Admission 2.92 (0.95 - 6.05) 2.94 (1.40 – 8.25) 3.18 (1.67 – 9.13) 3.05 (0.95 – 9.13)  
 n= 7 (17.07%) n= 13 (31.71%) n= 21 (51.2%) n= 41 (100%)  
 Discharge 1.64 (1.06 - 2.41) 2.26 (1.53 – 5.41) 2.56 (1.75 – 5.56) 2.43 (1.06 – 5.56)  
Median difference 
between 
admission and 
discharge 
0.75 (-0.23 - 2.37) 0.50 (-0.73– 6.48) 0.45 (-0.08 – 3.57) 0.54 (-0.86 – 6.48) 0.9045 
ML sway (cm) 
 n= 9 (18.36%) n= 17 (34.69%) n= 23 (46.94%) n= 49 (100%)  
 Admission 2.81 (0.52 - 8.97) 3.66 (0.99 – 9.72) 2.56 (0.06 – 15.59) 3.04 (0.06 – 15.59)  
 n= 7 (17.07%) n= 13 (31.71%) n= 21 (51.21%) n= 41 (100%)  
 Discharge 1.65 (0.66 - 4.83) 2.70 (0.72 – 5.99) 2.58 (0.82 – 4.68) 2.44 (0.66 – 5.99)  
Median difference 
between 
admission and 
discharge 
 
0.36 (-1.00 - 4.99) 0.35 (-0.81– 8.20) 0.94 (-1.60 – 12.94) 0.62 (-1.60 – 
12.94) 
0.7931 
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4.6.5 Patient perception of functional outcome using the EQ5D 
The EQ5D is a self-reported measurement tool used in various conditions including 
HIV/AIDS and stroke (Hunger et al., 2012). In scoring, patients were asked to tick off the 
statement/level (1 to 3) that best described their current health status in each domain. 
Level 1 being the best option and level 3 being the worst. Patients were also asked to 
score their health status using a Visual Analog Scale (VAS) rating 0 to 100; the score of 
0 being worst and 100 the best. The results are presented below. 
4.6.5.1  Perception of best imaginable health state  
As expected, the overall scores were high for all participants prior to stroke with the 
maximum score of 100 as the median (Table 4.13). The majority of participants reported 
independence in ADLs as well as being pain free and having lower levels of anxiety. 
These overall scores dropped by half, as would be expected on admission to 
rehabilitation after a stroke. The scores improved significantly with a median of 30 points 
on discharge, showing great improvement. One participant however displayed 
deterioration on reassessment prior to discharge and this is reflected in the negative 
score in the range within the HIV- group. With regard to the Best Imaginable Health State 
Scale on comparing the difference between ‘prior to stroke’, admission and discharge 
scores, no statistical significant difference was found among groups (p = 0.8048). 
Table 4.13:  Best imaginable Health State Scale as measured by VAS and EQ5D 
Best Imaginable 
Health state scale  
HIV+  
mdn (min- max) 
HIV-  
mdn (min- max) 
HIV undiagnosed 
mdn (min- max) 
Total  
mdn (min- max) 
 n= 9 (18.37%) n= 17 (34.69%) n= 23 (46.94%) n= 49 (100%) 
Prior to stroke 100 (80-100) 100 (50-100) 100 (70-100) 100 (50-100) 
Admission 50 (20-65) 50 (20-100) 50 (10-90) 50 (10-100) 
 n= 7 (17.07%) n= 13 (31.71%) n= 21 (51.21%) n= 41 (100%) 
Discharge 75 (60-100) 80 (59-90) 85 (50-100) 80 (50-100) 
Median difference 
(between  admission 
and discharge scores) 
30 (15-40) 30 (-30- 70) 30 (5-75) 30 (-30- 75) 
Mdn- median; Min- minimum; Max- maximum 
4.6.5.2.  Perception of function, pain and anxiety 
On admission, scores dropped with 85.71% (n = 42) of participants reporting problems 
with walking and self-care, nearly half (n = 24; 48.98%) reported some problems with 
usual activities and 44.90% (n = 22) reported an inability to perform usual activities (Table 
Stellenbosch University  https://scholar.sun.ac.za
 55 
 
4.14). Participants who reported moderate pain and discomfort doubled on admission 
and those who experienced anxiety or depression increased by 22.45% (n = 11). 
Great improvement in perception of function, pain and discomfort as well as anxiety and 
depression were noted on discharge. The mobility scores on discharge improved 
significantly with 51.22% (n = 21) participants reporting no problems with walking 
compared to 6.12% (n = 3) on admission. The odds of attaining a better perceived 
outcome for mobility on discharge was 48% (p = 0.001), 36% better outcome on self-care 
(p = 0.001) and 41% better chance of attaining a better perceived score on discharge for 
usual activities (p = 0.001). No significant differences were found for these items among 
groups. 
When comparing prior and admission scores for items, pain and discomfort as well as 
anxiety and depression showed a significant decrease (p = 0.022 and p = 0.001 
respectively). When comparing prior and discharge scores, no significant difference was 
noted for items pain and discomfort nor anxiety and depression (p = 0.279 and 
p = 0.101 respectively). This showed that discharge scores improved from admission 
scores and most patients returned to their perceived baseline level. No significant 
differences were noted among groups. 
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Table 4.14:  Patient perception of function according to EQ5D questionnaire 
 
Mobility, self-care and usual activities: Level 1= independent in activity; Level 2= assistance needed with activity; Level 3= inability to do activity 
Pain/discomfort and anxiety /depression: Level 1= does not experience symptoms; Level 2= experience moderate symptoms; Level 3= experiences severe symptom  
Prior Admission Discharge Admission Prior Admission Discharge Prior Admission Discharge
n= 9 
(18.37%)
n= 9 
(18.37%)
n= 7 
(17.07%)
n= 17 
(34.69%)
n= 23 
(46.94%)
n= 23 
(46.94%)
n= 21 
(51.21%)
n= 49 
(100%)
n= 49 
(100%)
n= 41 
(100%)
Mobility Level 1 9 (100.00) 1 (11.11) 5 (71.43) 1 (5.88) 22 (95.65) 1 (4.35) 8 (38.10) 48 (97.96) 3 (6.12) 21 (51.22)
Level 2 0 (0.00) 7 (77.78) 2 (28.57) 16 (94.12) 1 (4.35) 19 (82.61) 13 (61.90) 1 (2.04) 42 (85.71) 19 (46.34)
Level 3 0 (0.00) 1 (11.11) 0 (0.00) 0 (0.00) 0 (0.00) 3 (13.04) 0 (0.00) 0 (0.00) 4 (8.16) 0 (0.00)
Self-care Level 1 9 (100.00) 1 (11.11) 6 (85.71) 3 (17.65) 23 (100.00) 2 (8.70) 16 (76.19) 49 (100.00) 6 (12.24) 32 (78.05)
Level 2 0 (0.00) 8 (88.89) 1 (14.29) 14 (82.35) 0 (0.00) 20 (86.96) 5 (23.81) 0 (0.00) 42 (85.71) 9 (21.95)
Level 3 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00) 1 (4.35) 0 (0.00) 0 (0.00) 1 (2.04) 0 (0.00)
Usual Activities Level 1 9 (100.00) 0 (0.00) 5 (71.43) 2 (11.76) 22 (65.65) 1 (4.35) 14 (66.67) 48 (0.00) 3 (6.12) 24 (58.54)
Level 2 0 (0.00) 5 (55.56) 2 (28.57) 9 (52.94) 1 (4.35) 10 (43.48) 6 (28.57) 1 (2.04) 24 (48.98) 16 (39.02)
Level 3 0 (0.00) 4 (44.44) 0 (0.00) 6 (35.29) 0 (0.00) 12 (52.17) 1 (4.76) 0 (0.00) 22 (44.90) 1 (2.44)
Pain/ discomfort Level 1 7 (77.78) 4 (44.44) 5 (71.43) 13 (76.47) 15 (65.22) 11 (47.83) 12 (57.14) 38 (77.55) 28 (57.14) 28 (68.29)
Level 2 1 (11.11) 4 (44.44) 1 (14.29) 4 (23.53) 8 (34.78) 12 (52.17) 9 (42.86) 10 (20.41) 20 (40.82) 12 (29.27)
Level 3 1 (11.11) 1 (11.11) 1 (14.29) 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00) 1 (2.04) 1 (2.04) 1 (2.44)
Anxiety/ depression Level 1 7 (77.78) 6 (66.67) 5 (71.42) 10 (58.82) 20 (86.96) 16 (69.57) 17 (80.95) 43 (87.76) 32 (65.31) 32 (78.05)
Level 2 1 (11.11) 3 (33.33) 2 (28.57) 4 (23.53) 3 (13.04) 7 (30.43) 4 (19.05) 5 (10.20) 14 (28.57) 8 (19.51)
Level 3 1 (11.11) 0 (0.00) 0 (0.00) 3 (17.65) 0 (0.00) 0 (0.00) 0 (0.00) 1 (2.04) 3 (6.12) 1 (2.44)
17 (100.00) 5 (38.46)
0 (0.00) 8 (61.54)
0 (0.00) 0 (0.00)
0 (0.00) 1 (7.69)
16 (94.12) 11 (84.62)
1 (5.88) 2 (15.38)
0 (0.00) 0 (0.00)
16 (94.12) 10 (76.92)
1 (5.88) 2 (15.38)
0 (0.00)
17 (100.00) 8 (61.54)
0 (0.00) 4 (30.77)
0 (0.00) 0 (0.00)
17 (100.00) 10 (76.92)
0 (0.00) 3 (23.08)
0 (0.00)
Prior Discharge
n= 17 
(34.69%)
n= 13 
(31.71%)
EQ5D Admission Scores
EQ5D Items HIV + HIV - HIV Undiagnosed Total
HIV- status
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4.7 Summary 
The aim of the study was to describe the functional outcomes of stroke patients post 
inpatient rehabilitation with regard to their HIV status. This chapter described the 
demographic, stroke-related information, clinical presentation as well as function of 
participants, highlighting differences among the respective groups. Even though some 
differences between demographics and functional scores were seen, the sample size as 
well as the distribution of participants among groups was too small to conclude statistically 
significant differences. The next chapter will discuss the findings in detail, comparing current 
results with local and international literature. 
 
 
 
 
 
 
 
  
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
 58  
 
Chapter 5:  Discussion 
 
5.1 Introduction 
This chapter discusses the results obtained and how they compare to other local and 
international studies. The results are discussed under various headings, such as 
demographics and clinical presentation of people with stroke, functional outcomes on 
admission and discharge, and patient perception of function.  
 
5.2 Demographics of Sample 
 
5.2.1 Gender 
 
The male to female ratio was closely matched in our study. Even though the HIV+ group 
was the only group with more females, no significant difference was found among groups. 
In sub-Saharan Africa more females than males are diagnosed with HIV. According to 
UNAIDS (2016) 56% of the newly infected HIV population in sub-Saharan Africa were 
female. Seven of the 11 studies in the scoping review (see Chapter 2) had more females 
than males but none of them showed this difference to be significant (Heikinheimo, 2012; 
Mlay & Bakari, 2010; Tipping et al., 2007; Modi et al., 2007; Kumwenda et al., 2005; Patel 
et al., 2005; Mochan et al., 2003). All of these studies had a small HIV+ stroke population. 
This may have been due to not all paients being tested for HIV and seen in the undiagnosed 
group of the current study. Majority of the primary studies were based at one hospital so this 
is not a true reflection of the wider HIV+ stroke population. Being that these patients are 
young, some may have recovered well in hospital and are referred home or to their local 
CHC or day hospital. Some who are in their late stages of HIV may even be referred to 
palliative care as their prognosis was poor. Larger samples are needed to consider whether 
gender has a significant impact on the prevalence of HIV+ stroke patients. 
 
5.2.2 Race 
Overall, mixed race was the largest ethnic group in our study. With regard to race, the 
majority of the HIV+ group were of black ethnicity and the majority of the HIV- and 
undiagnosed groups were mixed race. The differences between groups were not significant 
although, admittedly the sample was small. A study done by Hoffman et al. (2000) in Durban 
(KwaZulu Natal, South Africa) which focused on the black-white racial difference in stroke 
distribution, found that in addition to being significantly younger, the black racial category 
had a majority of HIV+ participants. Three other studies conducted in South Africa, which 
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focused only on HIV+ stroke participants, also based their studies solely on the black racial 
category as a larger percentage of HIV+ people are considered to be of black ethnicity (Modi 
et al., 2007; Patel et al., 2005; Hoffman et al., 2000). According to UNAIDS (2016), more 
than half of the global HIV+ population reside in Southern Africa. The majority of sub-
Saharan African people are of black ethnicity; this may be why these studies were focused 
on one particular race. 
5.2.3 Age 
What seemed to be a common thread through literature is the significant age difference 
between HIV+ and HIV- stroke patients. According to UNAIDS (2016) 34% of the young 
HIV+ population who are aged between 15 and 24 years reside in sub-Saharan Africa, 
whereas globally 22% of the HIV+ population are aged between 15 and 24 years. This was 
seen in the current study with the HIV- and HIV undiagnosed groups having a median age 
of 51 and 53 respectively and the HIV+ group with the median age of 30. A prospective 
cohort study done by Tipping et al. (2007) reported that 91% of the HIV+ stroke sample were 
less than 46 years of age. The HIV+ group had a mean age of 33.4 years and 64 years for 
their control group who were HIV negative. Similar results were yielded by three other 
African studies (Heikinheimo et al., 2012; Malay & Bakari, 2010; Kumwenda et al., 2005). 
Other studies in our scoping review which looked only at the HIV+ stroke patients found that 
the majority of participants were aged younger than 50 years (Jowi et al., Modi et al., 2007; 
2007; Mochan et al., 2003).  
 
5.3 Clinical Presentation of Stroke 
 
5.3.1 Side of stroke 
In terms of the presentation in left and right stroke patients, symptoms originate from a lesion 
in the contralateral side of the brain i.e. a right sided brain lesion/stroke would give rise to 
symptoms on the left side of the body and vice versa (Kottorp, Ekstan & Lie, 2013). Both left 
and right strokes may experience symptoms of hemianopia, hemianaesthesia and 
hemiplegia (Kottorp et al., 2013). Problems such as understanding speech or word finding 
issues occur mainly in left sided brain lesions/stroke, while both left and right lesions could 
have difficulty speaking clearly due to vocal cord control being affected (Kottorp et al., 2013; 
Hart, 1990;). Hemineglect as well as lack of insight and difficulties with visual and spatial 
skills occur mainly in right sided brain lesions/stroke (Kottorp et al., 2013). Hemiplegia refers 
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to the decrease in strength or paralyses, but is used often as a term that encompasses all 
impairments that are expected with left or right sided brain lesions (Hart, 1990). 
A Swiss study which looked at the difference of awareness between left and right sided 
hemiplegia, found that of 183 participants 42.63% had left sided brain lesions and 57.38% 
had right sided brain lesions (Kottorp et al., 2013). This Swiss study found no significant 
difference between groups in terms of functional status and ability to perform ADLs. 
Similarly, of the overall sample in our current study, 51.02% of participants had left 
hemiplegia and 46.94% had right hemiplegia. This distribution was similar in all three groups, 
with one participant in the HIV undiagnosed group having a cerebellar stroke. Similar to 
Kottorp et al. (2013) no significant differences were seen in functional outcome between left 
and right hemiplegic participants of the current study. 
5.3.2 Risk factors for stroke 
The most common risk factors or combination of risk factors for stroke are hypertension and 
type 2 diabetes (Hu, Sarti, Jousilahti, Peltonen, Qiao, Antikainen & Tuomilehto, 2005). The 
current study displayed similar results with the most common risk factor being hypertension 
in both HIV- and undiagnosed groups. The most common combination in the HIV- group 
was hypertension and smoking, and in the HIV undiagnosed group hypertension and 
diabetes. This differed significantly to the HIV+ group with regard to hypertension and 
diabetes. This was reiterated in the scoping review with the usual risk factors, such as 
diabetes and hypertension, being uncommon in the HIV+ groups (; Heikinheimo et al., 2012; 
Tipping et al., 2007; Hoffman et al., 2000). Heikinheimo et al. (2012) suggested that this may 
be due to hypertension and diabetes type 2 being strongly correlated with age. 
A study conducted by Tipping et al. (2007) found similar results and suggested that HIV 
could be a risk factor for stroke as participants were significantly younger with no other risk 
factors. Having HIV could be considered a risk factor for stroke. The current study showed 
22.22% of the HIV+ group without a known risk factor for stroke which was not seen in the 
HIV- and undiagnosed groups. Similarly, of the HIV+ participants in a study conducted by 
Hoffman et al. (2000), 85% fell into the unknown stroke cause category. Patel et al. (2005) 
who conducted a study to determine whether HIV seropositivity confers a predisposition to 
stroke by comparing age-matched HIV+ and HIV- black African patients with 
cerebrovascular disease reported an odds ratio of 2.3, indicating that individuals who were 
HIV+ were twice as likely to have a stroke. Patel et al. (2005) also stated that until studies 
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on larger cohorts are done, an HIV+ test should not preclude further investigations to rule 
out other causes for stroke. 
The current study found opportunistic infections to be the most common reported risk factor 
of stroke in the HIV+ group. Five studies in the scoping review had similar findings (Tipping 
et al., 2007; Kumwenda et al., 2005; Patel et al., 2005; Mochan et al., 2003; Hoffman et al., 
2000). These studies suggested that there is a strong correlation between HIV-related stroke 
and opportunistic infection. These studies also suggested that opportunistic infection was 
more prevalent than the conventional risk factors such as hypertension, diabetes, smoking 
and substance abuse amongst the HIV+ stroke group. In the current study, HIV+ participants 
still presented with some conventional risk factors, e.g. both smoking and substance abuse 
occurred in 22% of participants and hypertension and cholesterol in 11% respectively. This 
varied significantly from the HIV- and undiagnosed groups. 
A low CD4 count has also been considered to be a risk factor for stroke in HIV+ populations. 
Five studies in the scoping review showed that a CD4 count of less than 200 was seen in 
most HIV+ stroke patients (Heikinheimo et al., 2012; Mlay & Bakari, 2010; Jowi et al., 2007; 
Modi et al., 2007; Tipping et al., 2007;). Similarly, the current study had a median CD4 of 
130 (range 54-883). Mlay and Bakari (2010) also suggested that stroke or severe 
neurological manifestations may be an indication of late stage HIV. Other common risk 
factors for HIV-related stroke were vascular manifestations such as vasculitis, coagulopathy, 
cardiac embolisms and atherosclerosis (Heikinheimo et al., 2012; Tipping et al., 2005; 
Mochan et al., 2003). None of these was documented as risk factors in patient folders and 
none of the diagnostic tools used to diagnose these vascular conditions was evident in our 
sample. 
As 100% of the HIV+ group in the current study were diagnosed with infarction type strokes, 
one could hypothesize vascular involvement since few of these participants had the more 
common risk factors for stroke, such as hypertension. None of the HIV+ participants suffered 
haemorrhagic strokes, but this type of stroke was evident in a small percentage of the HIV- 
group and HIV undiagnosed groups. This could be due to the high percentage of participants 
with hypertension in these groups in our sample.  
5.3.3 Type of stroke 
The type of stroke may affect functional recovery and a poorer functional outcome may 
contribute to the burden of disease. (Krishnamurthi, Feign, Forouzanfar... Murray, 2013; 
Scheepers, Ketelaar, Visser-Meily, de Groot, Twisk & Lindeman, 2008). The WHO describes 
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Disability Adjusted Life Year (DALY) as one year of a healthy life lost and the sum of these 
can be calculated for a particular population to estimate the burden of disease 
(www.who.int). A global burden of disease study was conducted, focusing on the global and 
regional distribution of ischaemic and haemorrhagic strokes (Krishnamurthi et al., 2013). In 
2010, it was estimated that the global incidence of ischaemic strokes was more than double 
the amount of haemorrhagic strokes (Krishnamurthi et al., 2013). Even though significantly 
fewer people had haemorrhagic strokes, the DALYs for haemorrhagic strokes were 
significantly higher, being almost double the amount of ischaemic strokes, indicating a 
greater decrease in functional abilities of the haemorrhagic strokes (Krishnamurthi et al., 
2013). 
Scheepers et al. (2008) found similar results after conducting a longitudinal study to 
compare the difference in recovery between ischaemic and haemorrhagic strokes at four 
Dutch rehabilitation centres. They found that ischaemic strokes made a faster recovery and 
continued to recover over a longer period of time compared to haemorrhagic strokes 
(Scheepers et al., 2008). Similarly, the current study showed that the BI scores on both 
admission and discharge were lower for the haemorrhagic group with a median score of 45 
on admission compared to the ischaemic strokes with a score of 55. The discharge scores 
for the haemorrhagic strokes were also indicative of these strokes being less functionally 
independent, with a median score of 60 indicating moderate dependence with ADLs, 
whereas ischaemic strokes were slightly dependent with a median score of 92.5. No 
significant age differences were seen between these stroke types. However, the 
haemorrhagic group had a significantly smaller sample size, making statistical analysis 
problematic. 
5.3.4 Severity of stroke (mRS) 
On admission, all groups in the current study displayed similar stroke severity with the 
majority in each group admitted with moderately severe disability (grade 4). This indicated 
the inability either to walk or to attend to own bodily needs without assistance. None of the 
HIV+ group were severely disabled (grade 5) on admission, whereas a small percentage of 
the HIV- and undiagnosed groups were severely disabled, requiring constant nursing care, 
and were both bedridden and incontinent. This was possibly due to some of these 
participants being 75 years and older, having multiple risk factors and one of whom having 
had a haemorrhagic stroke which is known for having a poorer outcome.  
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On discharge the HIV+ group seemed to be more independent than other groups. More than 
half of the HIV+ group had no significant disability despite symptoms (grade 1) and were 
able to carry out all previous activities, whereas less than a third of the HIV- and 
undiagnosed groups had slight disability. A majority of the lower functioning strokes was 
seen in the HIV- and undiagnosed groups. The HIV+ group had one participant with 
moderately severe disability. This participant was 62 years of age, 28 years older than the 
median age and had multiple risk factors, which could be the reason for poor functional 
recovery. The HIV+ group also had better admission scores; hence they may have had 
better discharge scores. Even though the HIV+ group showed a better functional recovery 
according to the mRS scores, no statistical significance was shown among groups. 
Rouillard, de Weerdt, De Wit & Jelsma (2012) conducted a longitudinal descriptive study on 
the functional recovery of participants post first ever stroke. Having the same mean age and 
mRS scores to the current study’s HIV- group, their sample also had fewer participants with 
slight to no disability while the majority had moderate disability when compared to the current 
study’s HIV+ group. Again, this may be due to age and multiple risk factors. Rouillard et al. 
(2012) did not exclude HIV+ participants in their total sample and 11.76% (n = 6) of 
participants were known to be HIV+. The author conceded that the subgroup was too small 
to permit a comparative statistical analysis in terms of functional outcome (Rouillard et al., 
2012).  
Studies that compared HIV+ and HIV- groups using the mRS, such as Tipping et al. (2007) 
and Hoffman et al. (2000), showed no significant difference between groups but also had 
significantly smaller HIV+ samples. Heikinhemo et al. (2012) did a prospective one year 
follow up study and found a significant difference at six to eight weeks (p = 0.015), with the 
HIV+ group having a better score, but no significant difference at six-month to one year 
follow up. Again, their HIV+ group had a significantly smaller sample size not permitting a 
comparative statistical analysis for functional outcome. 
 
5.4 Function Post Stroke 
 
5.4.1 The role of age on functional recovery 
Functional recovery is dependent on neural plasticity, which is the ability of the brain to learn 
and relearn function by adapting neurons and re-circuiting neural synapses, which expand 
the amount of cortex involved in controlling function or movement (Kleim, 2011). 
Neurorehabilitation done by physiotherapists and occupational therapists uses techniques 
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which utilise neural plasticity (Kleim, 2011). As we age, the capacity of neural plasticity 
decreases, hence older patients may have a poorer functional outcome (Park & Bischof, 
2013). Hence, the HIV+ group of the current study may be expected to have a better 
functional outcome due to these participants being significantly younger. 
 
5.4.2 Impact of stroke on activities of daily living (Individual Barthel items) 
On discharge the majority of participants were independent in self-care ADLs such as eating, 
bathing, grooming, dressing, toileting and transfers (in and out of the wheelchair), indicating 
that they may require minimal assistance from caregivers. Concerning mobility and stair 
climbing, admission scores were similar in all groups for participants who were immobile and 
unable to climb stairs. On discharge, the HIV+ group had a greater percentage of 
participants being independent in mobility and stair climbing compared to other groups. In 
both items 71.43% (n = 5) the HIV+ group was independent in mobility (able to walk > 50 
yards independently) and stair climbing, while the HIV- and undiagnosed groups had less 
than half of their sample being independent in these activities. This may indicate a larger 
percentage of the HIV+ group being able to participate independently in usual activities, 
being introduced back into the community and possibly returning to work. Because the BI is 
based mostly on being independent in self-care ADLs, it is hard to say whether these 
participants were reintegrated into the community and returned to work. Other outcome 
measures such as the Nottingham extended activities of daily living (NEADL) scale could be 
used in future studies to give a better understanding on reintegration and other ADLs which 
include housework (Rouillard et al., 2012).  
5.4.3 Level of dependence post stroke (Total Barthel Index scores) 
In our study, there were no significant functional differences seen among groups on 
admission. On discharge overall 17.07% (n = 7) of the entire sample was categorised as 
severely dependent (a score of 21 to 60) requiring maximal assistance with self-care and 
mobility on the BI. These participants were older than the median age of the total sample 
and had multiple risk factors impacting recovery. With a score of 40 or less on discharge, 
they may require assistance with ADLs throughout their life span (Sulter et al,1999).  
It has been advocated that using a combination of outcome measures to assess levels of 
independence is more effective in describing participant function (Sulter et al., 1999). The 
mRS and BI are commonly used in combination to describe stroke populations (Cioncoloni 
et al, 2012; Huybrechts & Caro, 2007; Sulter et al., 1999). Sulter et al. (1999) suggested that 
a mRS score <3 and BI score <60 most likely resulted in an unfavourable outcome as these 
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participants struggled with mobility and were dependent in most ADLs. A score of 60 is the 
pivotal point at which participants go from dependency to assisted independence (Sulter et 
al., 1999). The majority of the HIV undiagnosed group (52.38%, n = 11) in our study had 
participants with moderate dependence (a score of 61 to 90) transitioning from dependence 
to assisted independence, indicating that assistance was still needed with self-care and 
mobility. Conversely, the majority of the HIV+ group (71.43%, n = 5) and the HIV- group 
(53.85%, n = 7) showed slight dependence (a score of 91 to 99) and complete independence 
(a score of 100) in ADLs needing minimal to no assistance with ADLs and mobility (Sulter 
et al., 1999).  
The majority of the HIV+ and HIV- groups seemed to have a better functional recovery. 
Since the majority of all groups, including the HIV undiagnosed group, were at the pivotal 
stage in regaining independence (i.e. mRS> 3 and BI> 60), however, continued rehabilitation 
may assist in these participants improving functionally six months to a year post incident. 
This could mean that some of the current non-ambulant participants in our study may 
continue to improve and be walking with further rehabilitation (Heikinheimo et al., 2012; 
Sulter et al., 1999).  
Similar to the current study, another study done at the WCRC by Rouillard et al. (2012) had 
HIV+ participants who were all aged under 40 years while the HIV- participants had a mean 
age of 51.9 years. Although this particular subgroup in Rouillard et al (2012) was not used 
for comparative statistical analysis (small group size), the researcher found that the HIV+ 
group had a good functional recovery and had a premorbid BI function of 100, except for 
one participant who reported poor function prior to stroke. On six-month follow up, all HIV+ 
participants were doing well except for the one participant (with low premorbid function) who 
was discharged to palliative care (Hospice) possibly due to late stage HIV (S. Rouillard, 
2017, personal correspondence, 24 May 2017). Another study looking at the functional 
outcomes of early rehabilitation post stroke had a BI mean score of 73.1 at two months from 
admission (Laufer, Sivan, Schwarzwann & Sprechter, 2003). This score is significantly less 
that the current study overall median on discharge possibly due to these participants being 
older and having a larger percentage of participants with multiple risk factors (Laufer et al., 
2003). On the contrary other studies with significantly older stroke participants having 
multiple risk factors had similar BI scores to the current study (Rasmussen, Kjaer, Skerris, 
Skou, Christoffersen, Seest, Paulsen, Ronholt & Overgaard, 2016; Rhoda, Smith, Putman, 
Mpofu, De Weerdt and De Wit, 2014).  
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Rhoda et al. (2014) did a comparative study on functional recovery post stroke in developed 
versus developing countries. The two independent studies done in Germany and South 
Africa then compared the functional outcomes of their respective stroke samples. The mean 
age was similar between groups, with the German mean age at 63.9 and 63.4 for South 
Africans. Using the BI, at six months follow up the German sample had a median score of 
95, similar to the current study and the South African sample had a median score of 85 (p = 
0.003). The findings in Rasmussen et al. (2016) and Rhoda et al. (2014) suggested that 
strokes in developed countries may have a better outcome than in developing countries as 
participants in developed countries who are significantly older improve at the same rate as 
younger strokes do in developing countries. Rhoda et al. (2014) speculated that this may be 
due to lack of resources, manpower and facilities in South Africa. Stroke patients in 
developed countries are reported to receive more rigorous rehabilitation, hence the 
difference in functional recovery (Rhoda et al., 2014). No known studies have been 
conducted using the BI to assess functional recovery of stroke patients who are HIV+. Hence 
a comparison with current literature could not be made for this group alone.  
Even though the HIV+ group in the current study had a smaller change in median score on 
discharge compared to other groups, this was not seen as significant as all groups had 
similar change in median scores. The HIV- group was the only group to receive a negative 
score in the range for the BI change in score, indicating a decrease in function. As the BI 
was used as a self-reported measure on discharge, this particular participant felt that they 
had regressed in function but this finding was not consistent with the objective measures as 
they had improved in BBS and mRS scores. In addition, the improvements the patient made 
was to impairment and not function. Since the BI is a functional outcome measure it is not 
sensitive enough to pick up this difference. The BBS even though a measure of the risk of 
falling was able to pick up this discrepancy because there was an improvement in the 
balance impairment. 
5.4.4 Assistive devices issued on admission and discharge 
Immobility is common after an acute stroke due to impairments such as upper and lower 
limb weakness, balance, proprioceptive and visual neglect disorders and other than 
rehabilitation, it is often remedied with assistive devices (Kenzie, Semrau, Findlater, Herter, 
Hill, Scott & Dukelow, 2014; Hollands, Pelton, Tyson, Hollands & van Vliet, 2012; Jutai, 
Coulson, Teasell, Bayley, Garland, Mayo, Wood-Dauphinee 2007; Tyson, Hanley, Chillala, 
Selley & Tallis, 2006; Lawrence, Coshall, Dundas, Stewart, Rudd, Howard & Wolfe, 2001). 
This was seen in the current study, where on admission the majority of participants in each 
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group required a wheelchair as the attending clinicians considered them unsafe to mobilise 
independently. This was also reflected by low scores on the mRS and BI on admission, 
where the majority of participants were categorised as moderately severe in disability and 
being immobile.  
On discharge, the overall sample showed that a majority of participants were mobile with 
the HIV+ group having the largest percentage (85.71%, n = 6) of ambulant participants. 
More than half of the HIV+ group did not require assistive devices such as walking sticks, 
whereas a third of the HIV- and undiagnosed groups were able to mobilise without a device. 
One participant (14.29%) of the HIV+ group required a wheelchair, whereas a third and more 
of the HIV- and undiagnosed groups required wheelchairs. This was also reflected in the 
mRS and BI scores where a greater percentage of the HIV+ group had no significant 
disability despite impairments and were independent in mobility compared to the HIV- and 
undiagnosed groups. The HIV+ group may have done better due to age difference and 
having fewer risk factors and better baseline scores. However, a prospective study 
conducted in the United Kingdom had an older sample than the HIV- and undiagnosed 
groups of the current study and showed fewer participants needing wheelchairs (9.81%) as 
their primary aid, fewer participants requiring walking aids (32.91%) and more than half of 
the sample not requiring assistive devices (Jutai et al., 2007). This showed similar results to 
the younger HIV+ group of the current study. As stated before, developed countries seem 
to have a better outcome which could be ascribed to better resources, more manpower, and 
more intensive rehabilitation done more frequently (Rhoda et al., 2014). Even though a 
larger percentage of the HIV+ group was ambulant and fewer of the HIV+ group required 
assistive devices compared to the other groups, there was no significance seen with the use 
of assistive devices, as the majority of participants in each group were ambulant and showed 
less dependency in mobility and ADLs.  
Mobility still remains a functional problem for some stroke participants in the current study. 
Verma et al. (2012) stated that most stroke patients regain some ability to walk, but 40% 
require assistance and 60% are restricted in community ambulation. Patients with stroke 
may be independent indoors but lack the capabilities to negotiate rough terrain outdoors 
(Verma et al., 2012). It is also important to note that even though participants may not have 
required an ambulatory assistive device, 80.77% of the current study who were ambulant 
did require an ankle foot orthosis (AFO). This showed that participants still needed ankle 
support possibly due to muscle weakness and sensory impairments which impact balance 
and risk of falling, making community ambulation unsafe (Gorst, Lyddon, Marsden, Paton, 
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Morrison, Cramp & Freeman, 2016). Further investigation into community ambulation was 
not assessed in the current study but is suggested for future studies.  
 
5.5 Impact of Stroke on Balance 
 
5.5.1 Balance dysfunction 
Balance impairments were seen in the majority of participants in the current study. Balance 
recovery is seen as a determinant for both ADL and community ambulation (Braun, Marks, 
Thiel, Zietz, Zutter & Gruneberg, 2016; Gorst et al., 2016; Schmid, van Puymbroeck, 
Altenburger, Dierks, Miller, Damush & Williams, 2012; Michael, Allen & Marcko, 2005). The 
inability to sit during early recovery is closely linked to poor prognosis and independence in 
ADLs as well as mobility (Tyson, Hanley, Chillala, Selley & Tallis, 2006). This was evident 
in the current study with five participants of the entire sample not being able to sit 
independently on admission, three of whom were moderately severe to severely disabled 
on discharge. One of these participants from the HIV undiagnosed group, as mentioned 
before, regressed in BI score but this reflects the patient’s self-reported perception of their 
abilities. Looking at the BBS and mRS scores, this participant made slight improvements 
even though still moderately severe in disability; no regression was observed. The slight 
improvement may also be due the BBS not being sensitive enough to detect change in 
stroke patients at the lower end of functioning. The BBS has only one applicable item 
(independent sitting) to record function for this lower level of functioning (Salter et al., 2013). 
One participant in the HIV+ group who was unable to sit on admission was sent home two 
weeks into rehabilitation when the MDT concluded that the participant had a poor prognosis. 
The exact reason for this decision was not clear in the medical records, but may be related 
to HIV stage. The majority of participants in our study who were unable to sit on admission 
were older than the overall median age and had multiple risk factors. Only one of the 
participants (of the HIV- group) who was unable to sit on admission made a significant 
recovery with no significant disability despite symptoms on discharge. This may have been 
attributed to age as this participant was significantly younger having a greater capacity for 
neural plasticity and had fewer risk factors for stroke pre-morbidly. 
Other studies also found sitting balance as well as standing balance to be strong predictors 
of walking ability (Kwakkel & Kollen, 2013; Tyson et al., 2006; Kollen, van de Port, Lindeman, 
Twisk, Kwakkel, 2005). This was seen in the current study where the majority of participants 
of the entire sample (30.61%; n = 15) who were unable to stand on admission, had a poorer 
outcome than the rest of the sample. The majority of these participants (10/15) were 
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categorised as moderately severe in disability (mRS grade 4) meaning they were unable to 
walk and unable to attend to own bodily needs without assistance. Again, the majority of 
these participants were older than 50 years and had multiple risk factors. Even though the 
HIV undiagnosed group had fewer participants with a full score for standing independently 
than other groups on admission, this changed on discharge with the HIV- group having the 
smallest percentage of independent standing participants on discharge. This change may 
be attributed to the dropout rate in each group as more of the HIV- group were discharged 
earlier than expected than any other group, meaning that they were not able to perform the 
second assessment prior to discharge (see Table 4.9).  
Overall improvements were noted in all groups, specifically in the standing unsupported, 
sitting unsupported and transfer items with the HIV+ group having a larger percentage of 
participants being independent in these items (see Table 4.9). This indicates improvement 
in function and these improvements in balance are indicative of greater strength, improved 
sensation and decreased hemineglect (Tyson et al., 2006). One may conclude that as the 
majority of participants were able to sit and stand independently on admission, this sample 
may have a good prognosis, being more functionally independent in ADLs and possibly 
mobility (as seen in BI scores), together with a decreased risk of falling (Braun et al., 2016; 
Gorst et al., 2016; Schmid et al., 2012; Michael et al., 2005).   
5.5.2 Risk of falling 
Overall all groups showed a medium risk of falling according to the BBS on admission, 
meaning they were unsafe to mobilise independently which affects their ability to perform 
ADLs (see Table 4.7), with the HIV- group having the highest median score (see Table 4.11) 
for BBS. On discharge the HIV+ and HIV- groups had the lowest risk of falling score followed 
by the HIV undiagnosed group indicating that a majority of participants were able to mobilise 
independently or with minimal assistance, potentially being independent in community 
ambulation (Tyson et al., 2006).  
No statistical significant differences were seen among groups even though the HIV+ group 
seemed to have a higher percentage of full scores for more of the individual items of the 
BBS (see Table 4.9). This percentage was similar to the results seen with assistive devices 
where a greater percentage of HIV+ participants required no assistive devices compared to 
other groups, which could mean that the HIV+ group may have better balance and less of a 
risk of falling than the HIV- group. The MCD for the HIV+ group was half that of the HIV- and 
undiagnosed groups but they required fewer assistive devices than any other group (see 
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Table 4.11). The smaller change in score for the HIV+ group may be due to the smaller 
sample size and a greater percentage of participants with high scores on admission to begin 
with (see Table 4.11). It could also be due possibly to the BBS not being as sensitive to 
change in higher functioning stroke patients (Salter et al., 2013). It is important to note that 
there is no common interpretation of BBS results that exists, nor its relation to patient mobility 
and mobility aides, but only risk of falling (Salter et al., 2013). Therefore, the BI and recording 
of assistive devices issued was also described to enhance understanding of the sample’s 
functioning. The combination of outcome measures used gave us a good indication of safety 
and mobility indoors. It is necessary for future studies comparing HIV+ and HIV- strokes to 
include outcome measures that assess independence once participants are re-integrated 
into their community and whether or not they are able to return to work or premorbid function.  
Studies with stroke populations with a mean age over 60 years had similar admission scores 
falling within the range of medium risk of falling (23.8 to 28.3 points) as well as on discharge 
scores within the low risk of falling range (40.6 to 49.9 points) which were similar to the HIV 
undiagnosed group of our study (Chen, Chou, Yu, Chen, Shih & Hsieh, 2015; Garland, 
Ivaniva & Mochizuki, 2007; Garland, Willems, Ivanova, Miller, 2003). Garland et al. (2007) 
divided their stroke groups into mild and severe in disability. The authors found that severely 
disabled strokes were significantly older and had poorer BBS scores than their younger 
counterparts (mean age: 64.9 vs 52.8 and BBS mean: 49.9 vs 55.8 respectively). The overall 
BBS score of the current study was similar to that of the mildly disabled strokes in Garland 
et al. (2007) (see Table 4.11). This may be due to the samples being similar in age, hence 
having a greater capacity for neural plasticity (Park & Bischof, 2013; Salzman, 2010). There 
was no significance, however, regarding BBS scores found in the current study even though 
the HIV+ group was significantly younger.  
5.5.3 Static standing balance measurement by pressure mapping (MatScan) 
 
Kollen et al. (2005) state that improvement in control in standing balance is more pertinent 
than leg strength for attaining better walking balance. Most stroke survivors are able to stand 
independently but may have multiple impairments which affect balance, such as lateral 
deviation of the trunk towards the unaffected side, greater postural sway (i.e. COP velocity 
and distance), decreased leg strength on the affected side and weight bearing asymmetry 
(WBA) (Boukadida, Piotee, Dehail & Nadeau, 2015; Tysonet al., 2006). Asymmetry in weight 
bearing is due to less weight being taken on the affected leg because of the above 
mentioned impairments which cause smaller excursions when weight shifting to the affected 
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side. This could increase the risk of falling and is seen in all aspects of balance even in high 
functioning stroke patients (Pereira, Botelho & Martins, 2010; Tyson et al., 2006).   
The MatScan was used to assess static standing balance specifically assessing WBA, COP 
velocity and distance. Excessive postural sway is shown in COP velocity and distance. The 
faster and further the COP sways, the more the participant struggles to maintain postural 
stability (Kamphuis et al, 2013; Adegoke et al, 2012). A systematic review done by Kamphuis 
et al (2013) shows that the greater the WBA, the greater the postural sway. To get a better 
idea of what the normal range would be for WBA, we compared the results of WBA 
distribution between limbs to a study done on non-disabled participants. Kumar et al. (2014) 
conducted a cross-sectional study on 33 non-disabled participants with the mean age of 
59.24 years. Using the Symmetry Index (SI), a mathematical model utilised in the 
measurement of asymmetry which gives a score equivalent to the percentage of weight 
bearing asymmetry (PWBA). The PWBA was calculated and they found that the mean 
PWBA for nondisabled participants was 9.02 % (Kumar et al., 2014). The median PWBA in 
the current study are displayed in Table 4.12. The only group that had a similar PWBA on 
discharge was the HIV+ group (9%) and therefore considered to be more normal in their 
PWBA. The HIV- and undiagnosed groups had double the PWBA score of the HIV+ group 
meaning an increased level of asymmetry (17% and 18% respectively). Even though the 
HIV+ group had a higher median difference between admission and discharge scores (6% 
compared to 2% in the HIV- and undiagnosed groups), this was not seen as significant (p = 
0.3834). A Nigerian study conducted on stroke patients’ PWBA had similar findings to the 
HIV- and undiagnosed groups (Adegoke, Olaniyi & Akosile, 2012), with a mean age of 58.87 
years and the mean time period after stroke was 13.58 months. The investigators found the 
mean PWBA to be 20.8% (SD = 14.7%), again double the percentage of the HIV+ groups 
more than a year post stroke (Adegoke et al., 2012). This could be due to the HIV+ 
participants having a lower mean age hence having better balance, having a larger 
percentage of participants being in the low fall risk category and not requiring assistive 
devices on discharge. 
The velocity of sway of the centre of pressure (COP) was another factor assessed in the 
current study. According to a systematic review done by Ruhe, Fejer & Walker (2011), the 
mean COP velocity in healthy participants (mean age range: 13.8- 63 years) ranges from 
0.003m/s to 0.016m/s. The HIV- group had the biggest change in score of 0.01m/s for the 
median difference between admission and discharge. The HIV+ and undiagnosed group 
had a median difference of 0.001m/s. The discharge scores for median velocity were similar 
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to a post-acute stroke study conducted by de Haart et al. (2004) of 37 stroke inpatients in 
the Netherlands. The median velocity for lateral and AP sway at 12 weeks (final assessment) 
was 0.013 m/s (range 0.01-0.016m/s) and 0.02 (range 0.015-0.024m/s) respectively. The 
current study sample showed similar results on discharge with a median of 0.02m/s (0.01- 
1.00) for overall velocity. The distance of sway, as measured in centimetres (cm), was 
assessed in both AP and lateral directions. In both these directions no significant difference 
was seen among groups of the current study. The negative values seen in all MatScan 
measures may be due to over compensation to reduce weight-bearing differences between 
limbs as participants were purposefully trying to improve on their previous scores. Their 
performance prior to being discharged could be affected by a number of factors, e.g. 
regression in sway of one participant in the HIV undiagnosed group could be ascribed to 
feeling unwell on the day of testing prior to discharge.  
Overall, the majority of participants still struggled with WBA and COP sway on reassessment 
prior to discharge. This represents poorer standing balance that could be due to postural 
instability. It is reported that postural stability facilitates weight shifting and if affected hinders 
functional activities in ADL as well as mobility (Chengetanai, Tadyanemhandu, Chibhabha 
& Kaseke, 2016). Most participants of the current study may benefit from continued 
rehabilitation to address impairments causing instability in standing and walking, such as 
somatosensory deficits, weakness, poor muscle tone as well as spatial cognitive awareness 
deficits (Genthon, Rougier, Gissot, Froger, Pelissier & Perennou, 2008).  
 
5.6 Participation Perception of Function, Pain and Anxiety 
The general perception of function prior to stroke was good with the majority of participants 
being independent in all items and few experienced pain and anxiety/depression prior to 
having their stroke. On admission all participants experienced a decline in function, and a 
higher percentage of participants experienced pain/discomfort as well as anxiety/ 
depression. This change was seen to be statistically significant for all groups but no big 
difference was seen among groups. On discharge a definite improvement in all items was 
seen which was shown to be significantly better than the admission scores. These score 
were less than the “prior” scores, however, showing that participants did not feel they were 
as functionally capable as they were prior to having their stroke. Participants experienced 
more pain/discomfort and anxiety than they did prior to stroke. No significant differences 
were seen among groups.  
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Rouillard et al. (2012) also utilised the EQ5D to acquire patient perception of their health 
related quality of life post stroke. A total of 52% reported having problems with mobility. The 
least problematic domain was self-care with 30% reporting that they required assistance, 
whereas 61% required assistance with usual activities as seen in the HIV- group of the 
current study. The overall sample of the current study showed a better functional recovery 
on discharge than Rouillard et al. (2012). A significant age difference may have been the 
hindering factor in their functional recovery as the sample included in Rouillard et al. (2012) 
were older patients who could have a reduced capacity for neural plasticity.  
The VAS scores of the current study indicated that the majority of participants had a good 
pre-morbid function (VAS = 100) and dropped by half on admission (VAS = 50). On 
discharge all participants made a significant improvement with a median difference between 
admission and discharge of 30 points with the exception of one participant. This particular 
participant felt that they had regressed despite improvements in the BI and BBS. The HIV+ 
group reported slightly lower VAS scores than the other groups even though functionally, 
they did well. Again, this may be due to age as they may have been more functionally able 
prior to stroke than their older counterparts. 
In a health related quality of life study based in Cape Town, focusing on people living with 
HIV/AIDS (PLWA), differences were found in perceived health compared to the general 
community who were age matched (Hughes et al., 2004). A significant difference was found 
between both groups for most domains with the PLWA group experiencing more difficulties 
in each domain (p<0.001) besides the anxiety/ depression domain, which even though the 
PLWA had a higher percentage of those experiencing anxiety, the difference between 
groups was not significant (p = 0.123) (Hughes et al., 2004).  
HIV itself could cause problems with function as seen in Hughes et al. (2004), with the added 
effect of functionally impairing conditions such as stroke, to which PLWA are prone. 
Subsequently, their quality of life would also be lowered. Due to these patients being 
younger, this not only puts an increased burden on society, as some of these patients would 
not be able to return to work, but may cause mental health conditions as the current and 
other studies show. They are therefore more at risk for anxiety and depression (Hughes et 
al., 2004; Breuer, Myer, Struthers & Joska, 2011). As suggested by Hughes et al. (2004), 
not only medical management but rehabilitation and mental health services are needed to 
decrease the impact these conditions may have on the quality of life of PLWA. 
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5.7 Rehabilitation Post Stroke 
In-patient rehabilitation impacts functional outcome of stroke patients and is often delivered 
by a team of healthcare professionals. The multidisciplinary team may include 
physiotherapy, occupational and speech therapy, along with others such as, dieticians and 
social workers (Miller, Murray, Richards, Zorowitz, Bakas, Clark & Billinger, 2010; Keith 
1991).  Physiotherapy utilises a variety of techniques including strengthening exercises, 
balance retraining, facilitation of selective movement training and gait training (Rhoda et al., 
2014; Miller et al., 2010). Occupational therapy (OT) often focuses on task retraining, such 
as activities of daily living (Smallfield & Karges, 2009). Cognitive deficits may be jointly 
addressed by OT as well as speech therapy (Smallfield & Karges, 2009). Speech language 
and hearing therapy tend to focus on regaining speech and language skills (Rhoda et al. 
2014; Miller, et al., 2010). The exact type, content and duration of individual therapies 
received by participants in our sample were not the main focus of our study. Therapy is 
patient specific, hence each participant would have received a tailor-made rehabilitation 
programme dependent on their functional limitations and socioeconomic context 
(www.wcrc.co.za). However, the general outcome of participants in the current study was 
good, with the majority of these patients scoring in the higher percentiles for a number of the 
outcome measures, i.e. the mRS, BI and BBS at the end of their period of rehabilitation. 
5.8 Length of inpatient therapy and time between stroke onset to admission for           
rehabilitation 
Studies conducted in sub-Saharan Africa that compare the length of stay (LOS) of HIV+ and 
HIV- participants were medical studies which focused on LOS in an acute hospital setting 
specifically (Heikinheimo et al., 2012; Mlay & Bakari, 2010). Heikinheimo et al. (2012) 
showed no significant difference in LOS between HIV+ and HIV- strokes and had a mean 
LOS of 15.7 days. This differed from Mlay & Bakari (2010) who found a significant difference 
between the two groups in favour of the HIV- group (7.3 days and HIV+ group 10.3 days) 
(p = 0.001). This significant difference may be due to the stage of HIV, hence needing more 
medical treatment. Stroke is often a presentation of late stage HIV (Jowi et al., 2007). Once 
patients were medically stable their LOS may have differed.  
With regard to the current samples’ median time between stroke onset and admission to 
rehabilitation, differences were noted among groups but these were not seen as statistically 
significant. Unlike the study done by Mlay & Bakari (2010), the HIV+ group of the current 
study had the shortest stay with a median of two weeks, followed by the HIV- group (18 
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
 75  
days) and the HIV undiagnosed group who were hospitalised for almost a month (see Table 
4.5 in the previous chapter). The HIV+ and HIV- groups of the current study showed a similar 
median time between stroke onset and admission to the study done by Heikinheimo et al. 
(2012) which also showed no significant difference between the HIV+ and HIV- groups. 
However, there was one patient in the current study from the HIV- group who had medical 
complications unrelated to the stroke, which meant an extended acute hospital stay (218 
days). The HIV- group may have had a shorter median for the time between stroke onset 
and admission to rehabilitation if these outlying data were removed as it may have skewed 
the HIV- group’s data.  
As Table 4.5 in the Results chapter indicates, the median length of stay (LOS) between 
groups did not show a significant difference even though the HIV+ group had a shorter stay 
of up to 10 days compared to other groups (p = 0.0671). This may be due to the significant 
age difference as younger patients have a greater capacity for neural plasticity (Park & 
Bischof, 2013). The HIV+ group also had a larger percentage of participants who had a low 
risk of falling and not requiring assistive devices on discharge, possibly indicative of milder 
strokes. The HIV+ group also had a high percentage of participants who were able to sit and 
stand independently on admission according to the BBS, which is a strong predictor for a 
good prognosis (Kwakkel & Kollen, 2013; Tyson et al., 2006; Kollen et al., 2005). 
International studies conducted on stroke patients reported a mean LOS in inpatient 
rehabilitation ranging from 29 to 59.8 days (Bindawas, Mawajdeh, Vennu & Alhajdary, 2016; 
Grant, Goldsmith & Anton, 2014; Ozyemisci-Taskiran, Gunendi, Aknar, Karatas & Sepici, 
2011; Tan, Heng, Chua & Chan, 2009). The current study median LOS days fell within this 
range. Rouillard et al. (2012) had a mean LOS of 62 days, nine days longer than the median 
current study sample, and more than two weeks longer than the HIV+ group. This may be 
due to the current sample being younger than that of Rouillard et al. (2012). As suggested 
by Spengos & Vemmas (2010), young strokes generally have a good functional recovery. 
All groups within the current study fell within the LOS ranges of international studies. It is 
also important to note that LOS may differ globally as different countries, particularly 
developed and developing countries, have different treatment protocols as well as available 
resources, giving a possible explanation for the broad range in LOS (Rhoda et al., 2014). 
Once HIV+ patients who have suffered a stroke are medically stable, they seem to have a 
fast recovery, quicker than the other groups, which is expected of a younger population 
(Meintjies et al., 2014, Spemmos & Vengos, 2010). They often present with fewer risk factors 
due to younger age. Since a majority of HIV+ patients who suffered a stroke is diagnosed 
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only after the stroke incident, many of them are not on medical treatment, such as 
antiretroviral therapy (ART). Once patients at the WCRC are first diagnosed at the primary 
care level they may be required to start ARTs to become medically stable in order to 
participate effectively in rehabilitation. This could be an added reason that they recover 
faster (Meintjies et al., 2014; Tipping et al., 2007; Hoffmann et al., 2000). Since the effect of 
ARTs on functional recovery was not the focus of this study, this cannot be certain for the 
current study sample. 
The current study achieved its objectives of adequately describing the study sample, its 
functional outcomes on discharge, participant perception of function as well as LOS. The 
only major differences seen among groups was age with the HIV+ group being significantly 
younger, and substance abuse as well as opportunistic infections being the main risk factors 
in the HIV+ group compared to the older HIV- and undiagnosed groups with lifestyle related 
non-communicable diseases. Having a younger stroke population may suggest that HIV 
could be a risk factor for stroke. The overall sample showed a majority of participants scoring 
in the higher percentiles for the outcome measures, indicating mild disability, independence 
in ADLs, low risk of falling and an improved functional perception on discharge. Even though 
the HIV+ group had a larger percentage of participants scoring in the higher percentiles, 
there were no significant differences among groups with regard to functional outcome. 
Recovery could be affected by a number of variables, in this sample, HIV-status did not 
seem to negatively affect functional outcome. 
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Chapter 6:  Conclusion and Recommendations 
 
This chapter gives an overall conclusion to the current study. This chapter also discusses 
the limitations of the current study, recommendations for future studies and the clinical 
relevance of the findings. 
 
6.1 Overview of the Scope of the Thesis 
The initial research question posed was “What are the functional outcomes of post stroke 
patients following inpatient rehabilitation who are HIV positive, -negative and  
-undiagnosed?” To answer this question, an introduction and scoping review containing 
current literature pertaining to the rise and relevance of HIV+ stroke patients and the 
functional outcome of these patients was presented. After evaluating the methodology used 
by these studies, the aims, objectives and methodology of the current study was developed. 
All of the aims and objectives were completed, presented in the results chapter and the 
implications of these results were further discussed in Chapter 5.  
 
6.2 Objectives 
The primary and secondary objectives are discussed below: 
6.2.1 Primary objectives 
The HIV and immune status (CD4 count if relevant) and the functional outcomes of stroke 
patients in terms of activity or activity limitations on admission versus discharge from 
inpatient rehabilitation were described successfully. HIV status (HIV+, HIV- and 
undiagnosed) and immune status (CD4 count if relevant) were described as patients were 
grouped accordingly. The HIV+ group was the smallest in sample size, hence not as 
prevalent as originally envisaged during the conceptual phase of the study. The documented 
CD4 count of the HIV+ group (median CD4 count: 130) was found to be similar to the 
literature described in the scoping review, where patients with a CD4 count of less than 200 
were at risk of having a stroke.  
The objective outcome measures used were deemed appropriate and effective in describing 
the function of the study sample of stroke patients, as motivated in the methods chapter. 
The baseline admission scores were similar in all groups showing no statistically significant 
differences. On discharge, a higher percentage of the HIV+ group were less severe in stroke 
severity (mRS scores, see Figures 2 & 3), were independent in ADLs (BI, see Table 4.6) 
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and had better balance and decreased risk of falling (BBS and MatScan, see Tables 4.11 
and 4.12) compared to the HIV- and undiagnosed groups. The median change in score for 
the BI and BBS also indicates that a higher percentage of the HIV+ group had better baseline 
scores compared to the other two groups as they had a smaller change in score but better 
or similar overall outcome. This trend was also seen in the use of assistive devices where a 
higher percentage of the HIV+ group were ambulant and did not require an assistive device, 
compared to the HIV- and undiagnosed groups. Nonetheless, no statistical significance was 
seen among groups with regard to functional outcome or use of assistive devices issued. 
The majority of patients in the entire sample needed little to no assistance with ADLs or 
mobility and had a good prognosis.  
6.2.2 Secondary objectives 
After describing the demographics and risk factors of the study sample, it was clear to see 
that these were similar to other studies described in the scoping review. No significant 
differences among groups were seen concerning gender or race. The only significant 
difference between groups regarding demographics was age, with the HIV+ group being 
significantly younger, as seen in previous studies.  
In line with previous literature, the current study showed a significant difference with regard 
to risk factors. Hypertension and diabetes were most prevalent in the HIV- and undiagnosed 
group compared to the HIV+ group. On the other hand, the HIV+ group had a higher 
prevalence of substance abuse and opportunistic infections compared to the HIV- and 
undiagnosed groups which was also statistically significant. This finding is supported by 
previous literature and indicates that HIV may be a risk factor for stroke. 
The median time between stroke onset and admission to rehabilitation showed that the HIV+ 
and HIV- groups had similar time periods before admission, while the HIV undiagnosed 
group was the only group to have a lengthy pre-admission time period. Even so, no statistical 
significant difference was seen among groups. The length of stay in rehabilitation (prior to 
discharge) yielded no significant results even though the HIV+ group had an eight to ten day 
shorter stay in rehabilitation. This may indicate that if patients are medically stable, HIV- 
status has no bearing on stroke recovery. 
With regard to the EQ5D, a patient perception of health related quality of life scale, it was 
noted that the HIV+ group scored themselves lower on the VAS scale than the other groups. 
This may have been attributed to their age as they were younger and possibly more 
functionally abled than their older counterparts. Even so, no significant differences were 
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found among groups, indicating that HIV- status may have no bearing on patient perception 
of functional outcome post stroke.  
Even though the HIV+ group was significantly younger, had fewer risk factors, had better 
baseline scores as well as a larger percentage of participants who were more functionally 
abled compared to the HIV- and HIV undiagnosed groups, it was not statistically significant. 
This may indicate that HIV status may have had no bearing on functional outcome in this 
sample. However, this outcome could have been influenced by many unknown factors. 
Limitations to this outcome are discussed below.  
 
6.3 Limitations 
The overall sample size and the disproportionate amount of participants in each group, 
specifically the small number of HIV+ participants were the biggest limitations. The small 
sample size in the HIV+ group also had insufficient power when performing statistical 
analysis among groups, yielding no statistical significance for functional outcomes and other 
results. Due to the study being conducted only at one site, although having a big catchment 
area, not all Western Cape stroke patients would be admitted to the WCRC as they have 
admission criteria and limited bed capacity. Stroke patients may be placed at other facilities 
or be referred for outpatient treatment at their nearest day hospital or clinic. The WCRC is a 
government facility where the majority of patients admitted have low socioeconomic status. 
Therefore, not all patients within the respective stroke population would have an equal and 
mutually exclusive chance of being selected for the study. The dropout rate in such a small 
sample also introduced bias as this could have deviated results, specifically with regard to 
the data of functional outcome measures. The heterogeneity among groups may also impact 
a fair comparison being made, as the HIV+ group had a significant age difference together 
with different risk factors. The HIV+ group was also the only group not having haemorrhagic 
type strokes. As haemorrhagic strokes usually have a poorer outcome in the early stages 
post stroke, this may have also affected the heterogeneity of results. All of these factors 
combined makes it difficult to generalise the results to all stroke patients. 
Other factors that were limiting to the study include the time and financial constraints that 
limited the data collection period to six months, which resulted in the small sample size. The 
PI was not blinded to HIV-status so a potential observer bias was introduced. No fixed time 
intervals for assessment could impact functional outcome as the study only had admission 
and discharge intervals. The time of admission and discharge since time of incident varied 
drastically from participant to participant, and being in different physiological stages of 
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healing also impacts recovery as three to six months’ post incident is seen as the time in 
which stroke patients often reach a plateau in their recovery (Kwakkel & Kollen, 2012). The 
outcome measures selected for this study were able to describe activity limitations in stroke 
patients and even though participants scored high for the BI and BBS specifically, they may 
still need assistance with ADLs and mobility. Therefore, additional rehabilitation, perhaps on 
an outpatient basis, will facilitate further recovery. 
6.4 Recommendations 
 
6.4.1 Clinical relevance 
Due to the above-mentioned limitations, no statistically significant difference was seen 
among groups for functional outcomes. However, other clinically relevant outcomes for the 
sample were seen. Patients who had poor baseline scores i.e. mRS < 3 and BI< 60, and 
who were unable to sit independently on admission (BBS< 4), generally had a poorer 
outcome. Those with higher scores and who were able to sit and stand independently on 
admission had a better outcome, meaning they were less dependent and more mobile. 
Since the majority of participants fell into the mid-range of the BBS, it is a good tool to use 
to gauge improvement, in combination with other balance outcome measures for those 
patients who are more advanced. The MatScan may not be as inexpensive as the BBS but 
this tool may be more effective in measuring static standing balance impairments as it gives 
objective results. The participants were also more aware of their asymmetry when using the 
MatScan so this outcome may also be encouraging to patients to correct the asymmetry and 
offer potential therapeutic exercise input. Clinicians could use these outcome measures to 
tailor their patient specific programmes on admission and set realistic goals for in-patient 
rehabilitation. 
 
6.4.2 Future studies 
Future studies comparing HIV+ stroke patients to general strokes, could look at larger 
cohorts with similar sample sizes for comparative groups and use multiple sites with longer 
data collection periods to ascertain generalisable results. The HIV+ groups could also have 
age-matched HIV- groups to give a better comparison in functional outcome as it has been 
reported that younger strokes have a better functional outcome (Spengos & Vemmos, 2010). 
The type of strokes entered into future studies should initially be based on ischaemic strokes 
only, as the majority of HIV+ strokes most likely would be ischaemic due to the 
pathophysiology, as explained in the scoping review. Moreover, haemorrhagic type strokes 
are more common in HIV- strokes and are reported to have a poorer outcome overall.  
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In order to expand on how exactly HIV-related stroke affects individuals, future studies 
should include outcome measures such as the Nottingham extended activities of daily living 
(NEADL) scale which describes more aspects of function, such as instrumental activities of 
daily living, including all levels of mobility. These outcome measures should be context-
specific and culturally appropriate to be able to ascertain the impact of HIV-related stroke 
on daily life for African individuals from all walks of life, i.e. urban and rural. Furthermore, 
future studies should look at the impact of the stage of HIV and the use of ARTs in the 
functional outcome of the HIV+ group, which may also impact a person’s recovery. 
The current study was envisioned as a springboard for larger cohort studies. Duplicating the 
study and amending its limitations may result in a better understanding of the HIV-related 
stroke population and produce more meaningful results to understand their unique functional 
outcomes. Other than highlighting the need for larger epidemiological studies, the results 
may also impact future treatment of HIV-related strokes and highlight the socioeconomic 
impact that HIV-related disability has globally and more specifically its impact in the sub-
Saharan region. 
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Appendix A: English Consent Form 
 
PARTICIPANT INFORMATION LEAFLET AND CONSENT FORM 
 
 
TITLE OF THE RESEARCH PROJECT: 
 
 
The functional outcomes of stroke patients who are HIV positive, HIV negative and HIV 
undiagnosed, following inpatient rehabilitation: A descriptive study 
 
 
REFERENCE NUMBER: 
 
PRINCIPAL INVESTIGATOR: Tasneem Hartley 
 
ADDRESS:  Physiotherapy Division 
  Medical School; Stellenbosch University 
Francie Van Zijl Drive 
Tygerberg 
7505 
Cape Town 
South Africa 
 
CONTACT NUMBER: 079 474 8468 
 
You are being invited to take part in a research project.  Please take some time to read 
the information presented here, which will explain the details of this project.  Please ask 
the study staff or physiotherapist any questions about any part of this project that you 
do not fully understand.  It is very important that you are fully satisfied that you clearly 
understand what this research entails and how you could be involved. Also, your 
participation is entirely voluntary and you are free to decline to participate.  If you say 
no, this will not affect you negatively in any way whatsoever.  You are also free to 
withdraw from the study at any point, even if you do agree to take part. 
 
This study has been approved by the Health Research Ethics Committee at 
Stellenbosch University and will be conducted according to the ethical guidelines and 
principles of the international Declaration of Helsinki, South African Guidelines for Good 
Clinical Practice and the Medical Research Council (MRC) Ethical Guidelines for 
Research. 
What is this research study all about? 
 The study will be conducted at the Western Cape Rehabilitation Centre. 
 The aim of this study is to understand what affects functional outcome in people 
post stroke. Functional outcome entails one’s ability to go back to their daily 
activities as they did before their stroke. There is a lack of research in South 
Africa regarding functional outcome in stroke in terms of its associated risk 
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factors and this is concerning since South Africa is a country with a rapidly 
growing stroke population. 
 Once you have consented to the study, you will complete function tests as you 
would normally do during a physiotherapy assessment and this will be repeated 
once you have completed your rehabilitation. The physiotherapist (researcher) 
will ask you to do certain activities such as moving in bed, balance and standing. 
You will also be asked a few questions regarding your thoughts on these 
activities. The assessment may take more or less an hour and you should expect 
some fatigue (tiredness) after the assessment but nothing detrimental (that will 
harm you) to your health. You may take breaks during the physical assessment 
and snacks will be provided. 
 The information gathered about you is completely confidential and will be coded 
so that no one besides the researcher is able to know that information belongs 
to you. 
 
Why have you been invited to participate? 
 You fit the criteria of the patients we would like to assess namely: You have 
suffered your first-ever stroke are older than 18 years. 
 
What will your responsibilities be? 
 Your responsibility will only be to partake in the physical assessment (function 
tests). 
 
Will you benefit from taking part in this research? 
 The information given will assist in the research of stroke, its risk factors and 
functional outcome in the South African population. Future patients may benefit 
from this as this study will add to current literature to better develop our health 
care system as well as give us more insight or understanding as to how illnesses 
such as HIV may impact ones function once you have had a stroke. 
 
Are there risks involved in your taking part in this research? 
 There are minor risks involved in this study which may include fatigue during the 
physical assessment as well as the risk of falling. These assessments are clinical 
tests and standard precautions will be applied at all times of testing to ensure 
your safety. 
 
If you do not agree to take part, what alternatives do you have? 
 If you do not wish to take part in this study or feel the need to withdraw there will 
be no negative consequences, your participation is completely voluntary. 
 
Who will have access to your medical records? 
 The information collected will be treated as confidential and protected.  If it is 
used in a publication or thesis, your identity will remain anonymous.  Only the 
researcher and the healthcare staff who already have access to your medical 
records are able to see your medical records. 
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What will happen in the unlikely event of some form injury occurring as a direct 
result of your taking part in this research study? 
 In the unlikely event of an injury, participants will be treated by the nursing staff 
or Doctors at WCRC.  
 
Will you be paid to take part in this study and are there any costs involved? 
 Participants will be compensated with a snack pack. 
 
Is there anything else that you should know or do? 
 You can contact the Health Research Ethics Committee at 021-938 9207 if you 
have any concerns or complaints that have not been adequately addressed by 
your study researcher. 
 You will receive a copy of this information and consent form for your own 
records. 
 
 
Declaration by participant 
 
By signing below, I …………………………………..…………. agree to take part in a 
research study entitled ( 
The functional outcomes of stroke patients who are HIV positive, HIV negative and HIV 
undiagnosed, following inpatient rehabilitation: A descriptive study). 
 
I declare that: 
 
 I have read or had read to me this information and consent form and it is written 
in a language with which I am fluent and comfortable. 
 I have had a chance to ask questions and all my questions have been 
adequately answered. 
 I understand that taking part in this study is voluntary and I have not been 
pressurized to take part. 
 I may choose to leave the study at any time and will not be penalised or 
prejudiced in any way. 
 I may be asked to leave the study before it has finished, if the study doctor or 
researcher feels it is in my best interests, or if I do not follow the study plan, as 
agreed to. 
 
 
Signed at (place) ......................…........…………….. on (date) …………....……….. 
2016. 
 
Signature of participant Signature of witness 
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Declaration by investigator 
 
I (name) ……………………………………………..……… declare that: 
 
 I explained the information in this document to ………………………………….. 
 I encouraged him/her to ask questions and took adequate time to answer them. 
 I am satisfied that he/she adequately understands all aspects of the research, 
as discussed above 
 I did/did not use a interpreter.  (If a interpreter is used then the interpreter must 
sign the declaration below. 
 
 
Signed at (place) ......................…......………….. on (date) …………....……….. 2016. 
 
Signature of investigator Signature of witness 
 
Declaration by interpreter 
 
I (name) ……………………………………………..……… declare that: 
 
 I assisted the investigator (name) ………………………………………. to explain 
the information in this document to (name of participant) 
……………..…………………………….. using the language medium of 
Afrikaans/Xhosa. 
 We encouraged him/her to ask questions and took adequate time to answer 
them. 
 I conveyed a factually correct version of what was related to me. 
 I am satisfied that the participant fully understands the content of this informed 
consent document and has had all his/her question satisfactorily answered. 
 
 
Signed at (place) ......................…........…………….. on (date) 
…………....……………….. 
 
    
Signature of interpreter Signature of witness 
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Appendix B: Afrikaans Consent Form 
 
DEELNEMERINLIGTINGSBLAD EN -TOESTEMMINGSVORM 
 
TITEL VAN DIE NAVORSINGSPROJEK: 
Die funksionele uitkomste van MIV-positiewe, MIV-negatiewe en MIV onbekende 
status van mense post beroerte nadat hulle binne pasiënt rehabilitasie ontvang het: 'n 
beskrywende navorsings studie. 
 
VERWYSINGSNOMMER: 
 
HOOFNAVORSER: Tasneem Hartley 
 
ADRES:  Fisioterapie Afdeling 
  Stellenbosch Universiteit 
  Francie Van Zijl Rylaan 
  Tygerberg 
7505 
Suid Afrika 
 
KONTAKNOMMER: 079 474 8468 
 
U word genooi om deel te neem aan ’n navorsingsprojek.  Lees asseblief hierdie 
inligtingsblad op u tyd deur aangesien die detail van die navorsingsprojek daarin 
verduidelik word.  Indien daar enige deel van die navorsingsprojek is wat u nie ten volle 
verstaan nie, is u welkom om die navorsingspersoneel of fisioterapeut daaroor uit te 
vra.  Dit is baie belangrik dat u ten volle moet verstaan wat die navorsingsprojek behels 
en hoe u daarby betrokke kan wees.  U deelname is ook volkome vrywillig en dit 
staan u vry om deelname te weier.  U sal op geen wyse hoegenaamd negatief 
beïnvloed word indien u sou weier om deel te neem nie.  U mag ook te eniger tyd aan 
die navorsingsprojek onttrek, selfs al het u ingestem om deel te neem. 
 
Hierdie navorsingsprojek is deur die Gesondheids Navorsings Etiek Komitee (GNEK) 
van die Universiteit Stellenbosch goedgekeur en sal uitgevoer word volgens die etiese 
riglyne en beginsels van die Internasionale Verklaring van Helsinki en die Etiese 
Riglyne vir Navorsing van die Mediese Navorsingsraad (MNR). 
 
Wat behels hierdie navorsingsprojek? 
 Die studie sal uitgevoer word by die Wes-Kaapse Rehabilitasiesentrum. 
 Die doel van die studie is om te verstaan wat die funksionele uitkomste van 
mense post beroerte kan affekteer. Funksionele uitkomste behels 'n mens se 
vermoë om terug te gaan na hul daaglikse aktiwiteite soos voor hulle beroerte. 
Daar is 'n gebrek aan navorsing in Suid-Afrika met betrekking tot funksionele 
uitkomste in persone wat 'n beroerte gehad het, asook in terme van verwante 
risikofaktore. Navorsing hieroor is belangrik, aangesien Suid-Afrika 'n land is met 
'n vinnig groeiende beroerte populasie. 
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 Indien jy instem om aan die navorsings studie deel te neem sal jy funksionele 
toetse te voltooi soos jy normaalweg sou doen tydens 'n fisioterapie evaluering 
en sodra jy jou rehabilitasie voltooi het, sal die funksionele toetse herhaal word. 
Die fisioterapeut (navorser) sal jou vra om sekere aktiwiteite te doen soos om 
op en af te skuif in die bed, balans aktiwiteite en staan aktiwiteite. Jy sal ook 
gevra word om 'n paar vrae te beantwoord oor hoe u voel tydens die uitvoer van 
die funksionele aktiwiteite. Die evaluering kan min of meer as 'n uur duur en jy 
kan verwag dat jy moeg sal voel na die evaluering, maar dit sal nie nadelig vir 
jou gesondheid wees nie. Jy kan rusperiodes neem tydens die evaluering en 
versnaperinge sal voorsien word. 
 Die inligting wat verkry word, is heeltemal vertroulik en sal gekodeer word 
(kodes sal gegee word) sodat niemand behalwe die navorser sal weet dat die 
inligting aan jou behoort nie. 
 
Waarom is u genooi om deel te neem? 
 Jy voldoen aan die kriteria van die pasiënte wat ons wil insluit in ons studie: 
Naamlik jy het jou heel eerste beroerte gehad en is ouer as 18 jaar. 
 
Wat sal u verantwoordelikhede wees? 
 Jou verantwoordelikheid sal slegs wees om deel te neem aan die fisiese 
evaluering (funksionele toetse). 
 
Sal u voordeel trek deur deel te neem aan hierdie navorsingsprojek? 
 Die inligting sal help om te bepaal wat die risikofaktore en funksionele uitkomste 
is in die Suid-Afrikaanse bevolking wat 'n beroerte gehad het. Toekomstige 
pasiënte kan baat vind by inligting wat deur die studie ingesamel word, 
aangesien dit sal bydra tot die huidige literatuur om ons gesondheidsorg stelsel 
te help ontwikkel, asook om ons meer insig of begrip te gee oor hoe siektes soos 
MIV funksie kan beïnvloed van iemand wat 'n beroerte gehad het. 
 
Is daar enige risiko's verbonde aan u deelname aan hierdie navorsingsprojek? 
 
 Daar is geringe risiko’s betrokke by hierdie studie wat moontlik die volgende kan 
insluit: moegheid gedurende die fisiese evaluering, sowel as die risiko om te val. 
Tydens die evaluering sal voorsorgmaatreëls ten alle tye toegepas word op jou 
veiligheid te verseker. 
 
Watter alternatiewe is daar indien u nie instem om deel te neem nie? 
 As jy nie wil deelneem aan hierdie studie of die behoefte het om te onttrek, sal 
daar geen negatiewe gevolge wees nie. Jou deelname is heeltemal vrywillig. 
 
Wie sal toegang hê tot u mediese rekords? 
 Die inligting wat ingesamel word, sal as vertroulik hanteer en beskerm word. As 
dit gebruik word in 'n publikasie of verhandeling (tesis), sal jou identiteit anoniem 
bly. Slegs die navorser en die gesondheidsorg personeel wat reeds toegang tot 
jou mediese rekords het, sal in staat wees om jou mediese rekords te sien. 
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Wat sal gebeur in die onwaarskynlike geval van ’n besering wat mag voorkom 
as gevolg van u deelname aan hierdie navorsingsprojek? 
 In die onwaarskynlike geval van 'n besering, sal deelnemers behandel word deur 
die verpleegpersoneel of Dokters by WKRS.  
 
Sal u betaal word vir deelname aan die navorsingsprojek en is daar enige koste 
verbonde aan deelname? 
 Deelnemers sal vergoed word met 'n versnapering vir hulle tyd.  
 
Is daar enigiets anders wat u moet weet of doen? 
 U kan die Gesondheidsnavorsingsetiek administrasie kontak by 021-938 
9207 indien u enige bekommernis of klagte het wat nie bevredigend deur u 
studie navorser hanteer is nie. 
 U sal ’n afskrif van hierdie inligtings- en toestemmingsvorm ontvang vir u eie 
rekords. 
 
Verklaring deur deelnemer 
 
Met die ondertekening van hierdie dokument onderneem ek, 
…….....................……….....……...……….., om deel te neem aan ’n navorsingsprojek 
getiteld  (Titel van navorsingsprojek). 
 
Ek verklaar dat: 
 
 Ek hierdie inligtings- en toestemmingsvorm gelees het of aan my laat voorlees 
het en dat dit in ’n taal geskryf is waarin ek vaardig en gemaklik mee is. 
 Ek geleentheid gehad het om vrae te stel en dat al my vrae bevredigend 
beantwoord is. 
 Ek verstaan dat deelname aan hierdie navorsingsprojek vrywillig is en dat daar 
geen druk op my geplaas is om deel te neem nie. 
 Ek te eniger tyd aan die navorsingsprojek mag onttrek en dat ek nie op enige 
wyse daardeur benadeel sal word nie. 
 Ek gevra mag word om van die navorsingsprojek te onttrek voordat dit 
afgehandel is indien die studiedokter of navorser van oordeel is dat dit in my 
beste belang is, of indien ek nie die ooreengekome navorsingsplan volg nie. 
 
 
Geteken te (plek) ..............................…………….. op (datum) …………....……….. 
2016. 
 
 
 ..............................................................   ............................................................  
Handtekening van deelnemer Handtekening van getuie 
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Verklaring deur navorser 
 
Ek (naam) …………………………………...……………… verklaar dat: 
 
 Ek die inligting in hierdie dokument verduidelik het aan 
…………………….............................................……….. 
 Ek hom/haar aangemoedig het om vrae te vra en voldoende tyd gebruik het om 
dit te beantwoord. 
 Ek tevrede is dat hy/sy al die aspekte van die navorsingsprojek soos hierbo 
bespreek, voldoende verstaan. 
 Ek ’n tolk gebruik het/nie ’n tolk gebruik het nie.  (Indien ’n tolk gebruik is, moet 
die tolk die onderstaande verklaring teken.) 
 
 
Geteken te (plek) ..............................…………….. op (datum) …………....……….. 
2016. 
 
 
 
 ..............................................................   ............................................................  
Handtekening van navorder Handtekening van getuie 
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Verklaring deur tolk 
 
Ek (naam) …………………………………...……………… verklaar dat: 
 
 Ek die navorser (naam) ……….............................…………………. bygestaan 
het om die inligting in hierdie dokument in Afrikaans/Xhosa aan (naam van 
deelnemer) ……………………………......................... te verduidelik. 
 Ons hom/haar aangemoedig het om vrae te vra en voldoende tyd gebruik het 
om dit te beantwoord. 
 Ek ’n feitelik korrekte weergawe oorgedra het van wat aan my vertel is. 
 Ek tevrede is dat die deelnemer die inhoud van hierdie dokument ten volle 
verstaan en dat al sy/haar vrae bevredigend beantwoord is. 
 
 
Geteken te (plek) ..............................…………….. op (datum) …………....……….. 
2016. 
 
 
 
 ..............................................................   ............................................................  
Handtekening van tolk Handtekening van getuie 
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Appendix C: isiXhosa Consent Form 
 
INCWADANA ENGOLWAZI NGOMTHATHI-NXAXHEBA KUNYE NEFOMU 
YEMVUMELWANO 
 
ISIHLOKO SEPROJEKTHI YOPHANDO: 
 
 
INOMBOLO YONXULUMANO: S15/10/232 
 
UMPHANDI OYINTLOKO: 
Tasneem Hartley 
 
IDILESI:  
Francie Van Zijl Drive 
Tygerberg 7505 
Cape Town South Africa 
 
INOMBOLO YOQHAGAMSHELWANO: 079 474 8468 
 
 
 
 
  
Ukuchaza iziphumo zokusebenza kubantu abaneNtsholongwane kaGawulayo 
abakumaziko karhulumente okubuyiselwa kwezimo emva kokuba befe icala 
Uyamenywa ukuba uthathe inxaxheba kwiprojekthi yophando. Nceda uthathe ixesha 
lokufunda iinkcukacha ezibekiweyo apha, eziza kucacisa malunga nayiphi na indawo  kule 
projekthi ongayiqondiyo ngokupheleleyo. Kubaluleke kakhulu ukuba woneliseke 
ngokupheleleyo koko kuqulathwe kolu phando nokuba ungabandakanyeka njani. Kwakho, 
ukuthatha kwakho inxaxheba awunyanzelekanga kwaphela ukwenza 
ngokuzithandela, kwaye ukhululekile ukuba ungarhoxa ekuthatheni inxaxheba. Ukuba 
uthi hayi, oku akuzi kukuchaphazela kakubi nangayiphi na indlela. Ungarhoxa nanini na 
ekuthatheni inxaxheba kuphononongo, nokuba ubuvumile ukuba uza kuthatha inxaxheba. 
Olu phononongo luvunywe yiKomiti yokuziPhatha kuPhando lwezeMpilo yeYunivesithi 
yaseStellenbosch (S15/10/232) kwaye luza kwenziwa ngokwesikhokelo sokuziphatha 
nemithetho-siseko yesiBhengezo sikazwelonke saseHelsinki, kwiSikhokelo seNdlela 
yokuSebenza kakuhle kwezeMpilo eMzantsi Afrika neSikhokelo seNdlela yokuziPhatha 
kuPhando lwezoNyango (MRC). 
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Simalunga nantoni esi sifundo sophando? 
 Uphononongo luza kwenziwa kwiZiko lokuBuyiselwa kwezimo eNtshona Koloni 
neNdawo eNika inkathalo ephakathi eLife Esidimeni 
 
 Injongo yolu phando kukufuna ukuqonda ukuba yintoni echaphazela iziphumo 
zokusebenza ebantwini ebebehlaselwe kukufa icala nabaneNtsholongwane 
kaGawulayo. Iziphumo zokusebenza ziquka ukwazi ukubuyela kwimisebenzi 
yemihla ngemihla njengoko bebesenza phambi kokuba bahlaselwe sisifo 
sokufa icala. Kukho ukunqongophala kophando eMzantsi Afrika malunga 
neziphumo zokusebenza xa ubufe icala ngokunxulumene nemiba yoko 
kusemngciphekweni kwaye oku kuyaxhalabisa njengoko uMzantsi Afrika ililizwe 
elinabantu abakhula ngokukhawuleza abafa icala 

 Xa sele uvumile ukuba kolu phononongo, uza kwenza uvavanyo olujonga indlela 
oqhele ukusebenza ngayo xa uhlolwa yingcali enyanga umzimba ngokuthambisa. 
Ingcali enyanga umzimba ngokuthambisa (umphandi) uza kukucela wenze ezinye 
izinto ezinjengokushukuma ebhedini, ukungagungqi uqine ume neengxelo 
zokuhamba kwakho nexesha nomgama owuhambayo emva kokuba uhlaselwe sisifo 
sokufa icala. Uza kubuzwa nemibuzo embalwa malunga noko ukucingayo ngale 
misebenzi. Uvavanyo lungathatha ngaphezulu okanye ngaphantsi kweyure kwaye 
kufuneka ulindele ukuba ungadinwa emva kolo vavanyo kodwa akukho nto eza 
kubeka engxakini (eza konakalisa) impilo yakho. Ungamana uzipha ikhefu uphumla 
xa usenza uvavanyo usitya namashwamashwam oza kuwanikwa. 

 Iinkcukacha ezifunyenweyo ngawe ziza kuba yimfihlo kwaye ziza kufakwa ikhowudi 
apho kungekho namnye ngaphandle kwabo benza uphando abaza kuzazi ukuba 
zezakho ezo nkcukacha. 
 
Kutheni umenyiwe ukuba uthathe inxaxheba? 
 
 Uyilungele indlela yokukhethwa kwezigulane esifuna ukwenza uhlolo koku: 
Uhlaselwe sisifo sokufa icala kwaye uneNtsholongwane kaGawulayo

Luyakuba yintoni uxanduva lwakho? 
 
 Uxanduva lwakho iza kuba kukuthatha inxaxheba kuphela kuhlolo ngokwenza 
(uvavanyo lokwenza izinto xa ulaliswa naphambi kokuba ukhutshwe. 
 
Ingaba uza kuzuza ekuthatheni inxaxheba kolu phando? 
 
 Iinkcukacha ezinikeziweyo ziza kunceda kuphando lwesifo sokufa icala, imiba 
yokusemngciphekweni neziphumo zokusebenza kwabantu baseMzantsi Afrika. 
Izigulane zexesha elizayo zingaxhamla koku njengoko olu phononongo luza 
kubanento eyenzayo kwimeko ekhoyo ukuphuhlisa ngcono inkqubo 
yokukhathalelwa kwempilo yethu nokusenza sibone okanye siqonde ngakumbi 
ukuba ingaba izifo ezifana neNtsholongwane kaGawulayo zinganeempembelelo 
ezinjani ekusebenzeni komntu xa ubukhe wahlaselwa sisifo sokufa icala. 
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Ingaba zikho iingozi ezibandakanyekayo ekuthatheni kwakho inxaxheba kolu phando

 Mncinci umngcipheko okhoyo kolu phononongo onokuquka ukudinwa xa kusenziwa 
uhlolo lomzimba njengomngcipheko wokuwa. Ezi mvavanyo kukuvavanywa 
ezonyango nokhuseleko olusemgangathweni ziza kusebenza ngawo onke 
amaxesha ohlolo ukuqinisekisa ukhuseleko lwakho. 

Ukuba awuvumi ukuthatha inxaxheba, loluphi olunye unyango onalo? 

 Ukuba awunqweneli kuthatha inxaxheba kolu phononongo okanye ofuna ukurhoxa 
akuzobakho zimeko zimbi eziza kukuchaphazela, ukuthatha kwakho inxaxheba 
ukwenza ngokuzithandela akunyanzelekanga. 

Ngubani uza kufumana ingxelo yakho yamayeza 
 
 Linkcukacha ezifunyenweyo ziza kuthathwa njengeziyimfihlo nezikhuselekileyo. 
Ukuba ziye zasetyenziswa kupapasho lwethisisi, igama lakho alizovezwa. 
Ngabaphandi kuphela nabasebenzi bezempilo esele benazo iingxelo zakho zempilo 
abazokwazi ukuzibona iingxelo zakho zempilo. 
 
Kuza kwenzeka ntoni kwimeko yesiganeko esingalindekanga sokwenzakala ngenxa 
yokuthatha kwakho inxaxheba kwesi sifundo sophando? 
 
 Xa enokwenzakala, lowo uthatha inxaxheba uza kunyangwa ngoonesi nooGqirha 
eWCRC neLife Esidimeni. Abathatha inxaxheba kuphando bakwabone le lwa 
nge-inshorensi yiYunivesithi yaseStellenbosch. 
 
Ingaba uza kuhlawulwa ngokuthatha inxaxheba kwesi sifundo kwaye ingaba kukho 
iindleko ezibandakanyekayo 
 
Abathatha inxaxheba baza kunikwa ipakethi yezinto ezityiwayo nemali ngexesha labo 
abalichithe kuvavanyo. 
 
Ingaba ikho enye into ekumele uyazi okanye uyenze? 
 
 Ungaqhagamshelana neKomiti ejongene nokuziPhatha kuPhando lwezeMpilo ku-
021-938 9207 ukuba kukho izinto ezikuxhalabisayo okanye izikhalazo ezingakhange 
ziqwalaselwe ngokwaneleyo ngumphandi okolu phononongo. 
 Uza kufumana ikopi yezi nkcukacha nefomu yesivumelwano ukuze uzigcinele. 
 
Isifungo somthathi-nxaxheba 
 
Ngokuytyikitya ngezantsi, Mna …………………………………..…………. ndiyavuma 
ukuthatha inxaxheba kwisifundo sophando semfuzo esibizwa ngokuba (faka ishloko 
sesifundo). 
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Ndazisa ukuba: 
 
 Ndilufundile okanye ndalufunda olu lwazi kunye nefomu yemvumelwano kwaye 
ibhalwe ngolwimi endiliciko nendikhululekileyo kulo  
 Bendinalo ithuba lokuba ndibuze imibuzo kwaye yonke imibuzo yam iphendulwe 
ngokwanelisayo. 
 Ndiyakuqonda ukuba ukuthatha inxaxheba kolu phando kube kukuzithandela kwam 
kwaye andikhange ndinyanzelwe ukuba ndithathe inxaxheba. 
 Ndingakhetha ukusishiya isifundo naninina kwaye andisayi kohlwaywa okanye uqal’ 
ugwetywe nangayiphi indlela. 
 Usenokucelwa ukuba usishiye isifundo phambi kokuba siphele, ukuba ugqirha 
wesifundo okanye umphandi ukubona kuyinzuzo kuwe, okanye ukuba andisilandeli 
isicwangciso sesifundo, ekuvunyelenwe ngaso. 
 
 
Kutyikitywe e-(indawo) .........…........…………….. ngo-(usuku) ………....……….. 2016. 
 
 ..............................................................   ............................................................  
Umtyikityo womthathi-nxaxheba   Umtyikityo wengqina 
 
Isifungo somphandi 
 
Mna (igama) ………………………………………………… ndiyafunga ukuba: 
 Ndilucacisile ulwazi olu kweli xwebhu ku-…………………..……………... 
 Ndimkhuthazile ukuba abuze imibuzo kwaye athathe ixesha elifanelekileyo ukuba 
ayiphendule. 
 Ndiyaneliseka kukuba uyakuqonda ngokwanelisayo konke okumalunga 
nophando okuxoxwe ngasentla. 
 Ndisebenzise/andisebenzisanga toliki.  (Ukuba itoliki isetyenzisiwe kumele 
ityikitye isaziso ngezantsi. 
 
Kutyikitywe e-(indawo) .........…........…………….. ngo-(usuku) ………....……….. 2016. 
 
 
 ..............................................................   ............................................................  
Umtyikityo womphandi     Umtyikityo wengqina 
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Isifungo setoliki 
 
Mna (igama) ………………………………………………… ndazisa ukuba: 
 Ndicende umphandi (igama) …………………………. Ekucaciseni ulwazi olu 
lapha kweli xwebhu ku-(igama lomthathi-nxaxheba) …………………………….. 
ndisebenzisa ulwimi lwesiAfrikaans/lwesiXhosa. 
 Simkhuthazile ukuba abuze imibuzo kwaye athathe ixesha elifanelekileyo ukuba 
ayiphendule. 
 Ndimxelele eyona nto iyiyo malunga nokunxulumene nam. 
 Ndiyaneliseka kukuba umthathinkxaxheba ukuqonda ngokupheleleyo 
okuqulathwe loluxwebhu lwemvumelwano eyazisiweyo kwaye nemibuzo yakhe 
yonke iphendulwe ngokwanelisayo. 
 
Kutyikitywe e-(indawo) .........…........…………….. ngo-(usuku) ………....……….. 2016. 
 
 
 ..............................................................   ............................................................  
Umtyikityo wetoliki Umtyikityo wengqina 
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Appendix D: Data sheet: Socio-demographic, medical history, 
and outcome measure data score sheet 
HREC:  Project S/15/10/232 (Tasneem Hartley; Physiotherapy Division) 
Patient Name: Code: 
Date of 
admission: 
YYYY/MM/DD:  
Projected Date of 
discharge: 
YYYY/MM/DD: 
Actual Date of 
discharge: 
YYYY/MM/DD: 
Preferred 
Language: 
 
 
1. English  
2. Afrikaans  
3. Xhosa  
4. Other  
Sociodemographic History 
A. DOB  Age: B. Gender 1. Male  
2. Female  
C. Race 1. Black    
2. Mixed race   
3. White   
4. Indian    
5. Other  
Present Medical History Clinical D. Date of incident (stroke): 
E. Diagnosis 1. Hemorrhagic  
2. Infarction  
F. Side affected 1. Left hemiplegia  
2. Right hemiplegia  
G. Special 
Investi- 
gations 
1. CT 
2. MRI 
3. Other: ____________ 
Findings: __________________________________________________________ 
H. Documented 
stroke risk 
factors 
 
1. Hypertension   
2. Diabetes   
3. Cholesterol  
4. Smoker  How much? _____________ How long? ________________ 
5. Obesity   
6. Substance abuse  How much? __________ How long? ___________ 
7. Atherosclerosis (hardening and narrowing of arteries)  
8. Opportunistic infection (e.g. meningitis, TB, syphilis)   
9. Not known   
10. Other  Describe: ______________________________________________ 
I. HIV status 1. Diagnosed HIV+  
2. Diagnosed HIV- 
3. Undiagnosed/ Unspecified  (patient has not been tested or status is not 
documented)  
J. Most 
recent CD4 
count:  
CD4 count: ________________________________________________________  
Date: ______________________________________________________________ 
Not documented  
K. AD’s used 
during 
rehab  
(Initial 
assess-
ment) 
1. None 
2. Walking stick   
3. Crutches   
4. Walking frame/rollator   
5. Wheelchair   
6. Other  Describe: ______________________________________________ 
L. AD’s 
received 
on 
discharge 
1. None  
2. Walking stick   
3. Crutches   
4. Walking frame/rollator   
5. Wheelchair   
6. Other  Describe: ______________________________________________ 
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HREC:  Project S/15/10/232 (Tasneem Hartley; Physiotherapy Division) 
Outcome measure scores: Modified Rankin Scale; Barthel Index and Berg Balance 
scale (On admission and discharge) 
 
Patient name:      Code: 
Barthel Index Admission 
Date: 
Discharge 
Date: 
1. Feeding   
2. Bathing   
3. Grooming   
4. Dressing   
5. Bowels   
6. Bladder   
7. Toilet use   
8. Transfers (bed to chair and back)   
9. Mobility (On level surfaces)   
10. Stairs   
Total /100 /100 
Berg Balance scale   
1. Sitting to Standing   
2. Standing unsupported   
3. Sitting unsupported   
4. Standing to sitting   
5. Transfers   
6. Standing eyes closed   
7. Standing with feet together   
8. Reaching forward with outstretched arm   
9. Retrieving object from floor   
10. Turning to look behind   
11. Turning 360°    
12. Placing alternate foot on stool   
13. Standing with one foot in front   
14. Standing on one foot   
Total /56 /56 
Modified Rankin Scale   
Score 0-6 /6 /6 
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Appendix E: Modified Rankin Scale 
 
Patient name:      Code: 
MODIFIED Patient Name:  _____________________ 
RANKIN Rater Name: ______________________ 
SCALE (MRS) Date:                ______________________ 
 
 
Score Description 
 
 0 No symptoms at all 
 
 1 No significant disability despite symptoms; able to carry out all usual duties and 
activities 
 
 2 Slight disability; unable to carry out all previous activities, but able to look after 
own affairs without assistance 
 
 3  Moderate disability; requiring some help, but able to walk without assistance  
 
 4  Moderately severe disability; unable to walk without assistance and unable to 
attend to own bodily needs without assistance 
 
 5  Severe disability; bedridden, incontinent and requiring constant nursing care and 
attention 
 
 6  Dead  
 
TOTAL (0–6):  _______  
 
References 
 
Rankin J. “Cerebral vascular accidents in patients over the age of 60.” 
Scott Med J 1957;2:200-15  
Bonita R, Beaglehole R. “Modification of Rankin Scale: Recovery of motor function after stroke.” 
Stroke 1988 Dec;19(12):1497-1500 
Van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. “Interobserver agreement for 
the assessment of handicap in stroke patients.” 
Stroke 1988;19(5):604-7 
 
 
Provided by the Internet Stroke Center — www.strokecenter.org 
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Appendix F: Barthel Index 
 
THE 
BARTHEL 
INDEX 
Patient Name: 
Rater Name: 
Date: 
   
   
   
Activity  Score 
FEEDING 
  
0 = unable 
5 = needs help cutting, spreading butter, etc., or requires modified diet 
10 = independent 
 
BATHING 
0 = dependent 
5 = independent (or in shower) 
 
GROOMING 
0 = needs to help with personal care 
5 = independent face/hair/teeth/shaving (implements provided) 
 
DRESSING 
0 = dependent 
5 = needs help but can do about half unaided 
10 = independent (including buttons, zips, laces, etc.) 
 
BOWELS 
0 = incontinent (or needs to be given enemas) 
5 = occasional accident 
10 = continent 
 
BLADDER 
0 = incontinent, or catheterized and unable to manage alone 
5 = occasional accident 
10 = continent 
 
TOILET USE 
0 = dependent 
5 = needs some help, but can do something alone 
10 = independent (on and off, dressing, wiping) 
 
TRANSFERS (BED TO CHAIR AND BACK) 
0 = unable, no sitting balance 
5 = major help (one or two people, physical), can sit 
10 = minor help (verbal or physical) 
15 = independent 
 
MOBILITY (ON LEVEL SURFACES) 
0 = immobile or < 50 yards 
5 = wheelchair independent, including corners, > 50 yards 
10 = walks with help of one person (verbal or physical) > 50 yards 
15 = independent (but may use any aid; for example, stick) > 50 yards 
 
STAIRS 
0 = unable 
5 = needs help (verbal, physical, carrying aid) 
10 = independent 
 
 
TOTAL (0–100):      _ 
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The Barthel ADL Index: Guidelines 
 
 
1. The index should be used as a record of what a patient does, not as a record of what a patient could 
do. 
2. The main aim is to establish degree of independence from any help, physical or verbal, however 
minor and for whatever reason. 
3. The need for supervision renders the patient not independent. 
4. A patient's performance should be established using the best available evidence. Asking the 
patient, friends/relatives and nurses are the usual sources, but direct observation and common 
sense are also important. However direct testing is not needed. 
5. Usually the patient's performance over the preceding 24-48 hours is important, but occasionally 
longer periods will be relevant. 
6. Middle categories imply that the patient supplies over 50 per cent of the effort. 
7. Use of aids to be independent is allowed. 
 
 
 
 
 
 
 
 
References 
 
 
Mahoney FI, Barthel D. “Functional evaluation: the Barthel Index.” 
Maryland State Medical Journal 1965;14:56-61. Used with permission. 
 
Loewen SC, Anderson BA. “Predictors of stroke outcome using objective measurement scales.” 
Stroke. 1990;21:78-81. 
 
Gresham GE, Phillips TF, Labi ML. “ADL status in stroke: relative merits of three standard indexes.” 
Arch Phys Med Rehabil. 1980;61:355-358. 
 
Collin C, Wade DT, Davies S, Horne V. “The Barthel ADL Index: a reliability study.” 
Int Disability Study.1988;10:61-63. 
 
 
 
 
 
 
 
Copyright Information 
 
 
The Maryland State Medical Society holds the copyright for the Barthel Index. It may be used freely for non- 
commercial purposes with the following citation: 
 
Mahoney FI, Barthel D. “Functional evaluation: the Barthel 
Index.” 
Maryland State Med Journal 1965;14:56-61. Used with 
permission. 
 
Permission is required to modify the Barthel Index or to use it for commercial purposes. 
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Appendix G: Berg Balance Scale 
 
Berg Balance Scale 
 
The Berg Balance Scale (BBS) was developed to measure balance among older people with 
impairment in balance function by assessing the performance of functional tasks. It is a valid 
instrument used for evaluation of the effectiveness of interventions and for quantitative descriptions 
of function in clinical practice and research. The BBS has been evaluated in several reliability 
studies. A recent study of the BBS, which was completed in Finland, indicates that a change of eight 
(8) BBS points is required to reveal a genuine change in function between two assessments among 
older people who are dependent in ADL and living in residential care facilities. 
 
 
Description:  
14-item scale designed to measure balance of the older adult in a clinical setting. 
 
Equipment needed: Ruler, two standard chairs (one with arm rests, one 
without), footstool or step, stopwatch or wristwatch, 15 ft walkway 
 
Completion:    
 Time:  15-20 minutes 
 Scoring: A five-point scale, ranging from 0-4. “0” indicates the lowest level 
      of function and “4” the highest level of function. Total Score = 56 
Interpretation: 41-56 = low fall risk 
      21-40 = medium fall risk  
0 –20 = high fall risk 
 
A change of 8 points is required to reveal a genuine change in function between 2 assessments. 
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Berg Balance Scale 
 
 
Name: __________________________________ Date: ___________________ 
Location: 
________________________________ Rater: ___________________ 
ITEM DESCRIPTION SCORE (0-4) 
Sitting to standing ________ 
Standing unsupported ________ 
Sitting unsupported ________ 
Standing to sitting ________ 
Transfers  ________ 
Standing with eyes closed ________ 
Standing with feet together ________ 
Reaching forward with outstretched arm ________ 
Retrieving object from floor ________ 
Turning to look behind ________ 
Turning 360 degrees ________ 
Placing alternate foot on stool ________ 
Standing with one foot in front ________ 
Standing on one foot ________ 
Total ________  
 
 
 
GENERAL INSTRUCTIONS  
Please document each task and/or give instructions as written. When scoring, please 
record the lowest response category that applies for each item. 
 
In most items, the subject is asked to maintain a given position for a specific time. 
Progressively more points are deducted if:  
 the time or distance requirements are not met
 the subject’s performance warrants supervision
 the subject touches an external support or receives assistance from the examiner
 
Subject should understand that they must maintain their balance while attempting the 
tasks. The choices of which leg to stand on or how far to reach are left to the subject. 
Poor judgment will adversely influence the performance and the scoring. 
 
Equipment required for testing is a stopwatch or watch with a second hand, and a ruler or other 
indicator of 2, 5, and 10 inches. Chairs used during testing should be a reasonable height. 
Either a step or a stool of average step height may be used for item # 12. 
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Berg Balance Scale 
 
SITTING TO STANDING  
INSTRUCTIONS: Please stand up. Try not to use your hand for support.  
( ) 4   able to stand without using hands and stabilize independently  
( ) 3   able to stand independently using hands  
( ) 2   able to stand using hands after several tries  
( ) 1   needs minimal aid to stand or stabilize  
( ) 0   needs moderate or maximal assist to stand 
 
STANDING UNSUPPORTED  
INSTRUCTIONS: Please stand for two minutes without holding on.  
( ) 4   able to stand safely for 2 minutes  
( ) 3   able to stand 2 minutes with supervision  
( ) 2   able to stand 30 seconds unsupported  
( ) 1   needs several tries to stand 30 seconds unsupported  
( ) 0   unable to stand 30 seconds unsupported 
 
If a subject is able to stand 2 minutes unsupported, score full points for sitting unsupported. Proceed 
to item #4. 
 
SITTING WITH BACK UNSUPPORTED BUT FEET SUPPORTED ON 
FLOOR OR ON A STOOL INSTRUCTIONS: Please sit with arms folded 
for 2 minutes.  
( ) 4   able to sit safely and securely for 2 minutes  
( ) 3   able to sit 2 minutes under supervision  
( ) 2   able to able to sit 30 seconds  
( ) 1   able to sit 10 seconds  
( ) 0   unable to sit without support 10 seconds 
 
STANDING TO SITTING  
INSTRUCTIONS: Please sit down.  
( ) 4   sits safely with minimal use of hands  
( ) 3   controls descent by using hands  
( ) 2   uses back of legs against chair to control descent  
( ) 1   sits independently but has uncontrolled descent  
( ) 0   needs assist to sit 
 
TRANSFERS  
INSTRUCTIONS: Arrange chair(s) for pivot transfer. Ask subject to transfer one way toward a 
seat with armrests and one way toward a seat without armrests. You may use two chairs (one 
with and one without armrests) or a bed and a chair.  
( ) 4   able to transfer safely with minor use of hands  
( ) 3   able to transfer safely definite need of hands  
( ) 2   able to transfer with verbal cuing and/or supervision  
( ) 1   needs one person to assist  
( ) 0   needs two people to assist or supervise to be safe 
 
STANDING UNSUPPORTED WITH EYES CLOSED  
INSTRUCTIONS: Please close your eyes and stand still for 10 seconds.  
( ) 4   able to stand 10 seconds safely  
( ) 3   able to stand 10 seconds with supervision  
( ) 2   able to stand 3 seconds  
( ) 1   unable to keep eyes closed 3 seconds but stays safely  
( ) 0   needs help to keep from falling 
 
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
 123  
 
Berg Balance Scale continued… 
 
 
STANDING UNSUPPORTED WITH FEET 
TOGETHER INSTRUCTIONS: Place your feet 
together and stand without holding on. 
( ) 4   able to place feet together independently and stand 1 minute safely  
( ) 3   able to place feet together independently and stand 1 minute with supervision  
( ) 2   able to place feet together independently but unable to hold for 30 seconds  
( ) 1   needs help to attain position but able to stand 15 seconds feet together  
( ) 0   needs help to attain position and unable to hold for 15 seconds 
 
REACHING FORWARD WITH OUTSTRETCHED ARM WHILE STANDING  
INSTRUCTIONS: Lift arm to 90 degrees. Stretch out your fingers and reach forward as far as you 
can. (Examiner places a ruler at the end of fingertips when arm is at 90 degrees. Fingers should 
not touch the ruler while reaching forward. The recorded measure is the distance forward that the 
fingers reach while the subject is in the most forward lean position. When possible, ask subject to 
use both arms when reaching to avoid rotation of the trunk.)  
( ) 4   can reach forward confidently 25 cm (10 inches)  
( ) 3   can reach forward 12 cm (5 inches)  
( ) 2   can reach forward 5 cm (2 inches)  
( ) 1   reaches forward but needs supervision  
( ) 0   loses balance while trying/requires external support 
 
PICK UP OBJECT FROM THE FLOOR FROM A STANDING POSITION  
INSTRUCTIONS: Pick up the shoe/slipper, which is in front of your feet.  
( ) 4   able to pick up slipper safely and easily  
( ) 3   able to pick up slipper but needs supervision  
( ) 2   unable to pick up but reaches 2-5 cm(1-2 inches) from slipper and keeps balance    
independently  
( ) 1   unable to pick up and needs supervision while trying  
( ) 0   unable to try/needs assist to keep from losing balance or falling 
 
TURNING TO LOOK BEHIND OVER LEFT AND RIGHT SHOULDERS WHILE STANDING  
INSTRUCTIONS: Turn to look directly behind you over toward the left shoulder. Repeat to the 
right. (Examiner may pick an object to look at directly behind the subject to encourage a better 
twist turn.)  
( ) 4   looks behind from both sides and weight shifts well  
( ) 3   looks behind one side only other side shows less weight shift  
( ) 2   turns sideways only but maintains balance  
( ) 1   needs supervision when turning  
( ) 0   needs assist to keep from losing balance or falling 
 
TURN 360 DEGREES  
INSTRUCTIONS: Turn completely around in a full circle. Pause. Then turn a full circle in the 
other direction.  
( ) 4   able to turn 360 degrees safely in 4 seconds or less  
( ) 3   able to turn 360 degrees safely one side only 4 seconds or less  
( ) 2   able to turn 360 degrees safely but slowly  
( ) 1   needs close supervision or verbal cuing  
( ) 0   needs assistance while turning   
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Berg Balance Scale continued… 
 
PLACE ALTERNATE FOOT ON STEP OR STOOL WHILE STANDING UNSUPPORTED  
INSTRUCTIONS: Place each foot alternately on the step/stool. Continue until each foot has touched 
the step/stool four times.  
( ) 4   able to stand independently and safely and complete 8 steps in 20 seconds  
( ) 3   able to stand independently and complete 8 steps in > 20 seconds  
( ) 2   able to complete 4 steps without aid with supervision  
( ) 1   able to complete > 2 steps needs minimal assist  
( ) 0   needs assistance to keep from falling/unable to try 
 
STANDING UNSUPPORTED ONE FOOT IN FRONT  
INSTRUCTIONS: (DEMONSTRATE TO SUBJECT) Place one foot directly in front of the other. If 
you feel that you cannot place your foot directly in front, try to step far enough ahead that the heel 
of your forward foot is ahead of the toes of the other foot. (To score 3 points, the length of the 
step should exceed the length of the other foot and the width of the stance should approximate 
the subject’s normal stride width.)  
( ) 4   able to place foot tandem independently and hold 30 seconds  
( ) 3   able to place foot ahead independently and hold 30 seconds  
( ) 2   able to take small step independently and hold 30 seconds  
( ) 1   needs help to step but can hold 15 seconds  
( ) 0   loses balance while stepping or standing 
 
STANDING ON ONE LEG  
INSTRUCTIONS: Stand on one leg as long as you can without holding on.  
( ) 4   able to lift leg independently and hold > 10 seconds  
( ) 3   able to lift leg independently and hold 5-10 seconds  
( ) 2   able to lift leg independently and hold ≥ 3 seconds  
( ) 1   tries to lift leg unable to hold 3 seconds but remains standing independently.  
( ) 0   unable to try of needs assist to prevent fall 
\ 
 
 
 
( )   TOTAL SCORE (Maximum = 56) 
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Appendix H: English Version EQ5D-EL 
 
 
 
 
 
 
 
 
 
 
 
Health Questionnaire 
 
 
English version for South Africa 
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EQ5D-3L      Name:                                                                    Code: 
By placing a tick in one box in each group below, please indicate which statements best describe your 
own state of health TODAY. (P- Pre-morbid; A- on admission; D- discharge) 
  
Mobility P    A    D 
I have no problems in walking about    
I have some problems in walking about    
I am confined to bed    
  
Self-Care 
 
I have no problems with self-care    
I have some problems washing or dressing myself    
I am unable to wash or dress myself    
  
Usual Activities (e.g. work, study, housework, family or leisure activities) 
 
I have no problems with performing my usual activities    
I have some problems with performing my usual activities    
I am unable to perform my usual activities    
  
Pain / Discomfort 
 
I have no pain or discomfort    
I have moderate pain or discomfort    
I have extreme pain or discomfort    
  
Anxiety / Depression 
 
I am not anxious or depressed    
I am moderately anxious or depressed    
I am extremely anxious or depressed    
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To help people say how good or bad their state of health is, we 
have drawn a scale (rather like a thermometer) on which the best 
state you can imagine is marked 100 and the worst state you can 
imagine is marked 0. 
         
We would like you to indicate on this scale, in your opinion, how 
good or bad your own health is today. Please do this by drawing 
a line from the box below to whichever point on the scale indicates 
how good or bad your state of health is today. 
 
        P – Date                                     A – Date                                      D – Date 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0 
Your own state 
of health today 
Best imaginable 
state of health 
9 0 
8 0 
7 0 
6 0 
5 0 
4 0 
3 0 
2 0 
1 0 
100 
0 
Worst imaginable 
state of health 
Best imaginable 
state of health 
9 0 
8 0 
7 0 
6 0 
5 0 
4 0 
3 0 
2 0 
1 0 
100 
Worst imaginable 
state of health 
Best imaginable 
state of health 
9 0 
8 0 
7 0 
6 0 
5 0 
4 0 
3 0 
2 0 
1 0 
100 
0 
Worst imaginable 
state of health 
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Appendix I: Afrikaans Version 
 
 
 
 
 
 
 
 
 
Gesondheidsvraelys 
 
 
Afrikaanse weergawe vir Suid-Afrika 
 
(Afrikaans version for South Africa) 
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Dui asseblief aan watter stellings u eie gesondheidstoestand vandag die beste beskryf deur ’n regmerkie 
in een blokkie by elkeen van die onderstaande groepe te maak. (P- pre-morbid; A- On Admission; D- 
Discharge 
Name:                                                                    Code: 
  
Beweeglikheid P    A   D 
Ek het geen probleme om rond te loop nie    
Ek het sommige probleme om rond te loop    
Ek is beperk tot die bed    
  
Selfversorging 
 
Ek het geen probleme om myself te versorg nie    
Ek het sommige probleme om myself te was of aan te trek    
Ek is nie in staat om myself te was of aan te trek nie    
  
Gewone Aktiwiteite (bv. werk, studeer, huiswerk, familie- of 
ontspanningsaktiwiteite) 
 
Ek het geen probleme om my gewone aktiwiteite uit te voer nie    
Ek het sommige probleme om my gewone aktiwiteite uit te voer    
Ek is nie in staat om my gewone aktiwiteite uit te voer nie    
  
Pyn / Ongemak 
 
Ek het geen pyn of ongemak nie    
Ek het matige pyn of ongemak    
Ek het uiterste pyn of ongemak    
  
Angstigheid / Neerslagtigheid 
 
Ek is nie angstig of neerslagtig nie    
Ek is matig angstig of neerslagtig     
Ek is uiters angstig of neerslagtig    
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P- 
Datum:---------------------------------A- Datum:---------------------------------D- Datum 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Om mense te help om te sê hoe goed of sleg hul gesondheidstoestand is, het ons ’n 
skaal (baie soos ’n termometer) geteken waarop die beste gesondheidstoestand wat u 
u kan indink, gemerk is met 100 en die slegste gesondheidstoestand wat u u kan indink, 
gemerk is met 0. 
 
Ons wil graag hê dat u op hierdie skaal aandui hoe goed of sleg u eie gesondheid vandag 
na u mening is. Doen dit asseblief deur ’n streep te trek vanaf die blokkie hieronder (waar 
dit sê: “u eie gesondheidstoestand vandag”) tot by enige punt op die skaal wat aandui 
hoe goed of sleg u gesondheidstoestand vandag is. 
                                                                                                   
U eie 
gesondheids
-toestand 
vandag 
Beste denkbare 
gesondheidstoestand 
9 0 
8 0 
7 0 
6 0 
5 0 
4 0 
3 0 
2 0 
1 0 
100 
0 
Slegste denkbare 
gesondheidstoestand 
Beste denkbare 
gesondheidstoestand 
9 0 
8 0 
7 0 
6 0 
5 0 
4 0 
3 0 
2 0 
1 0 
100 
0 
Slegste denkbare 
gesondheidstoestand 
Beste denkbare 
gesondheidstoestand 
9 0 
8 0 
7 0 
6 0 
5 0 
4 0 
3 0 
2 0 
1 0 
100 
0 
Slegste denkbare 
gesondheidstoestand 
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Appendix J: isiXhosa Version 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Iphepha lemibuzo ngezempilo 
 
 
Inguqulelo yesiXhosa saseMzantsi Afrika 
 
(Xhosa version for South Africa) 
 
 
 
 
 
 
 
 
 
 
 
 
  
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
 132  
 
 
Beka uphawu kwibhokisi ibenye kwiqela ngalinye echaza imeko yempilo yakho namhlanje, kwezi bhokisi 
zilandelayo. (P- pre-morbid; A- On Admission; D- Discharge) 
Name:                                                                    Code: 
Musa ukuphawula ngaphezulu kwebhokisi enye kwiqela ngalinye. 
  
Ukuhamba P    A   D 
Andinangxaki zokuhamba    
Ndinazo ingxakana zokuhamba    
Ndingumlwelwe obopheleleke ebhedini    
  
Ukuzinonophela isiqu 
 
Andinangxaki zokuzinonophela    
Ndinazo ingxakana zokuhlamba okanye ukuzinxibisa    
Andikwazi ukuzihlamba okanye ukuzinxibisa    
  
Izinto zesiqhelo (Umsebenzi, Ukufunda izifundo Umsebenzi 
wasekhaya, Usapho, Ezolonwabo) 
 
Andinangxaki nokuzenzela izinto zesiqhelo    
Ndinazo iingxakana zokuzenzela izinto zesiqhelo    
Andikwazi kuzenzela izinto zesiqhelo    
  
Iintlungu / Ukungaziva kakuhle 
 
Andinazintlungu okanye ukungaziva kakuhle    
Ndinentlungwana okanye ukungaziva kakuhle okungephi    
Ndinentlungu ezigqithileyo okanye ukungaziva kakuhle okugqithileyo    
  
Ukuxhalaba / Ukudakumba 
 
Andinaxhala okanye andidakumbanga    
Ndibuxhalaba okanye ndibudakumba    
Ndixhalabe gqitha okanye ndidakumbe gqitha    
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P- Umhla:----------------------- A- Umhla:------------------------------- D- Umhla:  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ukunceda abantu ukuze baxele okokuba imeko yabo yempilo intle 
okanye imandundu na sizobe isikali (esifana nethemometha). Eyona 
meko entle yempilo iphawulwe ngo-100, eyona meko imandundu 
iphawulwe ngo-0. 
 
Singathanda ubonise kwesi sikali ngokoluvo lwakho ukuba impilo 
yakho intle okanye imandundu kangakanani namhlanje. Nceda wenze 
oku ngokuzoba umgca osuka ebhokisini engezantsi ukuya kulo ndawo 
esikalini ibonisa ukuba imeko yempilo yakho intle okanye imbi 
kangakanani namhlanje. 
Imeko yempilo 
yakho 
namhlanje 
Eyona meko entle 
yempilo 
onokuyiqikelela 
9 0 
8 0 
7 0 
6 0 
5 0 
4 0 
3 0 
2 0 
1 0 
100 
0 
Eyona meko 
imandundu yempilo 
onokuyiqikelela 
Eyona meko entle 
yempilo 
onokuyiqikelela 
9 0 
8 0 
7 0 
6 0 
5 0 
4 0 
3 0 
2 0 
1 0 
100 
0 
Eyona meko 
imandundu yempilo 
onokuyiqikelela 
Eyona meko entle 
yempilo 
onokuyiqikelela 
9 0 
8 0 
7 0 
6 0 
5 0 
4 0 
3 0 
2 0 
1 0 
100 
0 
Eyona meko 
imandundu yempilo 
onokuyiqikelela 
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Appendix K:  Ethics Approval Letter 
Stellenbosch University 
 
Ethics Letter 
 
 
 
23-Jun-2016 
Ethics Reference #: S15/10/232 
Title: The functional outcomes of stroke patients who are HIV positive, HIV negative and HIV 
undiagnosed, following inpatient rehabilitation: A descriptive study 
Dear Miss Tasneem Hartley, 
Your amendment request #3 dated 21 June 2016 refers. 
The Health Research Ethics Committee approved the amended documentation. 
The following amendments were approved: 
1.  Protocol version 3 dated 21 June 
2.  Consent form version 3 dated 21 June 
3.  Change of study title 
Comment: It would appear that the major problem here is with clearance at chosen study site (WCRC). It 
may be worthwhile (in future applications) to approach study sites with a draft proposal prior to application 
for Ethics approval. The site co-ordinator could give feedback and protocol adjusted prior to submission to 
Ethics. The study would then only start after Ethics approval - but at least one has had commitment from 
the study site. Requesting a letter of support from study site at time of Ethics application also places the 
study site in a position of having to deliver on the agreed protocol. 
If you have any queries or need further help, please contact the REC Oﬃce 219389819. 
Sincerely, 
REC Coordinator 
Ashleen Fortuin 
Health Research Ethics Committee 1 
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Appendix L:  Approval Letter 
Western Cape Government 
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Appendix M: Ethics Approval for extension 
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